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ABSTRACT.
The rabbit erythroid-specific lipoxygenase (RBC 15-LOX) is a 
member of a family of enzymes which catalyse the addition of molecular 
oxygen to certain polyunsaturated fatty acids. It functions in the 
inactivation and degradation of mitochondria during the final stages 
of erythroid maturation, following extrusion of the nucleus. The 
protein has been purified to homogeneity and extensively characterised 
(Rapoport et al, 1979), and both cDNA and genomic clones have recently 
been obtained (Thiele et al, 1987) . RBC 15-LOX expression shows 
several interesting features, including an erythroid-specific 
accumulation of its mRNA (Thiele et al, 1987), and translational 
inactivation of the messenger (Thiele et al, 1982) .
Data presented in this thesis includes the sequencing of the 
recently-cloned RBC 15-LOX gene in the region surrounding the ATG 
translation initiation codon, and mapping of the transcription 
initiation site to a position 28nt upstream of the ATG codon by a 
combination of primer extension and SI nuclease protection analyses. 
No transcripts arising from the available 2.7kb of sequences upstream 
of this point have been detected by Northern blot, primer extension or 
SI nuclease protection analyses. A unique mRNA sequence, matching the 
genomic sequence immediately downstream of the putative transcription 
initiation site, has been obtained by primer extension mRNA 
sequencing.
Functional analysis of 5' flanking sequences reveals two regions 
which affect transient expression of a cis-linked bacterial chloram­
phenicol acetyItransferase (CAT) reporter gene in established murine 
erythroleukaemia (MEL) and murine fibroblast cell lines. A proximal 
region within 150nt of the transcription initiation site functions as 
a promoter in both erythroid and non-erythroid cell lines, elevating 
CAT enzyme activity 7- to 8-fold above background, and can respond to 
a heterologous Friend Murine Leukaemia Virus enhancer. A distal 
region between 1.0 and 2.7kb upstream of the transcription initiation 
site confers a 6- to 8-fold cell type-specific effect upon CAT 
expression from the RBC 15-LOX promoter in the same assay system. The
xiii
proximal region contains several sequence motifs which are also seen 
in the 5' flanking sequences of a variety of other genes, including: a 
TATA-like sequence; two CACCC motifs; a GGGCGG element; and a sequence 
resembling the cognate binding site for the CTF/NF-1 family of 
transcription factors. In vitro DNasel footprinting of this proximal 
region using nuclear protein extracts from erythroid and non-erythroid 
murine cells shows protection of both the proximal CACCC sequence and 
the CTF/NF-l-like element.
Future experimental strategies for investigating a possible role 
for the regulation of transcription in the erythroid-specific 
accumulation of RBC 15-LOX mRNA are discussed. Also considered are 
aspects of the data presented here which, in conjunction with the work 
of others, may have implications for the translational inactivation of 
RBC 15-LOX transcripts, and for the evolution and structure-function 
relationships of the lipoxygenase enzyme family.
xiv
Chapter 1. 
INTRODUCTION
1.1 MECHANISMS OF GENE REGULATION IN EUKARYOTES.
During the development of eukaryotic cells, a wide variety of 
differentiated cell types is produced. The phenotype of each cell is 
the product of the genes which have been, or are being, expressed. 
Several lines of evidence, including nuclear transplantation 
experiments, cytogenetic analysis of chromosomal banding patterns and 
determination of gene copy number using molecular probes, indicate 
that, for most genes, somatic cell differentiation is not accompanied 
by any alteration in the genome (reviewed in Alberts et al, 1983) . 
The characteristic phenotypes of differentiated cell types are thus 
largely the result of differential gene expression, qualitative and 
quantitative differences in gene products being seen in each cell 
type, at different stages during differentiation, and in response to 
intra- and extra-cellular stimuli. Much attention has been devoted in 
recent years to establishing the mechanisms involved in such cell 
type-specific, stage-specific and inducible regulation of gene 
expression.
1.1.1 A variety of mechanisms for regulation of gene
expression.
The additional complexity in the cellular structure of 
eukaryotes offers additional possibilities for regulation of gene 
expression over those seen in prokaryotes. Every stage in the pathway 
of gene expression is a potential point for regulation (reviewed in 
Darnell, 1982) . Thus, as will be discussed further belowexamples are 
known where protein-coding genes are regulated at the level of 
transcription; processing, transport or stability of mRNA; translation 
of mature mRNA transcripts; and post-translational modification of 
proteins. Studies of a large number of genes have revealed that 
control at the level of transcription is an important mechnism for the 
regulation of gene expression in eukaryotes. As transcriptional 
control has been the main focus of this project, the evidence for, and 
mechanisms of, transcriptional regulation will be dealt with in 
greater detail in later sections. However, as outlined briefly below, 
an increasing number of examples are now known of control at almost
2
every other level of gene expression.
Quantitative regulation of gene expression at the level of 
transcription can be achieved either by increasing the number of 
tenplates available for transcription, as is seen in the 30-fold 
amplification of chorion protein genes during Drosophila oogenesis 
(Spradling and Mahowald, 1980) or by increasing the rate of initiation 
of transcription per DNA. template, as occurs in response to a wide 
variety of intra- and extra-cellular signals, and as will be discussed 
in detail below (Section 1.1.2) . Quantitative regulation need not 
just involve increases in the amount of gene product, however. 
Regulation of the stability of mRNAs can involve both stabilisation 
and destabilisation of mRNAs (reviewed in Raghow, 1987) . 
Stabilisation of mRNA involves a decrease in its rate of turnover, as 
seen in the 30-fold increase in half-life seen with the chicken 
vitellogenin gene in response to oestrogen (Brock and Shapiro, 1983) 
and for the 17- to 25-fold increase in casein mRNA in response to 
prolactin (Guyette et al, 1979). Conversely, Shaw and Kamen (1986) 
have demonstrated that an A/U-rich sequence from the 3' end of the 
mouse and human granulocyte/macrophage colony-stimulating factor 
(GM-CSF) mRNA, and which is similar to A/U-rich sequences seen in a 
variety of lymphokine, cytokine and proto-oncogene mRNAs, destabilises 
the rabbit [3-globin mRNA when incorporated into the 3' untranslated 
region of this mRNA. Regulation of translation can involve the 
presence of upstream AUG codons, as in the translational control of 
GCN4 mRNA (Fink, 1986), or the sequestering of mRNA as 
ribonucleoprotein particles, as occurs for a variety of maternal mRNAs 
in sea urchin and Xenopus eggs (reviewed in Hunt, 1985) .
Differential gene expression in eukaryotes also involves a 
number of qualitative regulatory mechanisms, many producing different 
products from transcription of the same gene. For example, 
comparisons of cDNA and genomic sequences have revealed that the 
initiation of transcription from alternative promoters is used to 
produce alternative transcripts in different cell types for mouse 
a-amylase (Hagenbuchle et al, 1981), the haem biosynthetic enzyme, 
porphobilinogen deaminase (PBG-D) (Grandchamp et al, 1987; Chretien et
3
al, 1988) and for human al-antitrypsin (Perlino et al, 1987) genes. 
Termination of transcription seems to be rarely used as a means of 
genearating alternative mRNAs in eukaryotes; rather, alternative forms 
of 3' processing seem to be used (reviewed in Bimstiel et al, 1985) . 
Thus, during B lymphocyte differentiation, alternative 3' cleavage and 
polyadenylation site selection events are involved in the production 
of membrane-bound and secreted forms of the immunoglobulin |l heavy 
chain (Alt et al, 1980; Rogers et al, 1980; Early et al, 1980). 
Alternative splicing can also be used to generate different mature 
mRNAs, and, therefore, different protein products, from the same 
primary transcript. This mechanism for differential expression has 
been known for some time in both DNA tumour viruses and in 
retroviruses (reviewed in Darnell, 1982), and has been recently shown 
to have a role in cell type-specific expression of the 
calcitonin/calcitonin gene-related peptide (calcitonin/CGRP) gene in 
neurons and thyroid cells (Leff et al, 1987) . Splicing is also used 
as a means of quantitative regulation of Drosophila P elements, and 
suppressor-of-white-apricot and transformer loci (Bingham et al, 
1988) . In these cases, transcription initiation is constitutive, and 
it is splicing which determines whether or not an RNA is translated. 
Another important qualitative control of gene expression is seen in 
the post-translational modification of enzymes of the glycogen 
metabolism cascade by phosphorylation (reviewed in Cohen, 1982) .
Of course, control of the expression of a particular gene may 
occur at more than one of these potential sites. For example, the 
expression of the mouse a-amylase gene from alternative promoters in 
different cell types also involves differential splicing of the 
alternative 5' sequences onto a common body of downstream sequences 
(Hagenbuchle et al, 1981), while cell type-specific expression of the 
calcitonin/CGRP gene involves alternative splice site selection which 
then determines alternative polyadenylation site utilisation (Leff et 
al, 1987).
1.1.2 Regulation of transcription initiation.
Since much of the information concerning the mechanism of
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regulation of transcription initiation has been obtained for 
transcription by RNA. Polymerase II (PollI), which transcribes
protein-coding genes, "transcription" will be considered here to refer 
to transcription by RNA Polymerase II, unless otherwise stated.
As the first step in gene expression, regulation of the rate of 
transcription initiation provides important possibilities for
quantitative control of levels of gene products in eukaryotes, even 
when subsequent steps may result in qualitatively different products 
from the same primary transcript. Evidence has been obtained in 
favour of a role for regulation of transcription in the expression of 
a variety of eukaryotic genes. So-called "nuclear run-on" 
transcription experiments, an in vitro technique in which 
previously-initiated RNA molecules are elongated in the presence of 
radio-labelled RNA precursors in isolated nuclei and the products 
hybridised with cloned DNA fragments, have been shown to accurately 
reflect transcription in vivo, as determined by pulse-labelling of
RNAs in intact cells (reviewed in Darnell et al, 1982) . Nuclear 
run-on transcription has therefore been widely used in establishing 
transcriptional control both in cell type-specific expression and in 
induced alterations in gene expression. For example, McKnight and 
Palmiter (1979) demonstrated a 20-fold increase in ovalbumin mRNA, and 
a 2- to 3-fold increase in conalbumin mRNA synthesis following 
oestrogen and progesterone treatment of chickens, while Derman et al
(1981) showed cell type-specific synthesis of a variety of RNAs in 
isolated nuclei from mouse liver, but not from mouse brain cells. 
Similar experiments, in which the DNA fragment hybridised with the in 
vitro labelled RNA comes from the very 5' end of the transcription 
unit indicate that regulation of transcription occurs at the level of 
initiation (Wilson et al, 1979).
Recent evidence suggests that the initiation of transcription is 
the final stage in a multi-step process of transcriptional activation. 
The salient points, discussed in greater depth in following sections, 
can be summarised as follows: an altered chromatin structure is 
believed to represent a pre-activation stage (Section 1.1.3) necessary 
for the following step, the binding of so-called "trans-acting"
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sequence-specific DNA-binding proteins (Section 1.3) to multiple, 
short cis-regulatory DNA. sequences (Section 1.2). The final step in 
transcriptional activation is then the association of various 
transcription factors to form a pre-initiation transcription complex 
which has a dual function in positioning RNA Polymerase on the DNA 
template ready for transcription initiation, and in maximising the 
efficiency of the initiation process.
1.1.3 Alterations in chromatin structure and transcriptional
activation.
One of the principal differences between gene regulation in 
prokaryotes and in eukaryotes concerns the conformational state of the 
genetic material. The much larger genome size of eukaryotes is 
present in a more condensed state as chromatin within the nucleus. An 
association of actively transcribed genes with alterations in 
chromatin structure has been appreciated for some time. 
Pulse-labelling of newly-synthesised transcripts in giant salivary 
gland cells of Drosophila larvae using H-undine has revealed that 
active transcription in these cells is associated with decondensed 
"chromosome puff" regions of chromatin (Bonner and Pardue, 1977). 
This relationship between transcription and chromatin structure was 
first observed at the molecular level by Weintraub and Groudine 
(1976), who observed an association of the chromatin of actively 
transcribed genes with increased sensitivity to the enzyme DNasel, 
presumed to reflect increased accessiblity of the enzyme to the DNA. 
In chick erythroblasts, the untranscribed ovalbumin gene was 
relatively insensitive to single-stranded cutting by DNasel, while a 
domain of increased DNasel sensitivity surrounded actively-transcribed 
globin genes. Within this domain, gene flanking sequences were 
intermediate in sensitivity between inactive genes and the high 
sensitivity of transcribed regions. However, within the flanking 
sequences were regions of even greater sensitivity than those of the 
transcibed region, the so-called DNasel hypersensitive sites (HSS), 
within which cuts are introduced into both strands (Stalder et al, 
1980; Wu et al, 1979).
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1.1.4 DNasel hypersensitive sites associated with regions
iinportant for transcriptional activation.
DNasel HSS have now been found in association with a wide 
variety of transcriptionally active eukaryotic cellular genes, usually 
in either 5' or 3' flanking regions (see Section 1.2) . Evidence that 
such HSS are associated with regions important for regulation of gene 
expression has been provided from studies on the Sgs4 gene of 
Drosophila, which encodes one of the pupal glue proteins. Shermoen 
and Beckendorf (1982) discovered a hierarchy of DNasel HSS upstream of 
Sgs4. Deletions of the HSS regions resulted in greatly reduced or 
completely abolished Sgs4 expression, depending upon which of the HSS 
had been deleted. Further evidence for the importance of DNasel HSS 
comes from the observation that they are frequently associated with 
regions which have been shown by deletion or mutation analysis to be 
important for regulation of transcription. For example, four of the 
nine DNasel HSS regions within 8kb of 5' flanking sequences of the 
chicken lysozyme gene have been shown by transient expression 
experiments to contain regulatory sequences having either positive or 
negative effects upon gene expression (Theisen et al, 1986; Steiner et 
al, 1987). Similarly, cell type-specific DNasel HSS are associated 
with regions which enhance transcription of genes, such as chicken 
(3-globin and immunoglobulin light chains, which are expressed in a 
cell type-specific fashion (Emerson et al, 1987; Parslow and Granner, 
1982) . Furthermore, DNasel HSS have been shown to include binding 
sites for proteins likely to be involved in transcription. For 
example, Plumb et al (1985 and 1986) have observed the in vitro 
binding of nuclear proteins to the DNasel HSS regions upstream of the 
chicken and pH-globin genes, while Kemper et_ al_ (1987) have
demonstrated protein binding to sequences within a DNAsel HSS 
immediately 5' of the chicken aP-globin gene. The same aP sequences 
are protected in both in vivo and in vitro "footprinting" assays for 
nuclear protein binding.
The altered chromatin structure indicated by increased DNasel 
sensitivity seems to be necessary but not sufficient for 
transcription. Weintraub et al (1982) demonstrated that, following
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the release of differentiation arrest upon switching to a higher 
temperature, the globin genes of chicken erythroblasts infected with 
temperature-sensitive Avian Erythroblastosis Virus showed DNasel HSS 
before the initiation of globin mRNA expression, while Groudine and 
Weintraub (1982) showed that DNasel HSS persisted for multiple cell 
divisions following the cessation of (inappropriate) transcription of 
globin genes in temperature-sensitive Rous Sarcoma Virus-infected 
chick embryo fibroblasts. This observation that altered chromatin 
conformation is not sufficient to ensure transcriptional activation 
can be ascribed to the requirement for subsequent steps, including the 
binding of transcription factors (see Section 1.3), for formation of 
an active transcription complex.
Sharp boundaries between domains of increased DNasel sensitivity 
and surrounding insensitive regions observed by Weintraub et al (1981) 
prompted the suggestion that the boundaries are defined by specific 
sequences. Evidence in favour of this has been presented by McGinnis 
et al (1983) who demonstrated that a single point mutation in one of 
the DNasel HSS regions of a naturally-occurring under-producer mutant 
resulted in a 50% reduction in expression of the Sgs4 glue protein 
gene of Drosophila. These domain boundary sequences may include 
so-called scaffold attachment regions (SARs) involved in attachment of 
DNA to the nuclear matrix and containing recognition sites for 
topoisomerase II cleavage. Gasser and Laemmli (1986) found SARs both 
5' and 3' of Drosophila aldehyde dehydrogenase, Sgs4 and fushi tarazu 
genes, and that the upstream SARs co-map with sequences required for 
enhanced expression of these genes. Furthermore, five of these SARs 
contained sequences closely related to the consensus sequence for 
topoisomerase II cleavage. Recently, the domain boundaries of the 
human (^-globin locus, some 70kb apart, have been analysed by Grosveld 
et al (1987), who have demonstrated that these regions can confer 
cell-type specific, high-level, position-independent expression of the 
human (3-globin gene in transgenic mice. Whether the sequences of such 
domain boundary sequences show any similarity with those of the SARs 
is not yet known, and it remains to be seen whether the (3-globin 
boundary sequences are conserved and can have similar effects when 
flanking other genes, or whether other genes contain distinct
sequences at their domain boundaries.
1.1.5 Mechanism of open chromatin structure formation.
The mechanism of alteration of chromatin structure as a 
pre-activation event in the regulation of transcription is uncertain 
at present. Weintraub and Groudine (1976) suggested that, as each 
newly-synthesised DNA strand is packaged into nucleosomes, altered 
chromatin structure might arise at replication. The behaviour of
looped chromatin domains, anchored to the nuclear matrix and each 
containing one or more transcription units, as independent units of 
supercoiling and replication (reviewed in Goldman, 1988) may provide a 
basis for such indirect effects of replication upon transcription. A 
model which views these independently-replicating chromatin domains as 
being units of gene regulation suggests that an open, pre-activated
chromatin structure is determined by the time of replication of a
chromatin domain (Goldman, 1988; Gottesfeld and Bloomer, 1982) . This 
model is supported by studies of the replication times of various
transcribed genes (reviewed in Goldman, 1988) which show that 
transcriptionally active genes are generally replicated early in S 
phase, while transcriptionally inactive genes are replicated later 
(e.g. Xenopus somatic and oocyte 5S rRNA genes - Guinta and Korn, 
1986). Goldman (1988) has suggested that determination of 
late-replicated genes as being inactive is not the result of late 
replication per se, but may be due to limiting amounts late in S phase 
of chromatin assembly factors required for replication in a 
transcriptionally active open chromatin conformation. However, if 
this is the case, it is still unclear what determines replication of a 
particular chromatin domain as being early or late in S phase in a 
particular cell type.
As explained above, the formation of an open chromatin 
conformation, whatever the mechanism by which it is achieved, does not 
seem to be sufficient to ensure transcription. This depends upon the 
next step in transcription activation - the formation of a 
pre-initiation transcription complex by the binding of transcription 
factors to multiple cis-acting regulatory sequences.
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1.1.6 Maintenance of an open chromatin structure: DNA
methylation.
DNasel HSS can persist through multiple cell divisions (see 
Section 1.1.4 above) . One mechanism proposed to explain this stable 
maintenance of open chromatin structure involves DNA. methylation, a 
modification of DNA known to be reproduced during DNA replication 
(Razin and Riggs, 1980) . In general, DNA methylation is associated 
with inactive genes, while expressed genes are frequently, but not 
always.hypomethylated (reviewed in Cedar, 1988; Bird, 1984). Thus, 
unmethylated copies of the human y-globin gene introduced into mouse 
fibroblast cells, in which the endogenous y-globin genes are 
methylated and transcriptionally inactive, can be transcribed, whereas 
methylated exogenous y-globins are transcriptionally inactive. 
Hypomethylated CpG-rich "islands" are associated with 
constitutively-expressed "housekeeping genes" (Bird, 1986). 
Conversely, genes expressed in a cell type-specific fashion are 
heavily methylated in non-expressing tissues, but are usually 
unmethylated in expressing tissues (reviewed in Cedar, 1988) . 
Expressing tissues seem to be capable of demethylating sequences 
required for transcription, since in vitro methylated muscle-specific 
a-actin is demethylated and expressed when introduced into myoblasts, 
but not in fibroblasts (Yisraeli et al, 1986). It is unclear at 
present, however, whether the demethylation which accompanies 
transcriptional activation in such cases is a cause or an effect of 
transcriptional activation (reviewed in Bird, 1986) . Whether 
demethylation is involved in causing activation of transcription, or 
whether it is a "passive" effect of the binding of factors required 
for transcription which also conincidentally hinder methylation (Bird, 
1986), the emerging picture seems to be that genes are "marked" as 
being transcriptionally inactive by DNA methylation, until, for 
example, transcription is activated in a cell type-specific or 
developmental stage-specific fashion, whereafter the hypomethylated 
DNA methylation pattern is maintained through subsequent cycles of 
replication.
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1.2 Cis-ACTING SEQUENCES INVOLVED IN THE REGULATION OF TRANSCRIPTION
INITIATION.
Regions of open chromatin structure likely to be important for 
the regulation of gene expression have been found in both 5' and 3' 
flanking sequences and in internal regions of genes. For example, in 
the [3-globin gene family, the human (3-globin gene locus shows DNasel 
HSS in both 5' and 3' regions, the upstream HSS at least being 
erythroid-specific (Grosveld et al, 1987) . Similarly, the 
developmentally regulated expression of the chicken adult p^-globin 
gene correlates with a developmental stage-specific DNasel HSS 
(Emerson et al, 1985), and erythroid-specific DNasel HSS are located 
in both 5' flanking sequences and within the second intron of mouse 
p-globin (Galson and Housman, 1988) . Indeed, as will be discussed 
further below, sequences important for the regulation of 
transcription, referred to as cis-acting regulatory sequences, have 
been found either in 5' flanking, 3' flanking or in intervening 
sequences. In several cases, most notably in immunoglobulin and 
globin genes, transcriptional control involves cis-acting sequences 
both 5' and 3' of the transcription initiation site (Sections 1.2.4.1 
and 1.4.2.3).
The formation of a transcription pre-initiation complex, 
following the extablishment of an open chromatin structure, can be 
summarised as involving the interaction of various transcription 
factors with multiple cis acting-sequences (reviewed in Dynan and 
Tjian, 1985; Maniatis et al, 1987). Characteristic combinations of 
cis-acting sequences thus provide a "blue-print11 for the assembly of 
the particular set of transcription factors required for initiation of 
transcription of a given gene, as will be discussed in greater depth 
in the sections which follow.
1.2.1 Modular organisation of eukaryotic promoters.
For several reasons, much of the early work in the 
investigation of regulation of transcription initiation in eukaryotes 
was directed towards the analysis of sequences immediately upstream of
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the transcription site, the so-called 5' flanking sequences. Firstly, 
intuition suggested that sequences involved in the control of 
transcription initiation are likely to affect the association of RNA 
Polymerase with DNA near the initiation site itself. Secondly, 
transcriptional control in prokaryotes provided a precedent for 
transcription regulatory signals immediately upstream of the 
transcription unit.
By analogy with prokaryotic transcription, these 5' flanking 
sequences immediately upstream of the eukaryotic transcription
initiation site, and containing sequences involved in the control of 
transcription initiation, are referred to as "promoter" regions. 
Initially, sequence elements within the promoter region likely to be 
of importance for the regulation of transcription were revealed by 
sequence comparisons between genes (Goldberg, 1979; Breathnach and 
Chambon, 1981; Efstratiadis et al, 1980) . The importance of these 
sequences has since been confirmed, and additional cis-regulatory
sequences revealed, by a variety of methods involving the generation 
in vitro of point mutations, deletions and re-arrangements of 5' 
flanking sequences followed by analysis of expression levels after the 
re-introduction of the modified genes into living cells (reviewed in
Spandidos and Wilkie, 1984a), or by analysis using in vitro
transcription systems (Manley et al, 1980).
As will be detailed in following sections, the emerging picture 
is that the promoter regions of eukaryotic protein-coding genes are 
modular (Serfling et al, 1985). There are no extended regions of 
sequence homology between promoters of unrelated genes. Rather, 
different promoters contain various combinations of multiple 
cis-acting sequences, often no more than a few nucleotides in length, 
and sometimes separated by considerable distances. Evidence obtained 
by introducing additional sequences corresponding in length to either 
full or half-tums of a DNA double helix into the repressor-binding 
operator sequences of bacteriophage lambda suggest that the spacing of 
such elements is important for efficient transcription initiation 
(Ptashne, 1986).
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In principle, a large number of regulatory possibilities can be 
achieved by the combination of a small number of such regulatory 
sequence elements, as recognised by Britten and Davidson (1969). 
Indeed, many sequence elements have been found to be associated with 
regulation of a wide variety of genes (Section 1.2.3). None of these 
sequence elements, however, have been found to be ubiquitous, and 
there would appear to be no such thing as a "typical" eukaryotic 
promoter. Nevertheless, elements of the organisation and function of 
regulatory sequences in various genes show many similarities, not just 
between eukaryotic protein-coding genes, but over an evolutionary 
range from prokaryotes, via lower eukaryotes such as yeasts, to 
primates including man (Guarente, 1988; Struhl, 1987a - see Section 
1,3,4) .
1.2.2 TATA-like boxes.
In bacteria, the promoter is the site for binding of RNA 
Polymerase, whereas, in eukaryotes it appears that RNA Polymerase does 
not itself bind DNA. Rather it is positioned relative to specific 
promoter sequences. In many genes, an A/T-rich region lying 25-3Obp 
upstream of the transcription initiation site, and typified by the 
so-called "TATA" or Goldberg-Hogness box first identified in 
Drosophila histone genes (Goldberg, 1979; Breathnach and Chambon, 
1981), appears to serve the positioning or "selector" function for RNA 
Polymerase II. Experiments in which the TATA boxes of SV40 early and 
sea urchin histone H2A genes were deleted and re-introduced into 
living cells, in contrast to results obtained using in vitro 
transcription systems, did not abolish transcription, but resulted in 
lower levels of "ragged" initiation of transcription at multiple sites 
(Grosschedl and Bimstiel, 1980; Benoist and Chambon, 1981; Ghosh et 
al, 1981) . Point mutations of the 5' flanking regions of (3-globin 
genes have since confirmed that mutation of a similar TATA-like region 
results in a 2- to 5-fold decrease in levels of transcription, as well 
as affecting the site of initiation (Dierks et al, 1983; Myers et al, 
1986) . In this respect, the function of the TATA box differs from 
that of the bacterial Pribnow box, of similar sequence, in that 
deletion of the Pribnow box completely abolishes transcription
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(Grosschedl and Bimstiel, 1980; Miller, 1978) .
Not all eukaryotic genes contain the "canonical" TATA sequence;
rather, for many genes, an A/T-rich region seems to serve the
positioning function. For example, many mammalian globin promoter 
regions contain a conserved A/T-rich sequence (Efstratiadis, 1980) at 
a similar distance from the transcription initiaition site to that of 
the TATA box in other genes, suggesting a similar function for this 
region in determining the position of transcription initiation. 
Indeed, in vitro point mutagenesis of this region of the rabbit and 
mouse p-globin genes have revealed that this region is of importance 
for accurate and efficient transcription (Dierks et al, 1983; Myers 
et al, 1986). The promoter regions of some other genes completely 
lack any similarity to a TATA-like sequence. These genes have 
G/C-rich promoters, and often encode gene products expressed in all 
cell types at all times - so-called "housekeeping" genes (Dynan,
1986). In these genes, other elements, or combinations of elements, 
are presumed to govern the positioning of RNA Polymerase.
1.2.3 Upstream promoter elements.
The quantitative efficiency of transcription initiation is
now known to be regulated by a wide variety of cis-acting sequence 
elements (Wingender, 1988) . Such sequences are analogous to the 
operator sequences of prokaryotic promoters, being involved in up- or 
down-regulation of the rate of transcription initiation, and have been 
referred to as "modulator" sequences (Grosschedl and Bimstiel, 1980) . 
These sequences are frequently found close to the transcription 
initiation site, but further upstream than the A/T-rich region, and 
are consequently frequently referred to as upstream promoter elements.
Some upstream promoter elements are found in a wide variety of 
genes. For example, the CCAAT sequence, first noticed upstream of 
ovalbumin genes (Benoist et al, 1980), is also found in the promoters 
of many eukaryotic genes, including mammalian globin genes, sea urchin 
histone genes and the Herpes Simplex viral thymidine kinase gene 
(Efstratiadis et al, 1980; Barberis et al, 1987; McKnight and Tjian,
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1986). Similarly the so-called G/C-box, GGGCGG, which was originally 
identified in the 21bp repeats of the SV40 viral Early promoter, is 
present in a variety of eukaryotic genes (reviewed in Dynan and Tjian, 
1985; Kadonaga et al, 1986) . These sequences are consequently often 
referred to as "general" or "constitutive" cis-acting elements and 
have important roles in the formation of the transcription 
pre-initiation complex, but not necessarily in the modulation of 
transcription in different cell types, at different stages of 
differentiation or development, or in response to cellular or external 
stimuli. Such functions seem to be due to other "specific" or 
"regulatory" sequences restricted to the promoter regions of single 
genes or families of genes whose gene expression shows characteristic 
regulatory features (Serfling et al, 1985). For example, the octamer 
motif of immunoglobulin genes, when linked to a minimal mouse renin-1 
promoter retaining only sequences downstream of the TATA box, is 
sufficient to confer lymphoid cell-specific expression when introduced 
into lymphoid and fibroblast cell lines (Dreyfus et al, 1987) .
Both general and specific cis-acting elements are frequently 
found in multiple copies within promoter regions. For example, the 
SV40 early promoter contains 6 copies of the G/C-box GGGCGG sequence 
within its three 21bp repeats, while the H2B-1 sperm histone gene of 
sea urchins contains two CCAAT motifs (Barberis et al, 1987), and most 
of the heat shock gene promoters studied in a variety of species 
contain multiple copies of the so-called heat shock element (HSE) 
unique to heat shock genes (Pelham, 1985).
In addition to genes possessing multiple copies of the same 
regulatory sequence, the organisation of many promoters is "modular", 
containing combinations of cis-acting sequences: some "specific" to a 
single gene or small sub-set of genes, others "general" elements of 
widespread occurrence (reviewed in Serfling et al, 1985). 5' flanking
sequences of the human metallothionein IIA gene, for example, contain 
several different types of cis-acting elements, including TATA and G/C 
boxes, a glucocorticoid response element (GRE) also found in steroid 
hormone-responsive genes, an AP-1 protein-binding site also seen in a 
variety of genes, including SV40 and human collagenase regulatory
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sequences, and several copies of a so-called metal-response element
(MRE) (Lee et al, 1987a and b).
1.2.4 Enhancers.
A third class of cis-acting sequences, known as enhancers, 
serve an important role in quantitative regulation of transcription 
initiation. Enhancers are capable of greatly elevating transcription 
from a linked gene, including genes transcribed from a heterologous 
promoter, in an orientation- and position-independent fashion, from 
either 5' or 3' of the gene body and often over large distances
(Banerji et al, 1981; Serfling et al, 1985). Originally identified in
viruses, many sequences from cellular genes which show similar 
properties have now been identified (see Harrison, 1988 for a recent 
review) and sequence homologies between certain cellular and viral 
enhancers have been observed. For example, Goodboum et al (1986)
observed homology between portions of the human (3-interferon enhancer, 
revealed by deletion studies to be capable of acting as a strong 
constitutive transcription element, and sequences within Adenovirus 
Ela, Polyoma, Cauliflower Mosaic Virus and SV40 viral enhancers. The 
homology with the SV40 enhancer "core" sequence is also seen in the 
immunoglobulin heavy chain enhancer.
Cellular genes containing enhancers include those encoding
enzymes such as rat elastase and chicken lysozyme (Hammer et al, 1987; 
Theisen et al, 1986; Steiner et al, 1987); hormones and growth factors 
such as insulin and interleukin-2 (Walker et al, 1983; Fujita et al,
1986); structural molecules such as mouse (X2 collagen (Rossi and de
Crombrugghe, 1987); nuclear histone proteins (Trainor et al, 1986); a- 
and (3-globin genes (Choi and Engel, 1986; Antoniou et al, 1988); and 
components of the immune system such as complement Ffactor B, 
immunoglobulins and the T cell receptor (3-chain (Wu et al, 1987; 
Banerji et al, 1983; Queen and Baltimore, 1983; Gillies et al, 1983; 
Krimpenfort et al, 1988).
Like upstream promoter elements, enhancers have been
classified according to their function, as "general" and "specific"
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(or "regulated"), depending upon the range of circumstances in which 
they exert their effects upon transcription. Thus, some enhancers, 
such as the archetypal SV40 enhancer, function equally well in a 
variety of cell types; others, such as that of polyoma virus or the 
cellular immunoglobulin enhancer, produce cell type-specific effects 
on transcription (see Serf ling et al, 1985; Maniatis et al, 1987 for 
recent reviews).
1.2.4.1 3' enhancers.
Enhancers are capable of functioning in a largely 
position-independent fashion. For example, the SV40 72bp repeats 
enhance transcription of a linked rabbit (^-globin gene in HeLa cells 
when artificially placed 3.3kb downstream of the globin transcription 
initiation site as well as from 1.4kb upstream (Banerji et al, 1981) . 
Enhancers positioned downstream of the transcription initiation site 
have now been identified in natural ly-ocurring situations: in
immunoglobulin heavy chain genes (Queen and Baltimore, 1983; Gillies 
et al, 1983; Baner ji et al, 1983) and mouse 0c2 (type I) collagen 
(Rossi and deCrombrugghe, 1987) genes, for example, where they are 
located in an intron; and in globin (Choi and Engel, 1986; Hesse et 
al, 1986; Emerson et al, 1987; Kollias et al, 1987,-Bodine and Ley,
1987), chicken histone H5 (Trainor et al, 1987) and human T cell 
receptor (3-chain (Krimpenfort et al, 1988) genes, where the enhancers 
lie beyond the 3' end of the transcription unit.
1.2.4.2 Mechanism of action of enhancers.
Enhancers function by increasing the frequencey of correct 
initiation of transcripts, increasing the density of RNA. Polymerase 
molecules as demonstrated by nuclear run-on transcription experiments 
in which transient expression of globin genes in HeLa cell nuclei 
resulted in increased levels of newly-initiated globin transcripts in 
the presence of the SV40 viral enhancer (Weber and Schaffner, 1985; 
Treisman and Maniatis, 1985) . The mechanism by which enhancers 
function is still unclear, however. Various models of enhancer 
function have been suggested, proposing a role either in the
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pre-activation stage or in the formation of the transcription complex 
itself. Enhancers have been seen as entry sites for the ENA 
Polymerase molecule or other components of the transcription apparatus 
on the basis that the enhancer's effect is often greatest on the most 
proximal promoter (Wasylyk et al, 1983). This model envisages that 
ENA Polymerase would then be positioned at the transcription 
initiation site either by sliding along the DNA template until 
encountering a positioning factor such as a TATA-binding protein, or 
by looping out of DNA (Ptashne, 1986) .
Other models suggest a role for enhancers in establishing an 
active, potentially-transcribable chromatin structure. Enhancers 
might be thought of as acting as "organiser" sites for alteration of 
chromatin topology or assignment of a given gene to a particular 
"nuclear address". These ideas are supported by the observation that 
enhancers are frequently associated with cell type-specific DNasel 
HSS, as in the cases of the chicken adult |$-globin, chicken lysozyme 
and mouse immunoglobulin kappa chain enhancers (Emerson et al, 1987; 
Theisen et al, 1986; Parslow and Granner, 1982). The observation that 
iinmunoglobulin genes can retain transcriptional activity even 
following the loss of their enhancer during the gene rearrangements 
which accompany B lymphocyte differentiation suggest that enhancers 
are required for establishment, but not maintenance, of an active 
transcription complex (Serfling et al, 1985).
1.2.4.3 Modular structure of enhancers.
Enhancers, like promoters, have modular structures. For 
example, in vivo studies of deletions of the SV40 enhancer have shown
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that it has a domain structure, confining multiple sequence elements 
(Zenke et al, 1986; Herr and Clarke, 1986). Furthermore, in vitro 
binding of nuclear proteins to enhancers shows protection of several 
sequence motifs against DNasel digestion. For example, multiple cell 
type-specific or developmental stage-specific factors protect at least 
five discrete regions in the chicken adult (3-globin 3' enhancer 
(Emerson et al, 1987). It has been suggested that the elements of an 
enhancer are themselves bi-partite, being composed of so-called
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enhansons (Ondek et al, 1988).
The modular structure of both promoters and enhancers serves to 
emphasise that the classification of cis-regulaory sequences using 
terminology such as upstream promoter elements and enhancers is 
somewhat artificial, and serves mainly to provide a conceptual 
framework for model-building. There is an increasing blurring of 
functional distinctions between upstream promoter elements and 
enhancers as envisaged by this type of classification (Serfling et al,
1985). For example, a single copy of the Drosophila hsp70 heat shock 
element, regarded as a "typical" upstream promoter element, has little 
effect upon transcription of a linked human (3-globin gene, but two 
copies behave as a strong heat-inducible enhancer (Bienz and Pelham,
1986). Further evidence of a functional homology between both 
promoter and enhancer elements comes from immunoglobulin genes, where 
the same octamer sequence is found in both promoter and enhancer 
regions of the immunoglobulin heavy chain gene (Falkner and Zachau, 
1984; Parslow et al, 1984) . This may well be the basis for the 
synergism of function observed between immunoglobulin promoters and 
enhancers (Garcia et al, 1986) where the immunoglobulin enhancer has a 
greater effect upon the homologous immunoglobulin promoter than on 
heterologous cis-linked promoters. The functional homology of modules 
of promoters and enhancers is the basis for the suggestion made by 
Ondek et al (1988) that modules of regulatory sequences ("enhansons") 
can be used in novel combinations to produce new enhancers.
The essential point to be made here is that modular sequence 
motifs, whether components of promoters or enhancers, act as binding 
sites for sequence-specific DNA-binding transcription factors and that 
characteristic combinations of cis-acting sequences and transcription 
factors are employed in the formation of an activated transcription 
complex for a particular gene.
1.3 TRANSCRIPTION FACTORS.
All the transcription factors identified to date are proteins 
(including the products of several nuclear proto-oncogenes such as
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c-jun and c-fos, which are now being discovered to have probable 
functions in the initiation of transcription - Bohmann et al, 1987; 
Chiu et al, 1988; Sassone-Corsi et al, 1988); but there is no reason, 
in principle, to expect that all will prove to be so.
Most of the transcription factor proteins identified thus far 
have DNA-binding activity, as has been demonstrated by " footprinting" 
and electrophoretic mobility shift assays using nuclear protein 
extracts containing mixtures of transcription factors. Exceptions, 
however, include the GAL80 protein of yeast, which inhibits the 
transcriptional activation function of another transcription factor, 
GAL4, by interacting with its C-terminal region (Ma and Ptashne, 
1987b) and, probably, the product of the c-fos proto-oncogene, which 
interacts with the c-jun product, the transcription factor AP-1 in
stimulating transcription (Chiu et al, 1988; Sassone-Corsi et al,
1988). Such transcription factors illustrate the principle that 
protein-protein, as well as DNA-protein interactions, play a vital 
role in the formation of a pre-initiation complex (Sigler, 1988). The 
role of some transcription factors may thus be to mediate indirect 
interactions between other components of the transcription complex 
(between two DNA-binding factors, or between a DNA-binding protein and 
ENA Polymerase, for example).
In contrast to these heterologous protein-protein interactions, 
other transcription factor combinations consist of homologous 
sub-units. Various eukaryotic DNA-binding transcription factors, like 
those in prokaryotic systems, bind to their cognate sequences as 
dimers - the yeast transcription factor GCN4 (Hope and Struhl, 1987), 
and a cAMP-response element-binding (CREB) protein which binds to the
CAMP response element of the rat somatostatin gene, for example
(Yamomoto et al, 1988).
1.3.1 Positively-acting transcription factors.
Most of the transcription factors characterised to date 
function in the activation of transcription, as has been demonstrated 
by analysis of expression from reporter genes driven by promoters
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which include transcription factor recognition sequences, either by 
addition of purified proteins to in vitro transcription systems, or by 
expression of cDNA clones in cells in vivo.
Many DNA-binding factors show precise sequence recognition. For 
example, the transcription factor AP-1 protects the same sequence 
(TGACTCA) in in vitro DNasel footprint ing experiments on SV40, 
metallothionein and collagenase promoters (Lee et al, 1987b). Yet the 
adenovirus transcription factor, ATF, recognises a sequence which 
differs by only one nucleotide from that recognised by AP-1 (Hurst and 
Jones, 1987). Such subtle differences in sequence specificity are 
reminiscent of the sequence specificity of DNA-binding proteins in 
prokaryotes, the restriction endonucleases. Not all transcription 
factors show absolute specificity for the sequences to which they 
bind, however. For example, a single yeast trans-activator, HAP1, 
appears to bind to different sequences in the CYC1 and CYC7 promoter 
regions (Pfeifer et al, 1987b). Conversely, not all cis-acting 
sequences act as recognition sites for only a single transcription 
factor. The same yeast CYC1 gene promoter sequence appears to be 
bound by two different transcription factors, HAP1 and RC2 (Pfeifer et 
al, 1987a).
A similar situation is seen in higher eukaryotes, where there 
appear to be a family of transcription factors capable of binding to 
sequences which include the CCAAT sequence found in a variety of 
eukaryotic promoters (Santoro et al, 1988; Chodosh et al, 1988a, b; 
Barberis et al, 1987; Dorn et al, 1987). Within this family, cDNA 
cloning has revealed that several different forms of the CTF/NF-1 
transcription factor are generated by alternative splicing of a single 
gene (Santoro et al, 1988) . The interaction of various members of the 
family with their appropriate recognition sequences seem to be subtly 
different, methylation interference analyses indicating that different 
residues are important for sequence recognition by the transcription 
factors CPI, CP2 and CTF/NF-1 (Chodosh et al, 1988b) . Furthermore, 
these three show widely different affinities for each other's extended 
recognition sequences, as determined by mobility shift assays in the 
presence of competitor oligonucleotides, suggesting that DNA sequences
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on either side of the common CCAAT recognition sequence may also be 
involved in protein binding (Chodosh et al, 1988b) .
Regulation of the activity of transcription factors is thought 
to be involved in cell type-specific, stage-specific and inducible 
regulation of gene expression. For example, recognition sequences in 
certain genes are bound in vitro by nuclear proteins only from cells 
of a particular type or at a particular stage of differentiation. 
Such differential DNA-binding activities might result from 
differences in the expression of the transcription factor itself, or 
to a modulation of its binding activity which allows it to bind to its 
recognition sequence in certain situations or cell types, but not in 
others. The appearance of DNA-binding activity of several 
transcription factors including the differentiation stage-specific 
induction of binding of transcription factor NF-kB to immunoglobulin 
gene regulatory sequences (Sen and Baltimore, 1986), has been found to 
be unaffected by inhibitors of new protein synthesis such as 
cycloheximide. This suggests that binding activity arises by 
modification of a pre-existing protein. The post-translational 
modification event might involve a covalent modification or a 
non-covalent interaction, either with a regulating ligand or with 
other essential components of the transcription complex. A situation 
in which transcription is altered by a covalent post-translational 
modification of an inactive, pre-existing factor is seen with the cAMP 
response element-binding (CREB) protein mentioned earlier, which binds 
its cognate sequence as a dimer. Phosphorylation of CREB in response 
to cAMP appears to be necessary for the activation of transcription in 
vivo (Montminy and Belizikjian, 1987) . An explanation of this may be 
provided by the observation that dimerisation and DNA binding activity 
in vitro are reduced by dephosphorylation (Yamomoto et al, 1988) .
1.3.2 Negative_______ regulation______ and_______ negat ively-act ing
transcription factors.
An increasing number of cis-acting sequences involved in 
negative regulation of transcription have recently been identified in 
a wide variety of eukaryotic genes (reviewed in Harrison, 1988) . One
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of the most intensively studied examples is the negative regulation of 
the yeast mating type HMR and HML loci. These loci contain 
transcriptionally inactive copies of the a and a mating type alleles, 
respectively. Either allele, when moved to the MAT locus by a 
recombination event which occurs almost every cell division, becomes 
transcriptionally active, resulting in a switch from a to a mating 
phenotypes, or vice versa (reviewed in Miller et al, 1985; Brent,
1985) . In studies of the mechanism by which the mating type alleles 
at HML and HMR are maintained in a transcriptionally "silent" state, 
Brand et al (1985) discovered a cis-acting "silencer" sequence 
element, HMRE, which shows similar properties to those of an enhancer, 
but acting to inhibit rather than to enhance transcription i.e. the 
silencer can function at a distance, in an orientation- and 
position-independent fashion. A "dehancer" region upstream of the PI 
promoter of the c-myc gene appears to act in an analogous fashion, 
being capable of exerting a negative regulatory effect at a distance, 
from either 5' or 3' of the transcription initiation site, in either 
orientation, and can also exert its negative effect upon a 
heterologous promoter (Remmers et al, 1986).
Negative regulation of this sort may be involved in the 
regulation of gene expression during differentiation. Somatic cell 
fusion experiments involving fusion of differentiated with 
undifferentiated cell types can result in the "extinction" of genes 
expresssed in a cell type-specific fashion which are characteristic of 
the differentiated state. Although the mechanisms by which extinction 
occurs are still unclear, the use of segregating inter-species hybrids 
has allowed the identification of chromosomes bearing genes encoding 
the factors involved in extinction. For example, genes involved in 
extinction of liver-specific tyrosine aminotransferase and albumin 
genes have been localised to mouse chromosomes 11 and 3 respectively 
(Killary and Fournier, 1984; Petit et al, 1986).
Transcription factors involved in negative regulation have long 
been recognised in prokaryotic systems. The most extensively studied 
have been the lac repressor of Eschericia coli (Miller, 1978) and the 
lambda (cl) and cro repressors of bacteriophage lambda (Ptashne,
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1986) . These act by binding to DNA. in a sequence-specific fashion, 
preventing access of RNA Polymerase, and thereby inhibiting the 
initiation of transcription. (Lambda repressor, however, shows the 
unusual property of being able to act as both a repressor and as an 
activator of transcription, having different effects upon 
transcription of genes on either side of its binding site - reviewed 
in Ptashne, 1986)).
In some cases of negative regulation in eukaryotes, DNA-binding 
proteins analogous to prokaryotic repressors appear to be involved. 
One example is that of the human |3-interferon gene. Goodboum et al 
(1986) demonstrated that the inducible enhancer located between 77 and 
36nt upstream of the transcription initiation site consists of two 
regions. Deletion of the more 3' region resulted in constitutive 
high-level expression of (3-interferon mRNA in the absence of the viral 
or double-stranded RNA inducers which are normally required for 
activation of transcription. It thus seems that the 3' half of the 
element of the enhancer negatively regulates transcription from the 
constitutive 5' portion, except in the presence of inducers. In vivo 
footprinting of this region of the (3-interferon gene (Zinn and 
Maniatis, 1986) show that a factor bound to the negative regulatory 
region of the enhancer dissociates upon induction, followed by binding 
of another factor to the constitutive region - a situation 
reminiscent of repressor action in prokaryotes. Similarly, binding of 
a so-called CCAAT displacement protein (CDP) to sequences overlapping 
the more proximal of two CCAAT motifs in the 5' flanking region of the 
sea urchin sperm histone H2B-1 gene prevents binding of a 
CCAAT-binding protein in the embryo, where the H2B gene is not 
expressed (Barberis et al, 1987).
Intriguingly, recent studies of protein-binding to the HMRE 
element involved in silencing of the yeast mating type HMR locus have 
resulted in the cloning of the gene encoding a transcription factor, 
RAP1, which appears to be involved in the regulation of a variety of 
genes in addition to the HMR locus, functioning as either a repressor 
or as an activator of transcription depending upon the context of its 
binding site (Shore and Nasmyth, 1987) .
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1.3.3 Structure of transcription factors.
A substantial number of eukaryotic transcription factors have 
been purified (Rosenfeld and Kelly, 1986; Jones et al, 1987; Briggs et 
al, 1986; Kadonaga and Tjian, 1986; Lee et al, 1987b) and an
increasing number are being cloned, including a factor, Spl, which 
binds to the GGGCGG box (Kadonaga et al, 1987), a family of 
CCAAT-binding proteins (Santoro et al, 1988) and various steroid 
hormone receptors (reviewed in Maniatis et al, 1987) . The
availability of structural information concerning transcription 
factors, and especially those involved in transcriptional regulation 
in yeast, are beginning to provide insights into the interactions 
involved in the transcription pre-initiation complex. Furthermore, 
comparisons of the structures of these factors further suggest an
evolutionary conservation of elements of the transcriptional apparatus 
(see Section 1.3.4 below).
Many of the transcription factor proteins characterised show 
similar structural characteristics, consisting of multiple domains
which can function independently of one another. This structural 
feature probably has a functional basis. Unlike bacterial repressors, 
where the function of the protein is merely to exclude the binding of 
another protein, eukaryotic transcriptional activators must interact 
with other components of the transcription complex in order to 
activate transcription. As discussed earlier, protein-protein 
interactions, as well as sequence-specific DNA-binding, are important 
in the formation of the transcription pre-initiation complex. Recent 
studies have begun to provide information concerning the structures 
both of regions of transcription factors involved in DNA-binding and 
of regions important for protein-protein interactions.
1.3.3.1 Activation domains.
The yeast transcription factors GAL4 and GCN4, each involved 
in the co-ordinate regulation of a number of metabolic enzymes 
(Giniger et al, 1985; Hill et al, 1986 and references therein), have
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both been shorn to contain functionally-independent DNA-binding and 
activation domains (Brent and Ptashne, 1985; Hope and Struhl, 1986). 
Functional dissection experiments, involving progressive deletions of 
coding portions of the respective GAL4 and GCN4 genes, have revealed 
that the analogous functional regions are located in different 
portions of the two proteins - the activation domain of GCN4 lies in 
the middle portion of the protein (Hope and Struhl, 1986), while that 
of GAL4 is near the C-terminus (Brent and Ptashne, 1985) . In the 
absence of the activation domain, DNA-binding activity is retained, 
but activation of transcription cannot occur. Furthermore, the 
expression of artificially-constructed fusion proteins in which the 
activation domains of either trans-activator are fused to the 
DNA-binding region of the bacterial lexA repressor protein, results in 
the activation of transcription from reporter genes whose promoters 
contain the recognition sequence for the lexA protein (Brent and 
Ptashne, 1985; Hope and Struhl, 1986), demonstrating that the 
DNA-binding and activation domains are functionally independent. This 
functional independence of DNA-binding and activation domains would 
seem to suggest that there is no conformational signalling process 
between the two domains necessary to activate the function of the 
activation domain following DNA binding.
Characterisation of the activation domains of GAL4 and GCN4 has 
not revealed any similarities in the primary sequence other than a 
preponderance of acidic residues. Mutations of the activating region 
of GAL4 which increased the activation of transcription all involved 
increases in the acidity of this region (Gill and Ptashne, 1987). It 
seems that almost any acidic region will suffice - Ma and Ptashne 
(1987b) observed that the expression of fusion proteins containing the 
DNA-binding domain of GAL4 and random polypeptides encoded by E. coli 
DNA fragments resulted in transcription activation. Each of the 
activating bacterial sequences were found to contain an excess of 
acidic residues. Hence, it would seem that the negative charge of 
such regions, rather than any particular protein conformation, as 
defined by primary sequence, is important for the activation function. 
It has been suggested that these activator domains, referred to as 
"acid blobs" or "negative noodles", function by making non-covalent
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protein-protein interactions with basic or hydrophilic regions of 
other components of the transcription complexes, including perhaps the 
C-terminal repeat domain of RNA. Polymerase II (reviewed in Sigler,
1988). This kind of "molecular imprecision" may allow the interaction 
of RNA Polymerase II with the wide variety of transcription complex 
components necessary for transcription of all the genes expressed in a 
cell.
Functionally-distinct domains are also seen in the case of the 
steroid receptor family of transcription factors in which DNA-binding 
and transcription activation domains within the N-terminal half of the 
hormone receptor molecule are separated from the hormone-binding 
domain by a "molecular hinge" (reviewed in Maniatis et al, 1987) . 
This modular design of transcription activator proteins and the 
ability to form functional trans-activators by fusing regions of 
transcription factors from widely-diverged species, may reflect the 
evolution of transcription factors by the assembly of multi-functional 
proteins from various combinations of protein domains by 
"exon-shuffling", as has been suggested to be the case for the 
evolution of other proteins (Blake, 1978).
1.3.3.2 DNA-binding domains.
In contrast to the activator domains discussed above, 
DNA-binding domains of eukaryotic transcription factors contain 
relatively well-defined structural motifs. Thus far, only a very few 
such motifs have been identified. The same motif is frequently seen 
in transcription factors from widely-diverged species, and involved in 
the regulation of widely different classes of genes. For example, the 
DNA-binding domains of the steroid receptor family of transcription 
factors contain a peptide sequence similar to a so-called "zinc 
finger" motif first identified in the repeating units of the RNA 
Polymerase III transcription factor, TFIIIA (Miller et al, 1985; Brown 
et al, 1985) . This motif has been suggested to exist as a loop 
projecting from the protein suface, held in place by co-ordination of 
a zinc ion at the base of the loop, and capable of interacting 
directly with DNA. Similar protein sequence motifs, including several
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containing two pairs of cysteine residues rather than the pair of 
cysteines and pair of histidines seen in TFIIIA, have now been 
recognised in protein sequences predicted by cloned cDNAs of a wide 
variety of transcription factors, including Spl (Kadonaga et al,
1987), the mammalian testis-determining factor (Page et al, 1987), 
Xfin of Xenopus (Ruiz i Altaba et al, 1987), and the product of a 
developmental regulatory gene, Kruppel, in Drosophila (Preiss et al, 
1985; Rosenberg et al, 1986). Not all of these, however, have been 
proven to contain co-ordinated zinc ions (reviewed in Klug and Rhodes,
1987).
Prior to the discovery of this large family of zinc-finger 
proteins, the only motif identified as being involved in DNA binding 
was the so-called "helix-loop-helix" motif first recognised in 
bacterial repressors (reviewed in Pabo and Sauer, 1984). This motif, 
too, has since been found in DNA-binding proteins from widely-diverged 
organisms, including the homoeobox domain of insect and mammalian 
developmental genes (Laughon and Scott, 1984), and a factor involved 
in the determination of yeast mating type (Shepherd et al, 1984) .
Recently, Landschulz et al (1988) have suggested that a periodic 
repetition of leucine residues, present in transcription factors 
CCAAT/enhancer-binding protein (C/EBP) and GCN4, and the products of 
c-jun, c-fos and c-myc proto-oncogenes, may be of importance in 
protein-protein interactions essential for DNA-binding. Such a 
"leucine zipper" is suggested to be involved in the formation of 
dimers between pairs of transcription factors by interdigitation of 
leucine residues projecting from one face of an a-helical region of 
each transcription factor protein. Although evidence is beginning to 
accumulate in favour of this suggestion (Marx, 1988), such a motif has 
not yet been conclusively demonstrated to play a major role in 
transcription activation. Nevertheless, an emerging feature of the 
mechanism by which transcription initiation is achieved seems to be 
that a limited number of DNA-binding protein structures are shared by 
families of proteins from widely-diverged evolutionary backgrounds.
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1.3.4 An evolutionary relationship of components of the
transcription pre-initiation complex.
Mention has already been made of various "families" of
transcription factors: either families which share common structural
motifs, such as the zinc finger proteins (Section 1.3.3.2); or 
families recognising a common sequence element, such as the 
CCAAT-binding proteins (Section 1.3.1). Each of these families has 
representative members found in a range of species. A particularly 
notable cross-species relationship concerns the GCN4 transcription 
factor of yeast, and the product of the avian c-jun proto-oncogene, 
which probably encodes a homologue of the mammalian transcription 
factor AP-1 (Bohmann et al, 1987) . The protein product encoded by the 
c-jun proto-oncogene shows homology with the DNA-binding domain of
GCN4 (Vogt et al, 1987), can bind to the recognition sequence of GCN4, 
and can activate transcription in yeast cells when its DNA-binding 
domain is fused to the GCN4 activator domain (Struhl, 1987b).
The organisation of cis-regulatory elements of yeast genes and 
of higher eukaryotes also show several similarities including the 
presence of TATA-like sequences. More importantly, there seem to be 
several functional similarities between the upstream activator 
sequence (UAS) elements of yeast genes, and enhancers of higher 
eukaryotes, both classes of element being capable of functioning in 
both orientations and in various positions relative to the
transcription initiation site and to other cis-acting sequences
(reviewed by Guarente, 1988; and by Struhl, 1987a) .
There is also now mounting evidence of a functional homology 
between yeast and mammalian transcription factors. The yeast 
transcription factor GAL4 can activate transcription of several 
chimaeric promoters containing a GAL4 recognition sequence (including 
a minimal promoter containing only a TATA box in addition to the GAL4 
sequence) when expressed in mammalian (human HeLa or Chinese hamster 
ovary) cells (Webster et al, 1988; Kakidani et al, 1988) . 
Furthermore, the activation domains of GAL4 and GCN4 can activate 
transcription from a promoter containing a mammalian homone response
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element when expressed as chimaeric fusion proteins containing the 
DNA-binding domain of the human oestrogen receptor (Webster et al,
1988), suggesting a conservation of the mechanism of transcription 
activation between yeast and mammals. Similarly, the human oestrogen 
receptor can function in a hormone-dependent manner in yeast cells 
(Metzger et al, 1988) . Furthermore, Chodosh et al (1988b) have 
demonstrated functional complementarity of sub-units of yeast and 
human CCAAT-binding proteins, while Buratowski et al (1988) and
Cavallani et al (1988) have shown that a yeast protein can substitute 
for a human TATA-binding protein in vivo and in vitro. Thus, it seems 
that not just the mechanism of activation of transcription, but more 
than one of the so-called "general" transcription factors involved in 
transcription initiation have been conserved between yeasts and
mammals.
The proposition that the overall mechanism of transcription 
initiation may have been conserved over large periods of evolutionary 
time is supported by the homology between the large subunit of RNA 
Polymerase II molecules from yeast, mouse and Drosophila (Allison et 
al, 1985; Corden et al, 1985; Briggs et al, 1985). This homology 
includes a region of multiple heptamer repeats at the C-terminus,
which contains a very large proportion of hydrophilic amino acids. 
These have been suggested to interact with the acidic regions of 
activation domains in the formation of a transcription pre-initiation 
complex (Sigler, 1988), though there is, as yet, no firm evidence in 
favour of this. The C-terminal repeat is not seen in the RNA 
Polymerase of E. coli. There is, however, homology of the eukaryotic 
RNA Polymerase II molecules with the (3-subunit of the prokaryotic
enzyme (Allison et al, 1985).
A common ancestry of eukaryotic RNA Polymerases may also be 
suggested by the homology between the largest subunits of yeast RNA 
Polymerases II and III (Allison et al, 1985) . However, there are 
differences between the arrangement of cis-regulatory sequences in 
some of the genes transcribed by these two polymerases, suggesting 
that other components of the transcription complex involving these 
polymerases may be different. For example, 5S rRNA genes contain an
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internal regulatory element (IRE) within the transcription unit, 
rather than in 5' flanking sequences (Sakonju et al, 1980) for binding 
by TFIIIA. Nevertheless, regulatory elements for PolIII transcription 
also reside upstream of the transcription initiation site, and there 
is increasing evidence of structural and functional similarities 
between the promoters of PolII and PolIII genes (reviewed in 
Sollner-Webb, 1988) including the discovery of the importance of a 
TATA-like sequence for in vitro transcription by RNA Polymerase III of 
the gene encoding human 7SK RNA, a stable nuclear RNA of unknown 
function (Murphy et al, 1987), and the presence of two copies of the 
immunoglobulin octamer in the Xenopus U6 snRNA promoter (Carbon et al,
1987). Thus, different eukaryotic RNA Polymerases may use common 
transcription factors. Furthermore, it appears that both RNA 
Polymerase II and III can initiate transcription of the first exon of 
c-myc in vitro (Chung et al, 1987) and that, when transfected into 
cells of another species, rRNA genes, normally transcribed by Poll, 
can be transcribed by Pol 11 (Jordan, 1987) . Not all RNA Polymerases 
seem to have the same origin, however. The highly homologous RNA 
Polymerases of yeast mitochondria and of T3 and T7 bacteriophages do 
not show any homology with the E. coli RNA Polymerase sub-units 
(Masters et al, 1987).
1.4 GENE REGULATION IN ERYTHROID CELLS.
One of the greatest challenges facing modem biology is the 
understanding of how gene expression is regulated during development. 
The unicellular zygote is totipotent, containing, either within its 
genome or as maternally-derived molecules, the whole range of 
developmental programmes required to produce the wide range of cell 
types of the adult organism. Development involves processes of 
cellular proliferation and differentiation. The emerging picture from 
studies of differentiation in a wide range of organisms, including 
nematode worms, sea urchins, the fruit-fly Drosophila and various 
mammalian tissues, is that differentiation involves a hierarchy of 
cells with increasingly restricted developmental potential, as cells 
proceed towards terminal differentiation. Terminally differentiated 
cells can be distinguished by their characteristic phenotypes, which
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are the product of the combinations of genes which are, or have been, 
expressed in that cell type. The co-expression of the various 
"differentiation marker" genes characteristic of a given cell type 
involves several interesting regulatory features, including induction 
in response to particular intra- or extra-cellular stimuli, expression 
only at a particular differentiation stage(s), and expression only in 
a specific cell type, or limited sub-set of cell types. Much recent 
work has been directed towards understanding cell type-specific 
co-expression during differentiation, since an understanding of the 
mechanisms by which sets of genes come to be co-expressed in a 
particular cell type during differentiation should allow a fuller 
understanding of the process of differentiation itself.
1.4.1 Erythropoiesis as a model system for the study of cell
type-specific co-expression during differentiation.
As will be discussed in detail below, the erythroid lineage 
represents a valuable model for the study of cell type-specific 
co-expression during differentiation. Cells from various stages of 
erythroid differentiation can readily be isolated (Section 1.4.1.1), 
and permanent cell lines are available which can be induced by 
chemicals to undergo differentiation in vitro, closely mimicking in 
vivo maturation (Section 1.4.1.2). Differentiation of erythroid cells 
is accompanied by alterations in gene expression which include the 
appearance of several well-characterised differentiation "markers", 
including haemoglobin. Regulation of expression of the globin gene 
family has been widely studied (Section 1.4.2) and shows 
characteristic alterations in which members of the family are 
expressed during development. One of the principal challenges of the 
erythroid system is the understanding of the mechanisms whereby the 
globin and other, non-globin erythroid differentiation markers come to 
be co-expressed during differentiation and development (Section 
1.4.3).
1.4.1.1 Ontogeny of erythroid cells.
Studies employing chromosome and enzyme markers (reviewed in
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Till and McCulloch, 1980) have demonstrated that the different types 
of blood cells, including the erythroid lineage, arise from the same 
haemopoietic pluripotent stem cell (Figure 1), as defined by the 
classic in vivo spleen clony-forming assay (Till and McCulloch, 1961), 
whereby injection of bone marrow cells into lethally irradiated mice 
results in the formation of macroscopic colonies in the spleen which 
contain mixtures of differing blood cell types. There has been 
controversy as to whether cells of the T and B cell lymphoid lineages 
arise from the same stem cells as the erythroid, granulocyte, 
macrophage, monocyte and megakaryocyte cells which comprise the 
myeloid lineages, but it is now widely accepted that they do share a 
common origin.
While the self-renewal capacity of pluripotent stem cells means 
that cell division results in the production of progeny which retain 
the characteristics of the pluripotent stem cell, they also produce 
so-called multipotent progenitor cells with limited self-renewal 
capacity, but with extensive proliferative capacity and the ability to 
differentiate down any one of several haemopoietic lineages. Further 
cell divisions result in still relatively undifferentiated precursor 
cells "committed" to particular lineages. The mechanism by which 
cells become committed to a particular haemopoietic lineage is 
uncertain, but it seems likely that commitment is determined by 
stochastic processes, and that once the commitment "decision" has been 
taken, differentiation down a particular lineage is facilitated by 
micro-environmental influences, probably including cell-cell 
interactions and the short-range actions of diffusible growth factors 
(reviewed in Harrison 1982a, b).
The earliest committed erythroid precursors are known as 
burst-forming unit-erythroid (BFU-E) and colony-forming unit-erythroid 
(CFU-E) cells (Figure 1), and were identified by in vitro cell culture 
of bone marrow explants (Axelrad et al, 1973; Stephenson et al, 1971) 
in the presence of the glycoprotein hormone, erythropoietin, the 
primary factor involved in erythroid differentiation (reviewed in 
Spivak, 1986). BFU-E represents a more primitive erythroid precursor 
than CFU-E, having greater proliferative capacity ("bursts" of several
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Figure 1. Differentiation of multiple cell lineages during
haemopoiesis.
Haemopoiesis involves a hierarchy of cells of increasingly 
restricted differentiation potential. A pluripotent stem cell with 
self-renewal capacity (top) gives rise to multipotential progenitor
cells - a lymphoid progenitor of B and T cell lymphocytes and a 
myeloid progenitor, CFU-GEPM (colony-forming unit-granulocyte/ 
erythrocyte/ macrophage/ megakaryocyte). These in turn proliferate
and differentiate to form committed precursor cells of the different 
blood cell lineages: BFU-E and CFU-E (burst-forming unit- and
colony-forming unit-erythroid, respectively); CFU-MEG (colony-forming 
unit-megakaryocyte); CFU-GM (colony-forming unit-granulocyte/
macrophage); and CFU-Eo (colony-forming unit-eosinophil). Further
proliferation and differentiation produces populations of 
terminally-differentiated cells: ''erythrocytes (RBC); megakaryocytes; 
monocytes; neutrophils (n); eosinophils (e); and basophils (b) .
Proliferation and differentiation are regulated by a variety of 
haemopoietic growth factors, varying in the specificity of their 
activities; interleukin-3 (IL-3); Granulocyte/ macrophage-colony
stimulating factor (GM-CSF); erythropoietin (Epo); granulocyte-colony 
stimulating factor (G-CSF); and macrophage-stimulating factor (M-CSF). 
(Reproduced from Clark and Kamen, 1987).
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thousand mature erythrocytes are formed over a period of 7 to 10 days 
in culture), but is less sensitive to erythropoietin - CFU-Es respond 
to one-tenth of the amount of erythropoietin required for 
burst-formation, undergoing approximately 5 or 6 cell divisions to 
from colonies of several dozen erythrocytes after 2 to 3 days in 
culture. There have been doubts as to whether BFU-Es have a 
requirement for erythropoietin in order to undergo further 
differentiation (see Harrison 1982b for a discussion), but it seems 
likely that expression of the erythropoietin receptor occurs at an 
intermediate stage between BFU-E and CFU-E, which are separated by 
around 6 cell divisions. CFU-Es, however, have an absolute 
requirement for erythropoietin (Iscove et al, 1980) if they are to 
proliferate further and undergo terminal differentiation, cell death 
occurring in the absence of the hormone.
BFU-E and CFU-E cells can be separated from mouse bone marrow by 
so-called velocity sedimentation, under unit gravity (Heath et al, 
1976) . The same technique had been used by Denton and Amstein (1973) 
to separate more mature erythroid cells from the bone marrow of 
anaemic rabbits. In normal bone marrow, erythroid precursors are only 
a minority of cells present, but anaemia results in homoeostatic 
increased production of erythroid cells. In mice, this anaemic stress 
results in recruitment of the spleen as a major erythropoietic organ: 
in rabbits, however, it is the bone marrow itself which becomes 
enriched in erythroid precursors, to as much as 85% (Thiele et al, 
1979). Anaemic stress, induced either by bleeding or phenylhydrazine 
treatment, is a particularly valuable method for obtaining ? from 
peripheral rabbit blood, cells at the penultimate, enucleate, 
reticulocyte stage of maturation, since the release of reticulocytes 
from bone marrow into the peripheral circulation is facilitated by 
the increase in erythropoietin levels which results from anaemic 
stress.
Separation of erythroid precursors by the velocity sedimentation 
technique depends upon a decrease in buoyant density which accompanies 
maturation of the erythroid precursors. This decrease in buoyant 
density results from morphological changes which accompany mammalian
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erythroid differentiation, including condensation and, finally, 
extrusion of the nucleus, and subsequent clearance of most of the 
intracellular architecture. The ability to separate different rabbit 
erythroid precursors on the basis of their buoyant density allowed 
Denton and Amstein (1973) to correlate metabolic changes prior to 
loss of the nucleus, including the cessation of mRNA and of DNA 
synthesis, and the commencement of haemoglobin production, with the 
different erythroblast stages (pro-, basophilic, polychromatic and 
orthochromatic erythroblasts) between CFU-Es and reticulocytes.
1.4.1.2 Murine erythroleukaemia (MEL) cells.
One of the most useful tools in studying erythroid 
differentiation has been the isolation of permanent cell lines 
including the murine erythroleukaemia (MEL), or Friend, cell lines 
(Friend et al, 1971), whose differentiation is arrested at a stage 
roughly corresponding to the first stage of development following the 
CFU-E, the pro-erythroblast stage. These cells can be induced to 
undergo terminal differentiation (including, under appropriate 
conditions, the extrusion of the nucleus) by a variety of chemicals 
including dimethyl sulphoxide (DMSO). Whilst this induced 
differentation is not perfectly analogous to in vivo maturation, being 
independent of erythropoietin, it mimics many of the morphological and 
biochemical changes which accompany normal differentiation, including 
decrease in cell size, condensation of nuclear chromatin, and the 
expression of various characteristic erythroid differentiation markers 
including haemoglobin (reviewed in Tsiftsogolou and Robinson, 1985) . 
The molecular mechanism of MEL cell induction, however, is still 
unclear, though it appears to involve a lag period during which 
commitment to different ate is reversible if the inducer is removed 
within a short time after initial treatment (reviewed in Harrison, 
1982b) . Analogous human leukaemic cell lines have been isolated, such 
as HEL, KM3E and K562 (which shows some of the characteristics of a 
foetal erythroid cell, including expression of embryonic and foetal 
globins - Chamay and Maniatis, 1983) . Such established erythroid 
cell lines have been extremely useful in the study of mechanisms of 
erythroid gene expression, particularly of the globin genes (Spandidos
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and Paul, 1982; Allan et al, 1983 and 1985; Wright et al, 1984; 
Charnay et al, 1984 and 1985).
1.4.2 Regulation of globin gene expression.
The mammalian and avian globin genes show complex patterns of 
expression, including absolute cell type-specificity and 
tightly-regulated developmental switching. The unlinked clusters of 
a-like and (3-like genes which give rise to the two types of 
polypeptide present in each haemoglobin tetramer are not co-ordinately 
regulated in the same sense as the genes encoding the enzymes of 
galactose or general amino acid metabolism in yeast which respond to 
the same transcription activation signal (Giniger et al, 1985; Hill et 
al, 1986 and references therein). Rather, it is now widely accepted 
that there must be major differences in the mechanism by which a-like 
and (3-like globins come to be expressed (Charnay et al, 1984). For 
example, the human adult a-globin gene is expressed at a much earlier 
stage of development than the adult (3-globin gene. Consequently, 
until recently, it has been unclear whether the a-like and (3-like 
globin genes share any common mechanisms in their erythroid-specific 
co-expression.
1.4.2.1 Promoter sequences of globin genes.
Globin genes from a variety of mammalian species were amongst 
the first to be cloned and have subsequently been the focus for much 
investigation of their mechanisms of regulation. Sequence comparisons 
of the 5' flanking regions of various (3-like globin genes (van Ooyen 
et al, 1979; Lacy and Maniatis, 1980; Efstatiadis et al, 1980) 
revealed the presence of three conserved regions, containing the 
ATAAAA, CCAAT and CACCC motifs.
All three of these regions seem to be important for efficient, 
high-level transcription of (3-globin genes, but not for 
cell)(type-specificity of transcription, as revealed by deletions and 
point mutations of the promoter region. The importance of regions 
containing ATAAAA and CCAAT sequences for high levels of transcription
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of rabbit (3-globin gene have been demonstrated by the expression of 
various promoter deletion mutants in mouse L cells and in human HeLa 
non-erythroid cells (Dierks et al, 1981; Grosveld et al, 1982a, b). 
Dierks et al (1983) exended this analysis by demonstrating that point 
mutations in the ATAAAA, CCAAT and CACCC regions all reduce the level 
of transcription in mouse 3T6 cells. Subsequently, similar results 
have been obtained from saturation mutagenesis of the whole of the 
first lOOnt of mouse (3ma3 or-globin 5' flanking sequences (Charnay et 
al, 1985; Myers et al, 1986) . It should be noted, however, that the 
CCAAT box does not seem to be essential for high-level expression of 
the rabbit (3-globin gene in vitro, using a HeLa cell extract (Grosveld 
et al, 1981b).
1.4.2.2 Upstream sequences involved in the modulation of
globin gene expression.
While the elements present within the first lOOnt of 5' 
flanking sequence appear to allow constitutive expression of globin 
gene promoter deletions in both erythroid and non-erythroid cells, 
there is evidence that sequences further upstream of globin genes may 
be involved in cell type-specific expression from the globin gene
promoter. By linking human (3- and y-globin sequences within 400nt of 
the transcription initiation site to the neo (G418 resistance) gene 
and assessing transcription by scoring for neo expression, Rutherford 
and Nienhuis (1987) demonstrated that the human (3-like globin 
promoters are active in human and murine erythroid (K562 and MEL) 
cells, but not in non-erythroid (HeLa and 3T3) cells. Recently, 
studies in which fragments of 5' flanking sequence of the mouse 
al-globin gene linked to a bacterial chloramphenicol acetyltransferase 
(CAT) gene have revealed several elements within 4kb of upstream
sequence which contribute to cell type-specific expression from this 
promoter in both transient and stable expression experiments in murine 
erythroid (MEL) and non-erythroid (STO fibroblast) cells (Frampton et 
al, manuscript in preparation) . Other 5' flanking sequences which 
appear to be involved in cell type-specific expression of globin genes 
have been analysed by Grosveld et al (1987), who have demonstrated
that the domain boundaries of the human (3-globin gene cluster can
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confer cell type-specific, position-independent, high-level expression 
of the human (3-globin gene in transgenic mice. Further, they have 
suggested that the 3' boundary may not be required for this 
regulation.
1.4.2.3 Sequences downstream of the transcription initiation
site involved in regulation of globin gene expression.
Experiments in which various promoter deletions and hybrid 
genes containing fragments of human and rabbit adult [3-globin genes 
were stably introduced into MEL cells, which were then induced to 
undergo differentiation by DMSO treatment, suggest that not all 
cis-regulatory sequences controlling globin gene expression are 
situated in the 5' flanking region (Charnay et al, 1984; Wright et al, 
1984). Wright et al (1984) demonstrated that rabbit (3-globin promoter 
deletions containing no more than 58bp of 5' flanking sequence can be 
correctly regulated upon induction of MEL cell differentiation, 
suggesting that 5' flanking sequences are not necessary for regulation 
of the rabbit [3-globin gene during erythroid maturation. Charnay et_ 
al (1985) reached a similar conclusion for the mouse ^na o^r-globin 
gene from experiments in which none of the linker scanning mutations 
introduced into the promoter region affected transcription of the gene 
following induction of MEL cell differentiation. Further support for 
this conclusion comes from experiments in transgenic mice in which 
human (3-globin promoter deletions containing as little as 48bp of 5' 
flanking sequence were sufficient for cell type-specific, 
developmentally-regulated expression, in a few cases approaching 
levels of endogenous (3-globin mRNA expression (Townes et al, 1985) .
Experiments involving transfection of oc/P hybrid globin genes 
(Charnay et al, 1984) suggest that sequences sufficient for increased 
(3-globin expression during MEL cell differentiation reside downstream 
of the transcription initiation sites of both genes. In the case of 
the (3-globin genes, however, it may be that both 5' and 3' sequences 
are involved in developmental regulation and that either alone is 
sufficient. Using hybrid genes containing the 5' flanking sequences 
from non-inducible y-globin and murine H-2K major histocompatability
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(MHC) gene promoters fused to the 3' sequences of human (3-globin and 
vice versa, Wright et al (1984) concluded that either 5' or 3' 
sequences of the human (3-globin gene were sufficient for regulated 
expression from a linked promoter, but that the presence of both is
not necessary. The existence of an induction-specific regulatory
: f 1  ^
element in the 5' end of/human (3-globin gene has recently been 
confirmed by Antoniou et al (1988) who have demonstrated that a 
promoter element between 138 and 164nt upstream of the transcription 
initiation site increases transcription from a linked H2-K gene 
following induction of MEL cell differentiation.
The realisation that globin genes contain regulatory sequences 
downstream of the transcription initiation site has culminated in the 
discovery of downstream enhancers in a variety of globin genes. The 
3' enhancer of the chicken adult (3^  globin gene, which lies 
approximately 400nt downstream of the polyadenylation signal, confers 
erythroid cell-specific and correct temporal regulation when assayed 
by the so-called "enhancer trap" experiment, in which potential 
enhancer sequences are linked in cis to the SV40 T antigen gene 
transcribed from the SV40 early promoter region (Choi and Engel,
1986). Cell type-specific and developmental expression is also 
conferred upon the human adult (3-globin gene by two downstream 
enhancers (Antoniou et al, 1988; Kollias et al, 1987): one is located
between 0.5 and 1.2kb downstream of the poly (A) addition site, and the 
other within the structural gene. Another enhancer also seems to be 
present within the human (3-globin gene cluster, between 400bp and 
1 .2 kb downstream of the polyadenylation site of the gene, as 
determined by its effect upon the ^/promoter used to drive the CAT 
reporter gene, but, in this case, the 3' enhancer does not appear to 
confer cell type-specificity (Bodine and Ley, 1987).
1.4.3 Co-expression of genes in erythroid cells.
Thus far, studies of the globin genes have provided little 
information concerning mechanisms by which co-expression of genes 
expressed in erythroid cells is achieved. The mechanisms by which 
human a-  and (3-globin genes are activated during differentiation would
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seem to be fundamentally different (Charnay et al, 1984) . Not only is 
the a-globin gene switched on at an earlier stage of ontogeny in the 
normal physiological situation, but cloned human (3-globin sequences in 
MEL cells are correctly regulated during chemically-induced 
differentiation (Chao et al, 1983; Wright et al, 1983), whereas cloned 
human a-globin sequences are constitutively expressed in both 
uninduced and induced MEL cells, unlike the endogenous mouse a-globin 
gene, which is activated only following induction (Charnay et al,
1984) . In contrast, human a- and (3-globin genes introduced into MEL 
cells on intact chromosomes by either chromosome-mediated gene 
transfer or cell fusion hybrids are both appropriately regulated 
(Willing et al, 1979; Pyati et al, 1980; Deisseroth et al, 1980a, b; 
Deisseroth and Hendrick, 1978).
Recent experiments concerning the regulation of globin and 
non-globin genes, however, may yield important clues as to the 
mechanisms of erythroid co-expression. A 3' enhancer has recently been 
discovered downstream of the transcription initiation site of the 
chicken histone H5 gene (Trainor et al, 1987) involved in the 
erythroid-specific expression of histone H5, which replaces histone HI 
during erythroid maturation. Interestingly, this cell type-specific 
enhancer shows homology with a 34bp segment of the erythroid-specific 
chicken adult (3-globin 3' enhancer, though this region alone does not 
seem to be sufficient on its own to confer cell-type specific 
expression in the "enhancer trap" experiment (Trainor et al, 1987) . 
Nevertheless, the finding of sequence similarities between 3' 
enhancers of globin and non-globin genes which are expressed in an 
erythroid-specific fashion may imply an evolutionary conservation of 
elements involved in erythroid-specific co-expression. This is 
supported by the observation that the chicken adult (3-globin enhancer 
also shows similarity, in a different region, with the enhancer of the 
human ^y-globin gene. Although is does not seem to confer cell 
type-specific expression upon a linked CAT gene, the ^y-globin 
enhancer is, however, associated with two cell type-specific DNasel 
HSS, indicating that it is available for the binding of trans-acting 
factors in erythroid cells (Bodine and Ley, 1987).
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In addition, a cell type-specific DNasel HSS upstream of the 
chicken oP-globin has recently been footprinted (Kemper et al, 1987), 
and may be the binding site for a factor involved in the co-expression 
of genes in erythroid cells (see below) . Nuclear extracts from 
erythroid nuclei of both embryonic and adult chicken protect a region 
within the DNasel HSS which contains the sequence element GATAAG. 
Similar sequences corresponding to the consensus sequence 
(T/A) GAPyAPuPu are seen in the promoters and enhancers of a variety of 
globin genes, including the mouse al- , human y-, chicken oP-, and 
chicken pP-globin promoters, and chicken p^- and human p-globin 
enhancers (Mantovani et al, 1988b) . GATAAG-like sequences have been 
footprinted in a variety of globin and non-globin genes from different 
species, including human y-globin, murine al- and pma^or-globin genes, 
and the erythroid-specific promoter of the human porphobilinogen 
deaminase gene, and appear to be the binding sites for an 
erythroid-specific DNA-binding activity (Mantovani et al, 1988b; Plumb 
et al, submitted for publication) . The GATAAG motif may thus 
represent an element which is involved in co-expression of genes in 
erythroid cells.
The finding of GATAAG-like sequences in both promoter and 
enhancer regions of globin genes provides an interesting analogy with 
the immunoglobulin octamer sequence present in both promoter and 
enhancer sequences of immunoglobulin genes, and which is involved in 
the cell type-specific expression of immunoglobulin genes (see Section
1.2.4.3 above) . However, unlike the immunoglobulin octamer, which can 
confer lymphoid-specificity upon expression from a minimal mouse 
renin-1 promoter containing only a TATA box (Dreyfus et al, 1987), the 
GATAAG motif in isolation does not seem to be sufficient to confer 
cell type-specificity: in transient expression experiments, mouse
al-globin promoter deletions which remove the GATAAG element also 
reduce the erythroid-specific expression of a linked CAT reporter 
gene; but the GATAAG element alone does not result in 
erythroid-specific expression in the same system when linked to a 
minimal murine al-globin promoter (Plumb et al, submitted for 
publication) .
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Another gene expressed in erythroid cells, the
erythroid-specific lipoxygenase (RBC 15-LOX) of rabbit reticulocytes, 
is the subject of this thesis, which is partly concerned with
investigating whether the erythroid-specific expression of this gene 
shows any common features with the transcriptional regulation of other 
genes expressed in erythroid cells.
1.5 THE LIPOXYGENASE FAMILY OF ENZYMES.
The lipoxygenases (EC 1.13.11.12 linoleate: oxygen
oxidoreductases) (LOXs) are a family of non-haem iron-containing
enzymes which share the common function of peroxidation of
polyunsaturated fatty acids by the addition of molecular oxygen to 
substrates containing a cis,cis-l,4-pentadiene arrangement (Figure 2).
Thus, the simplest naturally-occurring substrate is linoleic
acid, an 18-carbon fatty acid containing two C=C double bonds. 
Arachidonic acid, a 20-carbon fatty acid containing four double bonds
is an important substrate for many functions in mammalian cells,
including the LOX-catalysed generation of biological mediators known 
as leukotrienes (see Section 1.5.2). In principle, peroxidation of 
arachidonic acid can occur at either end of any of the four double 
bonds, at 5, 6 , 8 , 9, 11, 12, 14, and 15 positions relative to the
carboxylated end of the chain. Catalysis results in the abstraction 
of hydrogen from a carbon atom two positions from the site of 
peroxidation and a consequent shift of a double bond, forming a
conjugated 1,3-cis,trans double bond arrangement (Figure 2).
Originally isolated from plants (Theorell et al, 1947), LOXs
have since been found to be widely distributed in both animal and
plant kingdoms, and may be ubiquitous in mammalian tissues. As 
detailed in the sections which follow, they show many common features, 
but exhibit some diversity, most notably in their specificity for the 
position to which they add molecular oxygen, and in the different 
roles which they perform in different tissues (see Schewe et al, 1986 
for a recent review).
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1.5.1 Diversity in the positional specificity of various
lipoxygenases.
While the various different members of the lipoxygenase 
family all add molecular oxygen to a given fatty acid substrate, 
forming fatty acid hydroperoxides, they catalyse peroxidation at 
different points on the fatty acid chain, relative to the carboxyl 
terminus. Experiments with the erythroid-specific RBC 15-LOX of 
rabbit reticulocytes, using substrates of different fatty acid chain 
length indicate that the position for addition of molecular oxygen is 
determined by the distance from the terminal methyl group of the chain 
(Bryant et al, 1982; Schewe et al, 1986) . Thus 18-carbon linoleic 
acid, and 2 0 -carbon arachidonic acid are both peroxidised at the (n-6 ) 
position relative to the terminal methyl group. The main product 
with arachidonic acid is hence a 15-hydroperoxyeicosatetraenoic acid 
(the number 15 is, by convention, measured relative to the opposite, 
carboxylated end of the chain) .
Different tissues frequently contain LOXs with differing 
positional specificities. For example, human tissues contain at least 
three major LOX activities. A 5-LOX is the predominant form in 
leukocytes; a 12-LOX in platelets; and a 15-LOX in skin and epithelial 
tissues. However, not all LOXs have absolute positional specificity, 
the rabbit RBC 15-LOX forming 15-hydroperoxy and 12-hydroperoxy 
products of arachidonic acid in a ratio of 15:1 (Bryant et al, 1983; 
Schewe et al, 1986) . Nor does any one tissue necessarily contain only- 
one lipoxygenase - for example, in human neutrophils, the major LOX 
activity shows 5-specificity, but minor 8 -, 9-, 11- and 15-LOX
activities are also present (Parker, 1984) . Indeed, in mammalian
in
leukocytes, the presence of both 5- and 15-LOXs 'by mammalian 
leukocytes is vital for the formation of lipoxins, a 
recently-discovered species of biological mediators, which, together 
with the leukotrienes, are involved in inflammation and immunity
(reviewed in Samuelsson;  1987). Similarly, in plants, soybeans
contain four LOX isozymes, differing in various characteristics, 
including positional specificity. Although linoleic acid is the 
preferred substrate, soybean LOX-1 isozyme peroxidises arachidonic
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acid at the 15-position, while LOX-2 and LOX-3 isozymes peroxidise
both 11- and 15-positions (Axelrod et al, 1981) .
1.5.2 Diversity in the function of various lipoxygenases.
The physiological functions of LOXs in plants are not well
understood. Possible roles in the production of biological regulators
(e.g. jasmonic acid) involved in germination, fruit ripening, and
senescence have been suggested, as well as an involvement in
resistance to pathogens (see Yenofsky et al, 1988; Start et al, 1986 
and references therein). Both commercially desirable and undesirable 
effects of LOX action in crop plants are observed, most notably the 
bleaching of carotenoid pigments during bread-making and the spoilage 
of soy oil.
The biological roles of LOXs in mammals have been much more 
widely studied, due to the importance of certain LOX products as 
biological mediators. The 5-LOX of human leukocytes catalyses the
first two steps in the production of so-called leukotrienes (LTs) from 
arachidonic acid. (Arachidonic acid is also the substrate for the 
cyclo-oxygenase enzyme, generating a variety of other biological 
mediators, including prostaglandins, thromboxanes and prostacyclins). 
Leukotrienes are a family of substances containing a conjugated triene 
arrangement of double bonds as the result of peroxidation of 
archidonic acid by LOXs, followed by formation of an unstable epoxide 
intermediate known as leukotriene A^ (LTA^ ) which is the precursor of 
the other lekotrienes. All of the leukotrienes have pro-inflammatory 
effects: LTB^ primarily affects leukocytes, while LTC^, LTD^ and LTE^
mainly affect cells having contractile capacity (reviewed in 
Samuelsson et al, 1987) . LTC^, LTD^ and LTE^ are collectively 
referred to as "slow-reacting substance of anaphylaxis" (SRS-A) and 
are important as the major mediators of the immediate hypersensitivity 
imflammation of the bronchial tract in response to allergens which we 
know as asthma. Interactions between 5- and 15-LOXs are involved in 
the production of other mediators of inflammation and immunity, the 
lipoxins, which have similar, but distinct, biological activities to 
those of the leukotrienes (Samuelsson et al, 1987) .
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As will be discussed in more detail below (Section 1.6.1), a 
completely different function is served by the RBC 15-LOX enzyme of 
rabbit reticulocytes. Here, the LOX enzyme is not involved with the 
production of biological mediators, but with the inactivation and 
degradation of mitochondria in red blood cells during their maturation 
from reticulocyte to mature erythrocyte, following extrusion of the 
erythroid nucleus. Several aspects of the regulation of its 
expression uniquely suit this enzyme to its function, resulting in 
degradation of mitochondria only in erythroid cells, and only in the 
final phase of their maturation (see Section 1.6.3) .
1.5.3 Common features of the lipoxygenase enzyme family.
Despite these differences in positional specificity and 
function, the various members of the LOX enzyme family show many 
common features (reviewed in Schewe et al, 1986). All are capable of 
catalysing a variety of reactions, resulting in the formation of a 
wide variety of products. As well as the common feature of catalysing 
single dioxygenation reactions of substrates containing the cis,cis- 
-1 ,4-pentadiene arrangement, all are capable, under appropriate, often 
non-physiological conditions, of catalysing‘multiple dioxygenations; 
anaerobic "lipohydroperoxidase" reductions of fatty acid 
hydroperoxides to their reduced hydroxyderivatives; co-oxidations 
involving the free-radicals generated as a normal part of catalysis; 
and anaerobic formation of ketoacids and fatty acid dimers. Most 
notably, all LOXs, even those whose physiological role does not 
involve leukotriene synthesis, are capable of catalysing the formation 
of LTA4  (Schewe et al, 1986).
These similar catalytic activities are reflected in similar 
properties of the enzymes. All seem to require "product-activation" 
by hydroperoxy fatty acids, to show similar behaviour with various 
inhibitors, including "suicidal substrates", and to show similar 
kinetics. Most undergo "self-inactivation", involving loss of enzyme 
activity as a result of attack by free radicals formed during 
catalysis, and a similar catalytic mechanism appears to apply to all
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members of the family studied (reviewed in Schewe et al, 1986) .
1.5.4 Structure-function relationships of the lipoxygenases.
All the similarities and differences between various members 
of the I£)X enzyme family are presumably the result of their primary 
amino acid sequences. Concerted efforts are being made to understand 
features such as differing positional specificities in terms of the 
protein sequence of the LOX enzymes, and, at the nucleic acid level, 
to investigate whether the family of enzymes are encoded by an 
evolutionarily-related family of genes.
At the commencement of this project, in addition to the four 
purified soybean LOX isozymes (Axelrod et al, 1981), the only 
mammalian LOX enzyme to have been purified to homogeneity and 
characterized to any significant extent was an erythroid-specific, RBC 
15-LOX from rabbit reticulocytes (Rapoport et al, 1979; Thiele et al, 
1982; Bryant et al, 1983; Schewe et al, 1986). Subsequently, 
characterisation of several other mammalian LOX proteins has been 
reported, including 5-LOXs from rat basophilic leukaemia cells, human 
and porcine leukocytes, and murine mast cells (Hogaboom et al, 1986; 
Rouzer and Samuelsson, 1985; Ueda et al, 1986; Shimizu et al, 1986) . 
Further, the genes for the rabbit RBC 15-LOX (Thiele et al, 1987 and 
Section 1.6.5 below) and the soybean LOX-3 isozyme (Yenofsky et al, 
1988) have been obtained, and, very recently, cDNA clones for the 
human leukocyte 5-LOX (Dixon et al, 1988; Matsumoto et al, 1988) and 
the soybean LOX-1 isozyme (Shibata et al, 1987). The availability of 
protein sequences, predicted from nucleic acid sequences, will allow 
investigation of the structure-function relationships of the various 
LOXs (see Discussion), while the cloning of LOX genes will allow 
investigation of the regulation of their expression.
1.6. THE ERYTHROID-SPECIFIC RBC 15-LOX OF RABBIT RETICULOCYTES.
As will be discussed in more detail below, the expression of a 
15-LOX from rabbit reticulocytes shows several interesting features, 
including erythroid-specific expression of both mRNA and protein
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(hence the "RBC" 15-LOX) and restriction to the final stages of
erythroid maturation.
1.6.1 Biological function of the rabbit RBC 15-LOX.
Unlike the 5-LOX of mammalian leukocytes, the major role for 
rabbit RBC 15-LOX is not in the synthesis of leukotrienes. Rather, it 
serves a vital function in the final stages of maturation of erythroid 
cells, participating in the inactivation and degradation of 
mitochondria in reticulocytes (Schewe et al, 1975; Rapoport et al, 
1979) . The primary function of the erythrocyte is the carriage of 
oxygen in the form of oxygenated haemoglobin. In order to achieve
this function with maximum efficiency, the maturing erythroid cell 
produces haemoglobin in huge quantities and, following extrusion of 
the nucleus, is cleared of most of its intracellular structures, 
including the mitochondria. Inactivation and degradation of the 
mitochondria is important in two respects. Firstly, if oxygen is to 
be transported with maximum efficiency, then its utilisation by the 
process of aerobic respiration in the mitochondria must be inhibited; 
having achieved synthesis of large quantities of haemoglobin and of 
other proteins important in erythroid function, the mature erythrocyte 
no longer has need of large quantities of energy for synthetic
processes. Secondly, removal of the bulk of the mitochondria and
other intracellular organelles allows accumulation of the maximum 
quantity of haemoglobin within the cell and offers minimal resistance 
to deformation of the erythrocyte in passing through capillaries of 
the vascular system.
The RBC 15-LOX appears to be involved at several stages in the 
inactivation and degradation of mitochondria (reviewed in Schewe et 
al, 1986) . Unlike the situation for the human leukocyte 5-LOX in 
leukotriene synthesis, all of these activities appear to be direct 
effects of peroxidation of fatty acids by the RBC 15-LOX, rather than 
indirect effects mediated by biologically active products of LOX 
catalysis. Firstly, the RBC 15-LOX is involved in the inhibition of 
the respiratory chain, possibly at several points (Rapoport et al, 
1979; Schewe et al, 1981; Wiesner et al, 1981; Schewe et al, 1986).
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This action may involve changes in the electical properties and 
fluidity of the inner mitochondrial membrane as a result of lipid
peroxidation (Schewe et al, 1986) . Secondly, it is involved in the
lysis of the mitochondria (Schewe et al, 1975; Rapoport et al, 1979) . 
This activity is dependent upon a feature of the RBC 15-LOX which is 
unique among the LOXs - the ability to directly attack intact 
mitochondrial membranes, without prior release of the fatty acid 
chains from the membranes by phospholipase action, as is necessary for 
the activity of other LOXs. Nevertheless, the RBC 15-LOX can 
peroxidise free fatty acids with even higher efficiency (Rapoport et 
al, 1979) . The enzyme preferentially attacks mitochondrial membranes 
rather than the plasma membrane of the reticulocyte, probably due to 
differences in membrane composition, including the higher proportion
of cholesterol in the plasmalemma (Rapoport et al, 1979). Finally,
RBC 15-LOX appears to be involved in triggering degradation of 
proteins from the lysed mitochondria by ubiquitin-ATP-dependent 
proteolysis (reviewed in Schewe et al, 1986).
1.6.2 Characterisation of the RBC 15-LOX protein and its
mRNA.
RBC 15-LOX enzyme activity, as detected by the 
spectrophotometric change in absorbance at 234nm which accompanies the 
formation of a conjugated diene during fatty acid peroxidation, is 
virtually undetectable in peripheral blood or in bone marrow of normal 
rabbits. However, during anaemia, induced either by bleeding or by 
phenylhydrazine treatment, there is a large increase in RBC 15-LOX 
protein synthesis, with the result that the enzyme is one of the most 
abundant non-globin proteins in reticulocytes of the peripheral blood 
during anaemia. Thiele et al (1979) have shown, by incorporation of 
S-methionine into cellular proteins in density gradient-separated 
populations of reticulocytes from peripheral blood, that, between the 
third and fifth days of bleeding anaemia, synthesis of RBC 15-LOX 
protein increases from 14% to 30% of new non-globin protein synthesis, 
accounting for approximately 4% of total protein synthesis and 17% of 
total non-globin protein at this stage. The concentration of the 
enzyme at this point is higher even than that of catalase (Rapoport et
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al, 1979).
The protein has been purified to homogeneity from reticulocytes 
of anaemic peripheral blood by ammonium sulphate precipitation 
followed by anion-exchange chromatography and isoelectric focussing 
(Rapoport et al, 1979), and polyclonal antibodies have been raised 
(Thiele et al, 1979; Wiesner et al, 1977) . Its molecular weight by 
denaturing polyacrylamide gel electrophoresis is 6 8 kD (Thiele et al,
1987), though earlier reports quote a value of 78kD (Rapoport et al,
1979), of which about 5% represent neutral sugars (Rapoport et al,
1979). Like other LOXs, it contains 1 atom of iron per molecule, but
this is not present as haem or iron-sulphur (Wiesner et al, 1983;
Rapoport et al, 1979). Denaturing polyacrylamide gel electrophoresis 
and N-terminal protein sequencing (Thiele et al, 1987) show that it 
contains a single polypeptide chain. However, it can form
enzymatically-inactive oligomers (Hohne and Andree, 1980) . This means 
that amounts of protein, as detected by immunological methods, and 
amounts of enzyme activity are not always in proportion. The 
N-terminal amino acid is glycine (Rapoport et al, 1979) and it shows 
C-terminal micro-heterogeneity, possibly due to carboxypeptidase 
activity present in reticulocytes (Wiesner et al, 1983; Rapoport et 
al, 1979) . Its amino acid composition has been determined (Wiesner et 
al, 1983), and, recently, the sequence of 30 N-terminal amino acids 
has been obtained (Thiele et al, 1987).
The mRNA encoding the RBC 15-LOX has been isolated and
characterised (Thiele et al, 1982) . mRNA was isolated from polysomes
by protease digestion followed by poly (U) -Sepharose affinity 
chromatography. It was enriched by three cycles of density-gradient 
centrifugation, each followed by determination of fractions containing 
the RBC 15-LOX mRNA by in vitro translation and size comparison with 
the purified 15-LOX protein. The calculated molecular weight of the 
mRNA, averaged from determinations by sucrose density gradient 
centrifugation, gel electrophoresis and electron microscopy 
corresponds to 1x10%, or approximately 2.9kb. Estimates of the 
proportion of RBC 15-LOX mRNA by cell-free translation suggest that it 
represents about 2% of polyadenylated RNAs in reticulocytes from
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anaemic peripheral blood (Thiele et al, 1982) .
1.6.3 Erythroid-specific expression of the RBC 15-LOX.
Evidence discussed below shows that expression of 
immunologically-detectable RBC 15-LOX in rabbits is restricted to the 
erythroid cell type, and to late stages in the erythroid maturation, 
following extrusion of the nucleus. Accumulation of the RBC 15-LOX 
mRNA is also erythroid-specific (Section 1.6.4 below), and the 
differentiation stage-specific appearance of the protein seems to
involve translational inactivation. The regulation of RBC 15-LOX 
expression thus presents several interesting features.
As outlined earlier, LOXs are found in a wide variety of 
mammalian tissues, but the RBC 15-LOX protein is detected only in
reticulocytes, using antibodies raised against the purified RBC 15-LOX 
protein or by assaying for the inhibition of mitochondrial respiration 
characteristic of the RBC 15-LOX. The RBC 15-LOX is not enzymically 
active, nor immunologically-detectable in peripheral blood from mature 
erythrocytes; it is also very low in anaemic bone marrow, but high in 
peripheral blood reticulocytes of anaemic animals (Rapoport et al,
1979) . Thiele et al (1979 and 1982) have demonstrated that the 
appearance of LOX activity in reticulocytes is due to new protein
synthesis, not to a post-translational modification. Incorporation of
3 . . .H-leucme into a newly-synthesized non-globin protein of the same
size as the purified RBC 15-LOX protein was observed in peripheral 
blood reticulocytes after 3 - 5  days of anaemia induced by bleeding, 
but not in erythroblasts and reticulocytes from anaemic bone marrow. 
Furthermore, immuno-precipitation of non-globin proteins with anti-RBC 
15-LOX anti-serum resulted in precipitation of a labelled protein of 
the same size as the pure RBC 15-LOX protein in extracts of peripheral 
reticulocytes, but no immunologically-reactive material was obtained 
from bone marrow, suggesting that there is not even a precursor 
protein synthesized in bone marrow (Thiele et al, 1979) . Thiele et al 
(1982) further demonstrated that, within the reticulocyte population 
of anaemic animals, RBC 15-LOX synthesis occurs in older peripheral 
reticulocytes, but not in younger peripheral reticulocytes or
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reticulocytes from anaemic bone marrow. Reticulocytes were separated 
from other bone marrow cell populations by sucrose gradient 
sedimentation, and peripheral reticulocytes of different ages were 
separated according to size by serum albumin density gradient
centridugation. Cellular incorporation of radio-label into 
newly-synthesised protein of the same size as the purified RBC 15-LOX 
was seen only in older reticulocytes.
The appearance of RBC 15-LOX protein synthesis only in the
enucleate reticulocyte phase of erythroid maturation suggests that
there must be some translational regulation of RBC 15-LOX expression,
since synthesis of the RBC 15-LOX mRNA. must have ceased prior to loss
of the nucleus. Thiele et al (1982) have shown that RBC 15-LOX mRNA
is present, but in a translationally-inactive form, in younger
reticulocytes of anaemic peripheral blood. Older reticulocytes, but
not younger ones, were capable of cellular incorporation of 
85 . . .S-methiomne into an RBC 15-LOX-sized band; whereas in vitro 
translation of mRNA isolated from reticulocytes of both age ranges 
resulted in incorporation of radio-label into a protein of the 
appropriate size.
The mechanism by which this translational inactivation might
occur is unclear. However, inactivation as an mRNP complex is a 
possibility (Thiele et al, 1982), since, when mRNPs, ribosomes and 
ribosomal sub-units from anaemic peripheral reticulocytes were 
separated from polysomes by sucrose gradient centrifugation, RBC
15-LOX mRNA was found to be present predominantly, but not 
exclusively, in the mRNP fraction. In vitro translation produced an 
RBC 15-LOX-sized protein only after purification of mRNA from the mRNP 
fraction (Thiele et al, 1982). If inactivation of RBC 15-LOX mRNA 
does occur via formation of an mRNP particle, it is unknown whether 
masking from the translational apparatus is achieved by a protein, 
removed by protease K treatment during mRNA isolation, or by some 
other RNA present in the complex (Thiele et al, 1982) .
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1.6.4 Cloning of the RBC 15-LOX roRNA.
Using a cDNA library prepared from RBC 15-LOX-enriched mRNA 
(Thiele et al, 1982 and Section 1.6.2 above) a series of overlapping 
RBC 15-LOX cDNAs have been obtained (Thiele et al, 1987; J. Fleming, 
unpublished results) by screening with two complementary 
mixed-sequence 17-mer oligonucleotide probes whose sequences were 
based upon the N-terminal sequence of the purified RBC 15-LOX protein. 
One cDNA recombinant, pGF6 , which contains a 356bp cDNA insert, has 
been shown to represent a genuine RBC 15-LOX cDNA clone by a variety 
of methods (Thiele et al, 1987) . Most importantly, its nucleic acid 
sequence accurately predicts the first 30 amino acids of N-terminal 
RBC 15-LOX protein sequence. Furthermore, this cDNA clone 
hybrid-selects an mRNA from anaemic peripheral blood reticulocytes 
which can be translated in vitro in the rabbit reticulocyte lysate 
system to produce a radio-labelled protein of the same size as the 
purified RBC 15-LOX. Furthermore, immuno-precipitation of the
products of this hybrid-select ion/in vitro translation, using 
affinity-purified polyclonal anti-RBC 15-LOX antibodies, also 
precipitates a protein of the correct size.
Thiele et al (1987) have demonstrated by hybridisation of the 
pGF6 cDNA insert to Northern blots of RNAs from various rabbit tissues 
that the RBC 15-LOX mRNA accumulates in an erythroid-specific fashion, 
being expressed in reticulocytes, but not in bone marrow, heart, 
spleen or brain.
Hybridisation of the cDNA inserts of various RBC 15-LOX cDNAs 
with restriction digestions of rabbit liver genomic DNA produces a 
simple hybridisation pattern indicative of hybridisation to a single 
gene (Thiele et al, 1987; J. Fleming, unpublished results) . This 
might suggest either that mRNAs encoding the various LOXs found in 
different rabbit tissues are transcribed from the same gene, or that 
they are transcribed from other genes, with which the RBC 15-LOX cDNA 
inserts do not hybridise. The observation that none of the RBC 15-LOX 
cDNA inserts derived from different regions of the RBC 15-LOX mRNA 
hybridise with RNAs from various rabbit tissues (Thiele et al, 1987;
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J. Fleming, unpublished results) would seem to favour the idea that 
the LOX activities found in various other rabbit tissues are encoded 
by different genes.
1.6.5 Cloning of the rabbit RBC 15-LOX gene.
The RBC 15-LOX cDNA insert from the pGF6 recombinant 
described above has been used to screen a rabbit genomic library 
prepared from rabbit liver genomic DNA fragments cloned into a 
bacteriophage lambda vector. Two virtually identical clones, the 
longer of which contains a rabbit genomic insert of 17kb, have been 
isolated (Thiele et al, 1987) . The 5' end of the pGF6 insert, 
including sequences encoding the N-terminal region of the RBC 15-LOX 
protein, hybridises to a 1.5kb EcoRI fragment extending between 2.5 
and 4kb from one end of this genomic fragment (Thiele et al, 1987 and 
Figure 3) .
The cloning of the rabbit RBC 15-LOX gene will permit the 
investigation of structure-function relationships of the enzyme, and 
comparisons to be made with other members of the LOX enzyme family 
expressed in other tissues and in other species. Furthermore, it will 
allow the first investigation of the organisation of a mammalian LOX 
gene and of LOX gene expression.
1.6.6 Aims of this project.
The aims of this thesis have been to investigate 
transcription of the RBC 15-LOX gene and whether expression of the 
mRNA shares any common features with the expression of other genes in 
erythroid cells, particularly of globin genes. As a first step 
towards identifying possible cis-regulatory sequences, the 
transcription initiation site of the RBC 15-LOX mRNA has been mapped, 
allowing identification and characterisation of the 5' flanking 
region. Various properties of the 5' flanking sequences have been 
studied, including the binding of nuclear proteins and the ability of 
proximal upstream sequences to function as a promoter in vivo. 
Functional experiments designed to locate regions of the gene which
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may be involved in erythroid-specific regulation of transcription from 
the RBC 15-LOX promoter have also been performed.
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Chapter 2. 
MATERIALS AND METHODS.
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2.1 Materials.
All radio-isotopes, and the Ml3 sequencing kit were obtained 
from Amersham International PLC, Amersham, Buckinghamshire.
All restriction enzymes, polymerases (Avian Myeloblastosis Virus 
reverse transcriptase, and Klenow fragment of Eschericia coli DNA 
polymerase) and DNA modifying enzymes (SI nuclease, calf intestinal 
alkaline phosphatase, polynucleotide kinase, T4 DNA ligase, DNasel), 
oligo (dT) -cellulose, and proteinase K were obtained from Boehringer 
Mannheim, Lewes, East Sussex.
DNA size markers (X/Hindlll and <JfiQ74/HaeIII), RNA size markers, 
M13 Universal primer, agarose, low melting-point agarose and urea were 
obtained from Gibco/Bethesda Research Laboratories, Paisley.
Deoxy- and dideoxy-ribonucleotides, and mixed hexanucleotides 
for random-primed radio-labelling were from Pharmacia Ltd., Milton 
Keynes, Buckinghamshire.
Synthetic oligodeoxyribonucleotides were synthesised on an 
Applied Biosystems Model 381A automated DNA Synthesiser.
Biogel A-50m agarose beads for gel filtration column 
chromatography, and Bio-Rad Protein Assay Kit were from Bio-Rad 
Laboratories Ltd., Watford, Hertfordshire.
GeneClean kit for DNA purification was supplied by Stratech 
Scientific Ltd., London.
Elutip-d minicolums were from Schleicher and Schull, Dassel, FRG
RNAzol kit for RNA preparations was obtained from Biogenesis 
Ltd., Bournemouth.
Serum, media and supplements for cell culture were supplied by 
Gibco/Bethesda Research Laboratories, Paisley.
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Bacto-tryptone, Bacto-agar and yeast extract were from DIFCO 
Laboratories, Detroit, Michigan, USA.
Phenol was obtained as a water-saturated liquid from Rathbum 
Chemicals Ltd, Walkerbum, Peebleshire
Absolute ethanol was supplied by James Burroughs (F.A.D) Ltd, 
Witham, Essex.
All other chemicals and solvents were obtained from BDH LTD., 
Poole, Dorset or from Sigma Chemical Co. Ltd., Poole, Dorset.
Plastic-ware for cell culture was supplied by Nunc InterMed, 
Roskilde, Denmark and by Sterilin Ltd., Feltham, Middlesex.
Thin layer chromatography plates were supplied by Camlab, 
Cambridge.
Chromatography columns were from Bio-Rad, Watford, 
Hertfordshire.
Biodyne membranes for nucleic acid blotting were from Pall, Glen 
Cove, New York, USA.
2.2 General procedures involving nucleic acids.
2.2.1 Handling of nucleic acids.
All solutions used in the preparation and manipulation of 
nucleic acids were made up using water purified using the Millipore 
Milli-Ro and Milli-Q reagent grade water purification system. All 
solutions were autoclaved before usey or, in the case of thermolabile 
substances, filter-sterilised using 0 .2 2 |jm filters then stored in 
sterile plastic containers. In addition, all solutions for RNA work 
were treated overnight with diethylpyrocarbonate (DEPC) as a 0.1% v/v 
solution to minimise degradation of RNA due to endogenous or 
contaminating RNases, and then autoclaved to remove traces of DEPC. 
All glassware for work with RNAs was soaked in DEPC-treated water then
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baked. Microcentrifuge tubes and disposable pipette tips for handling 
nucleic acids were autoclaved before use, and disposable rubber gloves 
worn at all times.
2.2.2 Organic extraction of nucleic acid solutions.
Phenol, obtained as a water-saturated liquid, was 
equilibrated with TE buffer (lOmM Tris-HCl pH8.0; ImM EDTA) following 
sequential extractions with 1M Tris-HCl pH8.0 then twice with 0.1M 
Tris-HCl pH8.0. On each occasion, phenol was mixed thoroughly with an 
equal volume of buffer, which was removed after separation of the 
phases. TE-saturated phenol was made 0.1% w/v with respect to 
8 -hydroxyquinoline and stored in the dark at room temperature.
Chloroform was prepared as a 25:1 v/v mixture with isoamyl 
alcohol.
Nucleic acid solutions were deproteinised by vortexing with an 
equal volume of a 1 : 1  mix of the phenol and chloroform preparations 
described above. Phase separation was achieved by centrifuagation 
(12000g, 5min, room temperature).
2.2.3 Concentration of nucleic acids.
Solutions containing nucleic acids were adjusted to 0.3M with 
respect to monovalent cations using a 3M sodium acetate pH5.0 stock. 
Precipitation was achieved by addition of 2.5 volumes ethanol followed 
by chilling at -20°C for >2hours or at -70°C for lOmin. Precipitates 
were collected by centrifugation at 12000g for lOmin at room 
temperature. The nucleic acid pellet was then washed with 70% v/v 
ethanol and dried under vacuum before resuspension in water or an 
appropriate buffer.
Volumes of aqueous solutions were reduced by repeated cycles of 
addition of equal volumes of butanol, and removal of the upper, 
organic phase.
2.2.4 Spectrophotometric determination of nucleic acid
concentrations.
Nucleic acid concentrations were measured by determining the 
absorbance of an aqueous solution at 260nm using the convention that 
an absorbance of 1 unit is equivalent to a double stranded DNA
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concentration of 50|lg/ml and an RNA concentration of 40|ig/ml (Maniatis 
et al, 1982) .
2.3 Transformation of bacterial cells with DNA..
E. coli K12-derived bacterial strains used (Yanisch-Perron et al,
1985) were:
JM83: ara, A(lac-proAB), rpsL (=straA), <j)80, lacZAM15
JM101: thi, SupE, A(lac-proAB), [F' traD36, proAB,
lacIqZAM15]
Preparation of transformation-conpetent cells was carried out 
essentially as described by Mandel and Higa (1970) .
Fresh overnight cultures were diluted 1:100 in 50ml medium 
(L-broth (1% w/v bacto-tryptone; 0.5% w/v yeast extract; 1% w/v NaCl) 
for JM83 cells; 2x TY (1.6% w/v Bacto-tryptone; 1% w/v yeast extract; 
0.5% w/v NaCl) for JM101 cells) and grown to an OD^qq of 0.4-0.6 . 
Cells were pelleted by centrifugation (lOOOg, 5 min, 4°C), resuspended 
in 1/2 volume of pre-cooled 50mM CaC^, incubated at 0°C for 30 min, 
then pelleted and resuspended again in l/1 0 th original volume of 
ice-cold 50mM CaC^. Transformation-competent cells were stored for
up to 2days at 4°C.
Half of each ligation mixture, containing up to l|ig DNA, was 
added to 200|ll competent cells, incubated at 0°C for 30 min and then 
heat shocked at 42°C for 3min.
For plasmid transformation, heat-shocked JM83 cells were added
to 1ml of L-broth and the culture incubated at 37°C for 1 hour to
allow expression of plasmid-encoded functions before spreading onto 
L-broth supplemented with 1.5% w/v agar and 100|lg/ml ampicillin 
contained in 9cm Petri dishes.
For Ml3 transfection, heat-shocked JM101 cells were added to a
mixture containing 0.2ml exponentially growing cells; 40|ll 2% X-gal 
(5-bromo-4-chloro-3-indolyl-(3-galactoside) in dimethylformamide; 40(11 
lOOmM IPTG (isopropyl-(3-D-thiogalactopyranoside) . The mixture was 
immediately added to 3ml molten H top agar (1% w/v Bacto-tryptone; 
0.8% w/v NaCl; 0.8% w/v agar), mixed quickly and poured into a 9cm 
Petri dish containing solidified H agar (1% w/v Bacto-tryptone; 0.8% 
w/v NaCl; 1.2% w/v agar) .
Plates were incubated, inverted at 37°C overnight.
59
2.4 Preparation of nucleic acids.
2.4.1 Eukaryotic RNA
2.4.1.1 From rabbit reticulocytes.
Peripheral blood was enriched for reticulocytes by rendering 
adult rabbits anaemic by five daily injections of a 2 .5 % solution in 
PBS (Phosphate Buffered Saline - see Section 2.1.3.1) of 
1 -acety 1-2-pheny lhydraz ine to 7mg/kg body weight. Animals were 
sacrificed on the seventh day after commencement of anaemia induction 
and blood collected in BSS (balanced salt solution) containing 
lOunits/ml heparin. Total cytoplasmic RNA was prepared from 
peripheral blood essentially as described by Minty and Gros (1980) . 
Cells were pelleted by centrifugation (2000g, 20min./ 4°C) and the
supernatant and buffy coat layer removed from above the red cell 
pellet. Red cells were washed in BSS/heparin as above, followed by a 
second centrifugation and removal of the remaining buffy coat cells. 
The red cell pellet was resuspended in an equal volume of 140mM NaCl; 
1.5mM MgC^; lOmM Tris-HCl pH7.5, and 1/2 0th volume 
vanadyl-ribonucleoside complexes added to inhibit RNAses. Lysis was 
then achieved by addition of NP-40 to 0.5% v/v followed by incubation 
at 0°C for 5 min. Nuclei were pelleted by centrifugation (4000g, 
5min, 4°C) and RNA precipitated from the supernatant by the addition 
of an equal volume of 8M urea; 4M LiCl and incubation at 4°C for 
24hours. RNA was then pelleted by centrifugation (16000g, 15min, 
4°C), dissolved in 25ml 8M urea and reprecipitated by the addition of 
25ml 4M LiCl and incubation at 4°C for 24 h. RNA was again pelleted 
by centrifugation (16000g, 15min, 4°C), resuspended in 25ml lOmM 
Tris-HCl pH7.5; 0.2% w/v SDS followed by addition of sodium acetate to 
0.3M and additional SDS (sodium dodecyl sulphate) to a final 
concentration of 0.5% v/v and the resulting solution extracted 
thoroughly with 1:1 phenol: chloroform. Phase separation was achieved 
by centrifugation (16000g, 15min, 20°C), after which the RNA was 
ethanol precipitated and stored under 70% ethanol at -20°C.
2.4.1.2 From other rabbit tissues.
Tissues were dissected and immediately plunged into liquid
60
nitrogen. During dissection, gall bladders were removed from livers.
RNA. was obtained essentially according to Krieg et al (1983) . 
Tissues were ground under liquid nitrogen using a mortar and pestle. 
The ground powder was then added to a lysis/deproteinising mixture of 
10ml 6 6 % phenol; 0.3M sodium acetate pH7.5; 0.5% w/v SDS; 5mM EDTA.
The mixture was shaken gently but thoroughly for 5min before 
extraction with an equal volume of 25:1 chloroform: isoamyl alcohol
for 5min with shaking. Phase separation was achieved by 
centrifugation (12000g, 5min, 4°C) and the upper, aqueous phase 
re-extracted with chloroform: isoamyl alcohol prior to a further
extraction with an equal volume of chloroform (5min with shaking) . 
Following separation of phases by centrifugation as above, nucleic 
acids were precipitated from the upper, aqueous phase with two volumes 
of absolute ethanol overnight at -20°C and resuspended in 1ml of 
DEPC-treated water. RNA was selectively precipitated from this 
solution with an equal volume of 4M LiCl overnight at 4°C and pelleted 
by centrifugation (lOOOOg, 20min, 4°C) . Pellets were rinsed with 2ml 
70% ethanol and resuspended in 0.5ml DEPC-treated water. Magnesium 
chloride was added to a final concentration of 5mM and the solution 
treated with RNase-free DNasel at 25(lg/ml for 20min at room 
temperature to remove any contaminating DNA. The solution was then 
extracted once with an equal volume of 1:1 phenol chloroform and RNA 
precipitated by the addition of two volumes of absolute ethanol.
2.4.1.3 From cultured cell lines.
RNA for CAT mRNA analysis was obtained from adherent cell 
lines by a modification of the method of Chomczynski and Sacchi (1987) 
using the RNAzol kit.
Adherent cultured cells were collected in 1ml PBS from Petri 
dishes by scraping (Section 2.14.2) . 0.2ml of each suspension was
removed for assay of CAT enzyme activity (Section 2.14.4). The 
remaining 0.8ml was pelleted by centrifugation (500g, 30sec, room 
temperature) and the supernatant discarded. Pelleted cells were lysed 
in 0.8ml RNAzol solution (containing guanidinium isothiocyanate and 
phenol) by vortexing. The lysate was mixed with l/10th volume of 
chloroform by vortexing and incubated on ice for 15min. Phases were 
separated by centrifugation (12000g, 15min, 4°C) and RNA precipitated
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from the upper, aqueous phase by addition of an equal volume of 
isopropanol at -20°C for 3hours and pelleted by centrifugation 
(12000g, 15min., 4°C) . The pellet was washed once in 75% ethanol,
dried under vacuum, and resuspended in 0.1ml 0.5% w/v SDS, followed by 
precipitation with two volumes of absolute ethanol overnight at -20°C. 
The final RNA. pellet was resuspended in DEPC-treated water at lmg/ml.
2.4.1.4 Selection of poly A+ RNA.
This was performed according to Maniatis et al (1982) . 
Oligo(dT)-cellulose in loading buffer (0.1% w/v SDS; ImM EDTA; 0.5M 
NaCl; 20mM Tris-HCl pH 7.6) was poured to form a 1ml column in a 
sterile 10ml BioRad plastic disposable column. The column was then 
washed thoroughly in loading buffer. RNA was heated in loading buffer 
at 65°C for 5min, cooled and applied to the column. The flow-through 
was collected, re-heated and re-applied to the column twice. The 
column was then washed once with 5ml loading buffer and then three 
times with 2ml (loading buffer containing 0.1M NaCl) . The poly A+ RNA 
was then eluted from the column by the application of three successive 
lml aliquots of elution buffer (0.05% w/v SDS; ImM EDTA; lOmM Tris-HCl 
pH7.5), ethanol precipitated and stored under ethanol at -20°C.
2.4.2 Prokaryotic plasmid DNA.
2.4.2.1 Small scale preparation.
For preliminary analysis, plasmid DNA was prepared 
essentially according to the method of Bimboim and Doly (1979) .
A single transformed bacterial colony (Section 2.3) containing 
the plasmid of interest was inoculated into 5ml SuperBroth pH7.2 
(Gorman, 1985) [SuperBroth is a mixture of 9 volumes of Solution A 
(1.3% w/v Bacto-tryptone; 2.7% w/v yeast extract; 0.5% v/v glycerol) 
and 1 volume of Solution B (0.72M K2 HPO4 ; 0.28M KH2 PO4 ) ] . Ampicillin 
was added to 100pg/ml and the culture incubated at 37°C overnight in 
an orbital shaker. Bacterial cells were pelleted from lml of the 
overnight culture by microcentrifugation (12000g, 15sec, room 
temperature), resuspended in 0.1ml 50mM glucose; 25mM Tris-HCl pH8.0; 
lOmM EDTA; 2mg/ml lysozyme by vortexing and incubated at room 
temperature for 5 min to allow bacterial lysis. 0 .2 ml freshly-prepared
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0.2M NaOH; 1% w/v SDS was added and mixed gently without vortexing, 
followed by incubation on ice for 5min. The solution was neutralised 
by addition of 0.15ml ice-cold 5M potassium acetate pH4. 8 followed by 
thorough mixing. After a further 5-minute incubation on ice, 
precipitated genomic DNA and proteins were removed by 
microcentrifugation for 1 minute. Plasmid DNA was precipitated from 
the supernatant with 2  volumes of ethanol at room temperature for 
2 min, pelleted by microcentrifugation for 1 minute at room 
temperature, and, after rinsing with 70% ethanol resuspended in 20|ll 
water by vortexing and stored at -20°C . 2|il aliquots were used for 
analysis by digestion with restriction enzymes (Section 2.7.1) .
If required for later use, 0.5ml of the remaining 4ml bacterial 
culture was diluted with 0.5ml SuperBroth; 30% glycerol and stored at 
-20°C.
2.4.2.2 Bulk preparation
This was prepared essentially as a scaled-up version of the 
method of Bimboim and Doly (1979) described for small-scale 
preparations above (Section 2.4.2.1).
Bacteria containing the plasmid of interest were taken from 
storage (Section 2.4.2.1) and 100|ll inoculated into 10ml of SuperBroth 
(Section 2.4.2.1) supplemented with 100|ig/ml ampicillin and grown 
overnight at 37°C in an orbital shaker. 5ml of overnight culture was 
then transferred to an additional 500ml of SuperBroth containing 
100(Jg/ml ampicillin and incubated for 36 hours at 37°C in an orbital 
shaker. Bacteria were then pelleted by centrifugation (4000g, lOmin, 
4°C), resuspended in 10ml of lysis solution (50mM glucose; 25mM 
tris-HCl, pH8.0; lOmM EDTA; 5mg/ml lysozyme) and left at ambient 
temperature for 5min to allow bacterial lysis. 20ml of freshly 
prepared 0.2M NaOH; 1% w/v SDS was then added, mixed gently and the 
whole left on ice for 10 min. The solution was then neutralised by 
addition of 15ml 5M potassium acetate pH4.8, mixed thoroughly and 
incubated at 0°C for 10 min. Precipitated genomic DNA was then 
removed by centrifugation (16000g, lOmin, 4°C) and plasmid DNA 
precipitated from the supernatant by addition of 0 . 6  volumes of 
isopropanol and incubation at ambient temperature for 15min. After 
centrifugation (16000g, lOmin, room temperature) the pellet was
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resuspended in 2ml TE buffer (lOmM Tris-HCl pH8.0; ImM EDTA) . RNA 
was degraded by the addition of 50|ll of a boiled solution containing
lOmg/ml RNaseA and incubation for 30min at 37°C. Following extraction
with an equal volume of 1 : 1  phenol: chloroform, and ethanol
precipitation, the pellet was resuspended in lml TE buffer.
DNA was separated from degraded RNA by gel filtration colummn 
chromatography. After addition of 0.1ml lOx gel loading buffer
(Section 2.5.1) as a marker for the rate of migration, the
DNA-containing solution was loaded on to a 30cm, 1.5cm diameter Biogel 
A-50 column equilibrated in TE buffer. The column was run in TE 
buffer, and 2 ml fractions collected (approximately 6 -1 0 min per 
fraction) . Fractions containing the RNA-free peak were determined by 
spectrophotometry at 260 and 280nm (Section 2.2.4) and pooled. The 
pooled fractions were extracted once with an equal volume of 1 : 1  
phenol: chloroform, and ethanol precipitated twice. The purified DNA
was resuspended in water to lmg/ml and stored at -20°C
2.4.3 Single-stranded M13 viral DNA.
E . coli JM101 cells were transfected as described in Section 2.3 
and single, colourless plaques transferred to 1.5ml of a 1:100 
dilution in 2xTY (Section 2.3) of JM101 overnight culture, using a 
disposable plastic pipette tip. Growth was at 37°C with vigorous 
shaking for 5hours. Cultures wer transferred to 1.5ml microcentrifuge 
tubes and cells removed by microcentrifugation (12000g, 5min, room 
temperature) . After a second centrifugation to ensure complete 
removal of cells, the supernatant was decanted into a second tube and 
0.2ml 2.5M NaCl; 20% PEG (polyethylene glycol) 6000 added and mixed. 
Precipitated viral particles were pelleted as above and the 
supernatant removed. The tube was re-spun for 2min and all remaining 
traces of PEG supernatant removed. The pellet was redissolved in 
0.1ml TE buffer (lOmM Tris-HCl pH8.0; ImM EDTA) and 50)ll of 
TE-saturated phenol added to remove viral proteins. After vortexing 
for 15sec, the tube was allowed to stand for 15min at room 
temperature, vortexed for a further 15sec, and centrifuged for 3min. 
The aqueous phase was removed, and M13 single-stranded DNA recovered 
using the GeneClean kit as described in Section 2.6 .1.1.
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2.5 Gel electrophoresis of nucleic acids.
2.5.1 Agarose gel electrophoresis of DNA..
Agarose gel electrophoresis of DNA for either analytical or 
preparative purposes was performed using a flat bed apparatus. Gels 
were made from 0 .8 -2 .0 % w/v agarose dissolved and cast in buffer: lx
TAE (40mM Tris-HCl pH7.8; 20mM sodium acetate; ImM EDTA) when 
preparative isolation of fragments from low melting-point agarose was 
required; lx TBE (90mM Tris-HCl; 90mM boric acid; 2.5mM EDTA, pH8.3) 
in all other instances. Gels were cast by pouring agarose directly 
into the electrophoresis apparatus with a well-forming comb in place 
and the electrodes separated from the gel-forming chamber by removable 
plastic barriers. Once solidified the gel was submerged in the 
appropriate buffer and plasmid DNA solution (0.1-10|Og depending upon 
well size) containing l/10th volume of lOx gel loading buffer (50% 
glycerol; 0.4% w/v bromophenol blue; 0.4% xylene cyanol; ImM EDTA) 
loaded into the wells. The current applied was dependant upon the 
dimensions of the gel and the urgency of the immediate task but was 
generally in the range of 10-lOOmA for 0.5-18 h for gels cast and run 
in lx TBE buffer; 25 - 200mA for 2-18 h for gels cast and run in lx 
TAE buffer. Following electrophoresis, gels were soaked in ethidium 
bromide solution (3|Jg/ml) for lOmin and excess ethidium bromide 
removed by soaking the gel in water for lOmin. DNA was then visualised 
by illumination with short wave ultra-violet light and photographed 
through a red filter using Polaroid type 57 high-speed film.
2.5.2 Agarose gel electrophoresis of RNA.
Separation of RNA for "Northern" transfer was in formaldehyde 
denaturing gels prepared according to Maniatis et al (1982) . Agarose 
was dissolved in DEPC-treated water by boiling at 100°C. Following 
cooling to 60°C, 5x running buffer (200mM MOPS (morpholinopropane- 
sulphonic acid) pH7.0; 50mM sodium acetate; ImM EDTA) and formaldehyde 
were added to give a final gel composition of 1.4% w/v agarose; 2.2M 
formaldehyde; lx running buffer. Gels were immediately cast as 
described in Section 2.5.1 and submerged under lx running buffer. RNA 
samples were prepared for electrophoresis by lyophilisation and 
resuspension in lx running buffer followed by addition of formaldehyde
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and fomamide to 2.2M and 50% v/v respectively. These mixtures were 
then heated at 70°C for 15 min, cooled immediately on ice and l/10th 
volume of gel loading buffer (Section 2.5.1) added before loading. 
Electrophoresis was at 150mA with recirculation of buffer between 
electrode chambers until the dye had travelled 3/4 of the length of 
the gel. RNA size markers (9.5, 7.5, 4.4, 2.4, 1.4, and 0.3kb) were 
then stained in 3pg/ml ethidium bromide for 15 min, following 
separation of the lane containing the RNA markers from the rest of the 
gel, destained in lx running buffer for several hours and visualised 
as in Section 2.5.1 above.
2.5.3 Native polyacrylamide gel electrophoresis.
5% polyacrylamide gels for separation of fragments <500bp in 
length were prepared by polymerization of a de-gassed solution 
containing 4.75% w/v acrylamide; 0.25% w/v N, N' -methylene bis- 
acrylamide (1:19 bisracryl); lx TBE pH8.3; 0.2% v/v N,N,N',N'-tetra-
methylethylenediamine catalysed by the addition of ammonium 
persulphate to 0.1% w/v. Immediately after addition of ammonium 
persulphate, gels were cast by pouring between two glass plates 
separated by l-2mm, and a well-former inserted. Once solidifed, the 
gel was placed on a vertical apparatus with each end submerged in a 
reservoir of lx TBE buffer. DNA solution containing l/10th volume of 
lOx gel loading buffer (Section 2.5.1) was loaded and gels were run at 
25-100mA for 1-4 h. DNA was then visualised as in Section 2.5.1.
Non-denaturing strand-separating gels were prepared and run in a 
similar manner, except that the polymerised gels contained 5% (1:50
bis:acryl) polyacrylamide; 0.5x TBE, and were run at 100mA for 24-48 
hours.
2.5.4 Denaturing polyacrylamide gel electrophoresis.
6 % polyacrylmide denaturing gels (1:19 bis:acryl) were 
prepared as above (Section 2.5.3), except that the gel mix contained 
8 M urea and the separation of glass plates was only 0.6mm. Samples 
were denatured by heating at 100°C for 5min in 80% v/v formamide; 
0.08% w/v xylene cyanol; 0.08% w/v bromophenol blue then cooled 
immediately on ice. Gels were run at 1500V for 1.5-5 hours. After 
running, gels were transferred onto Whatman 3MM paper for drying.
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Gels containing 35S labelled DNA were exposed to Kodak X-AR5 film at 
room temperature; those containing 32P labelled DNA were exposed to 
Kodak XAR-5 film at -70°C with intensifying screens.
2.6 Purification of DNA restriction fragments
Depending upon the size of the DNA fragment of interest and the 
size of contaminating DNA fragments, electrophoresis was carried out 
either through low melting point agarose or polyacrylamide gels 
(Sections 2.5.1 and 2.5.3 above) . Following ethidium bromide staining 
and visualisation of stained bands, the appropriate region of the gel 
containing the DNA of interest was excised using a scalpel and the DNA 
purified by one of the following methods.
2.6.1 From low melting point agarose.
2.6 .1.1 Using silica beads.
In most cases, DNA fragments were recovered using the silica 
matrix suspension provided in the GeneClean kit using a modification 
of the method of Vogelstein and Gillespie (1979) .
The excised agarose slice was dissolved in 2.5 volumes of the 
sodium iodide solution provided (to an approximate final concentration 
of 4M Nal) at 55°C for 3min. 5|ll of the Glassmilk suspension supplied 
was added to the resulting solution, followed by incubation on ice for 
5min. DNA bound to the silica matrix was pelleted by centrifugation 
(12000g, 5sec, at room temperature) and the pellet washed by 
resuspension in 0.4ml of NEW (sodium chloride; ethanol; water) 
solution, prepared according to the manufacturer's instructions. 
After 2 more cycles of centrifugation and washing, the final pellet 
was resuspended in 10|Lll water and DNA eluted from the silica matrix by 
incubating at 55°C for 3min. The silica matrix was pelleted by 
centrifugation as above for 30sec and the DNA solution removed to a 
fresh tube. A second cycle of elution was performed on the silica 
matrix pellet, and the two eluates pooled. The DNA solution was 
stored at -20°C until required.
2.6 .1.2 Using Elutip-d mini-columns.
End-labelled fragments for DNasel footprinting (Section
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2.1.2) were recovered using Schleicher and Schull Elutip-d
mini-columns.
The gel slice containing the radio-labelled fragment was melted 
in an equal volume of solution I (0.2M NaCl; 20mM Tris-HCl pH7.5; lrrM 
EDTA) by heating at 70°C, and diluted to 10ml in Solution I at 42°C. 
The Elutip-d mini-column was hydrated by washing through with 3ml of 
solution II (1M NaCl; 20mM Tris pH7.5; ImM EDTA) using a disposable
plastic syringe, then equilibrated with 5ml of solution I at 42°C.
The molten agarose solution was then passed slowly through the column 
and agarose removed by washing with a further 5ml of solution I at 
42°C. Finally, radio-labelled DNA was eluted from the columm with 
0.6ml of solution II and ethanol precipitated with 30jjg yeast tRNA as 
carrier.
2.6.2 From polyacrylamide.
DNA fragments smaller than about 400bp were eluted from the 
gel slice in 0.5ml 0.5M ammonium acetate; ImM EDTA at 37°C overnight.
DNA fragments larger than about 400 b.p. were recovered by
electro-elution. The gel slice was placed in a piece of dialysis
tubing containing 3ml O.lx TAE buffer and the sealed dialysis tube 
placed in an electrophoresis tank containing O.lx TAE buffer. Elution 
of DNA was for 3hours at 100mA (600V) . During this period the DNA 
moves to the side of the dialysis tube, so a reversal of the current 
was applied for 3 min at the end of the electro-elution period. DNA
was ethanol precipitated with 10}Jg yeast tRNA as carrier, and
resuspended in water.
2.7 Manipulation of DNA
2.7.1 Digestion of DNA with restriction endonucleases.
Plasmid DNA was digested with 5-10 units enzyme/|ig DNA for 
1-3 hours under conditions specified by the supplier. In most cases, 
digests were phenol: chloroform extracted and ethanol precipitated 
(Sections 2.2.2 and 2.2.3) before proceeding to the next step.
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2.7.2 Conversion of 5' single-stranded regions of duplex DNA to
double-stranded DNA..
Blunt-ended DNA. for cloning was obtained by end-filling in 
the presence of deoxyribonucleotide triphosphates (dNTPs) using Klenow 
fragment of Eh_ coli DNA polymerase I. DNA was incubated at 14°C for 
2hours in 20(Jl of lOmM Tris-HCl pH7.9; 60mM NaCl; 7mM magnesium 
sulphate; 0.5mM p-mercaptoethanol; 0.5(JM each dNTP and 2 units Klenow 
fragment.
2.7.3 Ligation of DNA fragments into vectors.
Ligations were performed in 6 6 mM Tris-HCl pH7.5; ImM 
spermidine; 5mM MgCl2; 5mM DTT; ImM ATP overnight at 4°C using 1 unit 
of T4 DNA ligase. Reaction volumes (usually 10|ll) were such that the 
concentration of 5' ends was 0.1-1.0JJM. The molar ratio of vector to 
insert was generally in the range of 1:5 to 1:20 (in blunt-end 
ligations a greater proportion of insert was used to reduce religation 
of vector) .
2.7.4 Removal of 5' terminal phosphate groups.
In order to reduce the number of bacterial colonies 
containing non-recombinant plasmid molecules during sub-cloning, and 
as a prelude to 5' kinase end-labelling, the 5' phosphate groups of 
linear double-stranded DNA were removed by treatment with calf 
intestinal alkaline phosphatase (CIP) according to Maniatis et al 
(1982) .
At the end of a restriction enzyme digestion, the volume of the 
DNA solution was adjusted to 45|ll, and 5|H lOx CIP buffer (0.5M 
Tris-HCl pH9.0; lOmM MgCl2; ImM ZnCl2; lOmM spermidine) added. A 
ten-fold excess (0.1 units per pmole 5' ends) CIP (1 unit/jil) was 
added to ensure complete dephosphorylation. For dephosphorylation of 
5' overhangs, incubation was for 30min at 37°C, followed by addition 
of a second aliquot of enzyme and a second 30-minute incubation. For 
blunt ends and 3' overhangs, incubation was at 37°c for 15min, then 
56°C for 15min before addition of the second aliquot of enzyme and a 
second cycle of 37 and 56°C incubations. The dephosphorylation 
reaction was terminated by addition of 50|il water and SDS to 0.5% w/v,
followed by heating at 6 8 °C for 15min. CIP was removed by two rounds
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of 1:1 phenol: chloroform extraction, and dephosphorylated DNA was
recovered by ethanol precipitation.
2.7.5 Labelling of DNA with radio-i sot opes.
2.7.5.1 Random priming using Klenow polymerase.
Double-stranded fragments for probing DNA and RNA blots
(Section 2.11) were labelled using mixed hexadeoxyribonucleotide 
primers of random sequence essentially as described by Feinberg and 
Vogelstein (1983 and 1984).
An aqueous solution containing 50ng of DNA was boiled at 100°C 
for 7min then labelled in 50)ll of a solution containing 50mM Tris-HCl 
pH8.0; 5mM MgO^; lOmM (3-mercaptoethanol; 4mM each of dATP, dGTP and 
dTTP; 0.2M HEPES [N-2-hydroxyethyl-piperazine-N'-2'ethane sulphonic 
acid] pH6 .6 ; llOjlg/ml mixed hexadeoxynucleotides; 0.4mg/ml bovine 
serum albumin. Labelling was with 1.85xl0%q (1.lxl01 4 Bq/mmol) of
[a- P]dCTP using 10 units Klenow enzyme (labelling grade) . 
Incubation was for 2.5hours at room tenperature. The reaction was 
stopped by the addition of 34|il of 0.25M NaCl; 0.25M Tris-HCl pH7.5; 
25mM EDTA; 3% w/v SDS. Labelled products were ethanol precipitated 
with lOjlg yeast tRNA as carrier for 30min at -20°C. The labelled 
pellet was resuspended in water, heated at 100°C in boiling water for 
5min and rapidly cooled on ice before addition to the hybridisation 
solution (Section 2.1.1.4) .
2.7.5.2 Uniform labelling of SI probes.
Single-stranded, uniformly-label led probes for SI analysis of 
CAT and lacZ mRNAs were obtained essentially according to the method 
of Bentley (1984) .
Fragments were ligated (Section 2.7.3) into M13 mpl9 vector. 
The orientation of the fragments was such that primer extension on the 
Ml3 + strand template would generate probes complementary to the mRNA 
being analysed. Single-stranded M13 templates were generated as in 
Section 2.4.3. One quarter of each template preparation (5|ll) was 
added to Ifil (2|0g) of Ml3 Universal primer and l)ll of lOx Klenow 
buffer (lOOmM Tris-HCl pH8.0; 50mM MgC^) and annealed by heating to 
75°C in a beaker of water and then allowing to cool slowly to room
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temperature. Nucleotides were added to the annealed mixture to final 
concentrations of 1 0 0 |1M unlabelled dATP, dGTP and dTTP, 50|iM
unlabelled dCTP and 3(JM [a-3 2 P]dCTP (i.e 4.6x10^ of
14 ft1.1x10 Bq/mmol; 3.7x10 Bq/ml, dried down and resuspended in 2.9|il of
water) in a total volume of 14(il. Primer extension from the Ml3
Universal primer was catalysed by 2units Eh_ coli Klenow fragment
poymerase (sequencing grade) at room temperature for 15min. The
r
reaction was terminated by heating to 60°C for lOmin then probe 
released from the duplex by restriction enzyme cleavage at 37°C for 
lhour, using 2 (ll of the appropriate lOx buffer and 2 0 units of enzyme 
in a final volume of 20(il. Products were ethanol precipitated with 
10(lg yeast tRNA. as carrier, resuspended in 4(il of water and an equal 
volume of formamide sequenceing dye mix (Section 2.10.2.2) added. The 
probe was denatured by heating at 100°C in a boiling water-bath for 
5min, followed by rapid cooling on ice, then isolated on a 6 % 
denaturing polyacrylamide (1:19 bis:aery 1); 8M urea; lx TBE pH8.3 gel 
(Section 2.5.4) . Recovery of labelled probe from the polyacrylamide 
gel slice was by elution in 0.2ml of 0.5M ammonium acetate; lOmM 
magnesium acetate; O.lmM EDTA; 0.1% w/v SDS at 37°C overnight, 
followed by two rounds of ethanol precipitation of the eluate using 
lOjlg tRNA as carrier.
2.7.5.3 Kinase 5' end-labelling DNA.
Labelling of probes for primer extension and SI analyses, and 
for DNasel footprinting was performed as described by Maniatis et al 
(1982) .
Purified CIP-treated (Section 2.7.4) DNA (<20 pmoles 5' ends) was 
heated in 40(il of ImM spermidine; O.lmM EDTA; 20mM Tris-HCl pH9.5 at 
70°C for 5min, cooled immediately on ice and left for 5min. before 
addition of 5|ll of 0.5M Tris pH9.5; 0.1M MgC^; 50mM dithiothreitol;
50% glycerol and 3.7xl0%q (20pmoles) of 1.85xl014Bq/mmol [y-3 2 P]ATP. 
20 units (2|ll) of T4 polynucleotide kinase were then added and the 
mixture incubated at 37°C for 30min. The reaction was stopped by 
addition of 2(ll 0.5M EDTA and DNA precipitated with 10|lg yeast tRNA as 
carrier.
Kinase 5' end-labelled strands for use in SI and primer extension 
analyses were separated either on denaturing or non-denaturing
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polyacrylamide gels (Sections 2.5.3 and 2.5.4), depending upon whether 
the two strands were of different lengths.
2.8 SI nuclease protection analysis.
This was performed essentially according to the method of Berk 
and Sharp (1977), as modified by Weaver and Weissmann (1979) .
Kinase 5' end-labelled single-stranded probe (Section 2.7.5.3) 
was heated at 100°C in 10(11 80% v/v formamide for 2 min and cooled 
rapidly on ice. RNA. was precipitated, dried and the total amount of 
RNA made up to 50|lg with yeast tRNA where appropriate. l|ll of 4M 
NaCl; 0.4M PIPES [Piperazine-N,N'-bis (2-ethanesulphonic acid) ] pH6.4; 
lOmM EDTA was added to the RNA, dried and the whole resuspended in the 
1 0 ( 1 1 of probe/formamide mix and hybridisation performed at an 
appropriate temperature (usually 52°C) overnight in sealed glass 
micro-capillary tubes. Hybridised RNA:DNA hybrids were expelled into 
250(11 250rriM NaCl; ImM Zn SO4 ; 30mM sodium acetate, pH4.6. SI nuclease 
(usually 60 units) was then added and the mixture incubated at 37°C 
for lhour. Products were then ethanol precipitated, and resuspended 
in water. Following addition of 4 volumes of formamide sequencing dye 
mix (Section 2.10.2.2), samples were denatured by heating at 100°C in 
boiling water for 5min, and electrophoresed through a 6 % denaturing 
polyacrylamide (1:19 bis:acryl); 8M urea; lx TBE pH8.3 gel (Section
2.5.4) .
2.9 Primer extension analysis.
RNA:DNA hybrids were set up as for SI nuclease analysis above 
(Section 2.8). After hybridisation overnight, hybrids were expelled 
into 100(11 of ice-cold 03M sodium acetate and ethanol precipitated. 
Hybrids were then resuspended in 50(ll lOOmM Tris-HCl pH8.3; lOmM 
M 3CI2 ; 140mM KC1; 20mM (3-mercaptoethanol; ImM each dNTP and primer 
extension performed using lOunits AMV (Avian Myeloblastosis Virus) 
reverse transcriptase at 42°C. 10|ll 1M NaOH was then added to degrade
RNA and incubation at 42°C continued for a further lhour. 
Neutralisation was achieved by addition of 10(ll of 1M HC1 and products 
ethanol precipitated. Primer extension products were pelleted by 
microcentrifugation (12000g, lOmin, room temperature), resuspended in 
water and 4 volumes of formamide dye mix (Section 2.10.2.2) added.
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Products were denatured by heating at 100°C in boiling waterfor 5min, 
cooled rapidly on ice, then resolved on a 6 % denaturing polyacrylamide 
(1:19 bisracryl); 8M urea; lxTBE pH8.3 gel.
2.10 Sequencing of nucleic acids.
2.10.1 mRNA sequencing.
mRNA sequencing was performed exactly as for primer extension 
(Section 2.9), but reverse transcription was performed in the presence 
of one of the four dideoxynucleotide triphosphates (ddNTPs) in each of 
four reactions. ddNTP concentrations were varied from experiment to 
experiment in the following ranges: ddATP 0.1-0.8mM; ddCTP 0.05-0.8mM; 
ddGTP 0.05-0.4mM; ddTTP 0.2-1.5mM
2.10.2 DNA. sequencing.
Sub-cloning of fragments for sequencing, preparation of 
single-stranded templates and sequencing by the dideoxy 
chain-termination method of Sanger et al (1977) were performed 
essentially as described in the M13 cloning and sequencing manual 
provided by Amersham.
2.10.2.1 Sub-cloning of fragments for sequencing.
Fragments to be sequenced were ligated into linearised 
double-stranded, replicative form M13 mplO, mpl8 and mpl9 viral 
vectors (Massing and Vieira, 1982; Norrander et al, 1983; 
Yanish-Perron et al, 1985) as described in Section 2.7.3).
9pmoles of fragment were circularised for 90min at 4°C in 50(11 
of 6 6 mM Tris-HCl; 5mM MgC^; 5mM dithiothreitol; ImM ATP using 2 units 
of T4 DNA ligase to try to ensure random generation of fragments 
during sonication. Fragments for shot-gun sequencing were then 
generated by sonication (six lOsec bursts at low power - 10(1 amplitude 
- using an MSE Soniprep 150 sonicator) . Sonicated fragments were 
size-fractionated by agarose gel electrophoresis, and fragments within 
the range 200-400bp recovered as in Section 2.6 .1.1, and end-repaired 
as in Section 2.7.2 before cloning into Smal-cut vector.
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2 .1 0 .2 . 2  Dideoxy chain-temination sequencing.
Sequencing of single-stranded Ml 3 viral DNA templates, 
prepared as in Section 2.4.3, was performed according to the method of 
Sanger et al (1977) in the presence of [a-8 5 S]dATPcxS (Biggin et al, 
1983).
7.5|ll (approx. 0.4pmoles; 1/4 of the total) single-stranded 
template was annealed with ljil of M13 Universal primer (2jig/ml; 5' -GT- 
AAAACGACGGCCAGT-3') in a total volume of 10|ll of a 15mM Tris-HCl 
pH8.0; 7.5mM MgC^ solution by incubating at 60°C for 2 hours. 1.5jll
of 2.2xl01 3 Bq/mmol; 3.7xl08Bq/ml [oc3 5 -S]dATPaS (25pmoles) and l(ll (1 
unit) Eh_ coli Klenow polymerase were then added and incorporation of 
radio-label into a complementary strand to the Ml3 template was 
initiated by adding 2.5|ll of the resulting mixture to each of four 
tubes containing 2 |il of appropriate mixtures of deoxyribonucleotides 
(dNTPs) and dideoxyribonucleoties (ddNTPs) as follows:
Tube A
*
(dATP°/ddATP) 2.5mM Tris-HCl pH8 .0; 0.25mM EDTA; 0.12nM
dCTP; 0.12mM dGTP; 0.12mM dTTP; 0.05nM ddATP.
Tube C (dCTP°/ddCTP) 3.3mM Tris-HCl pH8.0; 0.33mM EDTA; 8.3|iM dCTP;
0.17mM dGTP; 0.17mM dTTP; 0.05mM ddCTP.
Tube G (cGTP°/ddGTP) ; 3.3mM Tris-HCl pH8.0; 0.33mM EDTA; 0.17mM
dCTP; 8 .3fiM dGTP; 0.17mM dTTP; 0.02mM ddGTP.
Tube T (dTTP0 /ddTTP) 3.3mM Tris-HCl pH8.0; 0.33mM EDTA; 0.17mM
dCTP; 0.17mM dGTP; 8 . 3|JM dTTP; 0.25mM ddTTP. 
(Where appropriate, sequencing reactions were fine-tuned to achieve 
incorporation into larger or smaller products by adjustment of the 
quantities of ddNTPs)
After incubation at room temperature for 20min, 2|Jl of chase 
solution (0.5mM each dNTP) was added and incubation continued for a 
further 15min at room temperature. The sequencing reaction was
terminated by addition of 4|H of formamide dye mix (95% formamide;
lOmM EDTA; 0.1% w/v bromophenol blue; 0.1% xylene cyanol) .
Products of the four sequencing reactions were denatured by
heating at 100°C in boiling water for 5min, cooled rapidly on ice and 
resolved on a 6 % denaturing polyacrylamide (1:19 bis:acryl); 8 M urea; 
lx TBE pH8.3 gel.
74
2.10.2.3 Conputer analysis of sequences.
Sequence analysis was performed on an IBM PC-AT microcomputer 
using "MicroGenie" software (Beckmann).
2.11 DNA:DNA and DNA:RNA hybridisation techniques.
2.11.1 Capillary transfer from agarose gels by Southern blotting.
DNA fragments separated by agarose gel electrophoresis
(Section 2.5.1) were transferred to Biodyne Membranes by the method of 
Southern (1975) prior to hybridisation (Section 2.11.4) with 
radio-labelled DNA probes prepared as in Section 2.7.5.1. Following 
ethidium bromide staining and photography, DNA was denatured by 
rinsing the gel twice in 0.5M NaOH; 1.5M NaCl for 30min each, followed 
by neutralisation in 3M sodium acetate pH5.5 for 1 hour. The gel was 
then transferred to a raised platform covered with two sheets of 
Whatman 3MM paper soaked in 20xSSC (3M NaCl; 0.3M sodium citrate 
pH7.0) such that the ends of the filter paper extended below the 
platform into a reservoir of 20xSSC. Care was taken to ensure that 
there were no visible bubbles between the filter paper and the gel. 
The complete assembly around the gel was then sealed off from the 
space above using plastic sheets to ensure that all movement of liquid 
occurred through the gel. A sheet of dry Biodyne membrane was then 
placed in direct contact with the gel, without any intervening 
bubbles. Two sheets of Whatman 3MM filter paper (pre-soaked in 2xSSC) 
were then placed directly on top of the membrane. Finally, the 
contents of a box of tissues were placed on top of the filter paper 
and compressed with a 1kg weight. The complete assembly was left 
overnight to allow transfer of DNA. The position of the gel wells was 
marked on the blotted membrane. Completion of transfer of DNA from 
the gel was checked by re-staining the gel in ethidium bromide. The 
filter was air dried, baked at 80°C for 2-3 hours and then stored dry 
in a sealed plastic bag at room temperature until required.
2.11.2 Electro-blotting.
Short DNA restriction fragments (<500bp) separated in 
polyacrylamide gels were transferred to Biodyne membranes by 
electro-blotting.
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Fragments were resolved on a 5% non-denaturing polyacrylamide 
gel (1:19 bis: aery 1 ), stained in ethidium bromide solution and bands 
visualised as in Section 2.5.1. DNA was then denatured by soaking in 
0.2M NaOH; 0.5M NaCl for 30min, followed by neutralisation by washing 
twice in 5x TBE pH8.3 buffer (Section 2.5.1) for lOmin each. The gel 
was then placed in contact with a sheet of pre-cut, dry Biodyne 
membrane between two sheets of Whatman 3MM filter paper soaked in 0.5x 
TBE. This assembly was inserted upright in the electro-blot 
apparatus, between two sponge pads held in a plastic holder, such that 
the membrane was on the anode side of the gel. Electrophoretic 
transfer in 0.5x TBE was for 14hours at 250mA (30V), after which the 
filter was baked at 80°C for 2hours. Successful transfer was 
confirmed by re-staining the electro-blotted gel in ethidium bromide 
solution.
2.11.3 Northern blotting.
RNA separated in denaturing agarose gels (Section 2.5.2) was 
transferred to nitrocellulose as described in Section 2.11.1, except 
that no pretreatment of the gels was performed before assembly into 
the transfer apparatus.
2.11.4 Hybridisation of nucleic acids immobilised on filters.
Blotted filters were wetted in 2xSSC and transferred to
plastic bags. Prehybridisation buffer (50% v/v formamide; 5xSSC; 5x 
Denhardt's solution [lOOx Denhardt's is 2% bovine serum albumin; 2% 
polyvinylpyrollidone; 2% Ficoll pH8.0]; lOjlg/ml polyA; 10pg/ml polyC; 
0.25 mg/ml denatured salmon sperm DNA; 0.1% w/v SDS) was then added, 
the bag heat-sealed and incubated overnight at 42°C with shaking. 
Prehybridisation buffer was then removed and replaced with 
hybridisation buffer (50% formamide; 10% w/v dextran sulphate; 5x SSC; 
lx Denhardt's solution; lOpg/ml polyA; 10}jg/ml polyC; 100pg/ml salmon 
sperm DNA; 0.1% w/v SDS) containing denatured radio-labelled probe of 
specific activity approx. 2xl0^cpm/|lg (prepared as in Section 2.7.5.1) 
such that the probe concentration was 10-20ng/ml. Bags were then 
sealed and incubated at 42°C overnight. Filters were then washed 
three times in 2xSSC; 0.1% w/v SDS at room temperature for 5min. and 
then twice in O.lxSSC; 0.1% w/v SDS at 65°C for 30 min. Filters were
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air dried, wrapped in thin plastic and exposed to Kodak XAR-5 film at 
-70°C with intensifying screens.
2.12 In vitro DNasel digestion.
DNasel 11 footprinting" was performed as described by Plumb and 
Goodwin (1987) . Plasmid DNA was linearised by restriction 
endonuclease cleavage, phosphatased (Section 2.7.4) and kinase 5' 
end-labelled (Section 2.7.5.3). An appropriate double-stranded 
fragment, end-labelled on only one strand was obtained by a secondary 
restriction digestion at an appropriate site, isolated by agarose gel 
electrophoresis (Section 2.5.1), localised by autoradiography and 
recovered as in Section 2.6 .1.2.
Various amounts (0-30(Jg protein) of nuclear protein extract, 
prepared as in Section 2.15, were incubated at 4°C for 90min. with 
approximately 2 ng of end-labelled restriction fragment in 1 0 0 ( 1 1 of 
50mM NaCl; 200mM HEPES (N-2-hydroxyethyl-piperazine-N' -2-ethane 
sulphonic acid) pH7.9; 5mM MgCl2; O.lmM EDTA; 20% glycerol; ImM EDTA; 
l|Ug/ml poly(dlidC) : (dlrdC) . DNase I digestion (0.5-4|il of 0.2mg/ml 
enzyme in 50mM NaCl; 200mM HEPES pH7.9; 5mM MgCl2; O.lmM EDTA; O.lmM 
CaCl2  for DNA-protein complexes; 2-4fil of 0.02mg/ml enzyme for 
zero-protein controls) was for 30sec at room temperature. The 
reaction was terminated by addition of lOOpl of 80mM Tris-HCl pH8.0; 
8mM EDTA; 1% w/v SDS; 250mM NaCl; 0.4mg/ml proteinase K; 70|lg/ml yeast 
tRNA and incubation at 37°C for 30min, followed by heating to 90°C for 
2min. Products were extracted once with 1:1 phenol: chloroform and
once with chloroform, then precipitated at -70°C for lOmin following 
addition of 1/16th volume 4M LiCl and 3 volumes absolute ethanol. The 
pellet was washed with absolute ethanol, dried under vacuum, and 
resuspended in formamide sequencing dye mix (Section 2.10.2.2) . 
Products were heated to 90°C for 2min., cooled rapidly on solid C02, 
vortexed, heated and cooled again, then resolved on a 6 % denaturing 
polyacrylamide (1:19 bis:acryl); 8M urea; lx TBE pH8.3 gel and 
visualised by autoradiography.
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2.13 Eukaryotic cell culture.
2.13.1 Culture of cells.
All cells were obtained from Beatson Institute stocks.
The adherent murine erythroleukaemia (MEL) Friend cell line 
F4-12B2 and murine STO fibroblast line were grown in Special Liquid 
Medium (SIM) supplemented with 4mM glutamine; 10% v/v bovine foetal 
serum;37.5|Jg/ml penicillin; lOOfig/ml streptomycin in 5% CC>2 /9 5 % air at 
37°C. Cells were grown as adherent monolayers in sterile plastic 
flasks until subconfluent, then harvested and subcultured at 1.7-3x10^
O
cells/cm .
To remove adherent cells from culture flasks, medium was first 
removed by aspiration and the cells washed once in PBS (phosphate 
buffered saline: 0.14M NaCl; 27mM KC1; lOmM Na2 HPO^; 15mM KH2 PO4 .
Trypsin solution (0.025% w/v in citrate buffer, pH7.8) was then added 
to the monolayer and cells dislodged by briefly rinsing cells. Cells 
were then mixed with an equal volume of medium to inactivate trypsin 
and an aliquot removed for determination of cell numbers using a 
Coulter counter. Appropriate dilutions of the cells were made in SLM 
plus supplements (as above) following pelleting of cells by
centrifugation at 1500rpm for 5min at room temperature in sterile 
plastic Universal containers.
All cell lines were examined for the presence of mycoplasma using 
the Hoechst 33258 staining method of Chen (1977). Only cells in which 
mycoplasma was undetectable were used for experimentation. Any cell 
stocks in which mycoplasma was detected were removed from the 
Institute and destroyed.
2.13.2 Storage of cells in liquid nitrogen.
Cells were trypsinised, pelleted and resuspended at 
0 .5 -lxl0 7  cells/ml in medium containing 1 0 % v/v dimethylsulphoxide. 
lml aliquots were placed in plastic 1.5ml Nunc tubes and these were 
wrapped in cotton wool inside a polystyrene box and placed at -70°C 
overnight. (Cooling of cells is at approximately 1°C per minute under 
these conditions). Frozen cells were then stored in liquid nitrogen.
Recovery from storage was effected by rapid thawing at 37°C. 
Thawed cells were then washed in 10ml of DMSO-free medium, harvested
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as above, and transferred to a small flask of DMSO-free medium.
2.14 Assay of transient expression of exogenous DNA in cultured 
cells.
2.14.1 DNA mediated gene transfer into eukaryotic cells.
Adherent cells were transfected essentially according to the 
calcium phosphate co-precipitation method of Graham and van der Eb 
(1973) as modified according to Gorman (1985) .
24 hours before transfection, cells were harvested and counted as 
in Section 2.13.1, and plated out at 10^ cells per 9cm Petri dish 
(1. 6xl0^cells/cm^ in 10ml medium and incubated in an atmosphere of 5% 
C0 2 /9 5 % air at 37°C.
For each precipitate, 2.4pmoles of the CAT recombinant plasmid 
under test (ll-20|Jg, depending on size) and 4pmoles (20|Ug) of internal 
control plasmid, pHSV-(3gal (Fig. 17) were added to 1ml of ImM Tris-HCl 
pH8.0; 0.0ImM EDTA; 0.25M CaC^, and pUC18 plasmid DNA added to a
total of 40|ig DNA. This mixture was then added slowly to 1ml of 2xHBS 
(280mM NaCl; 50mM HEPES [N-2-hydroxyethylpiperazine-N'-2' -ethane
sulphonic acid]; 1.3mM ^ 2 ^ 0 4 .2 ^ 0  pH7.1) using a sterile plastic 
pipette tip, and aerated by pipetting up-and-down vigorously. 
Precipitates were allowed to stand for 30min at room temperature then 
half of each precipitate (1ml; 20jog DNA) was added to a dish of each 
of the two cell types being transfected.
Cells were returned to the incubator for 18-24hours before 
removing the precipitate and medium, replacing with 1 0 ml fresh medium, 
and returning to the incubator for a further 18-24hours.
2.14.2 Harvesting transfected cells and preparation of soluble 
protein extracts
Cells were harvested approximately 48hours after addition of 
calcium phosphate: DNA co-precipitates. Medium was removed by 
aspiration and cells were rinsed briefly with 10ml PBS. The cells 
were then scraped off the dish surface in 1ml PBS using a disposable 
spatula, transferred to a microcentrifuge tube and pelleted by 
centrifugation (500g, 30sec, room temperature) . The cell pellet was 
then resuspended in 200jll of 250mM Tris-HCl pH7.8 by vortexing.
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Cells were disrupted by three freeze-thaw cycles, alternating between 
-70°C for 5 min and 37°C for 5 min. After pelleting debris by 
microcentrifugation at 1 2 0 0 0 g for 2 min at room temperature, the 
supernatant was removed to a fresh tube and stored at -20°C.
2.14.3 Determination of protein concentration of extracts.
This was determined by the method of Bradford (1976) using 
prepared reagents purchased from Bio-Rad.
The absorbance caused by complex formation between 0.9ml of 
Bio-Rad reagent and protein from an aliquot of extract (the equivalent 
of lfll of extract made up to 1 0 0 ( 1 1 in water) was measured 
spectrophotometrically at 595nm and compared with that due to a range 
of concentrations of bovine y-globulin prepared at the same time. 
Absorbances were measured within 15min of mixing of the reagents to 
avoid distortion of results due to formation of a turbid precipitate.
2.14.4 (3-galactosidase assay.
Transfected cell lysates, prepared as in Section 2.14.2 were 
assayed for (3-galactosidase activity as internal control for 
transfection efficiency essentially as described by Gorman (1985).
lml of 60mM Na2 HP04; 40mM NaH2 P04; lOmM KC1; ImM MgCl2; 50mM 
P-mercaptoethanol and 0.2ml of 60mM Na2 HP04; 40mM NaH2 P04; 2mg/ml ONPG 
(o-nitrophenyl-fi-galactopyranoside) were mixed in plastic spectro­
photometer cuvettes and the reaction commenced by addition of 60|il 
(from a total of 200|ll) of transfected cell lysate. After incubation 
at 37°C for lhour, the reaction was terminated by addition of 0.25ml 
1M Na2 C0 3 , and ONP (o-nitrophenol) production measured 
spectrophotometrically at 420nm (E42q = 2.13xl04 ltr.mole ^.cm )^ .
2.14.5 Measurement of chloramphenicol acetyItransf erase (CAT)
activity
Aliquots of cell extracts prepared as detailed in Section
2.14.2 were diluted to 89|ll with 250mM Tris-HCl pH7.8 such that the 
same amount of (3-galactosidase activity (as determined in Section
2.14.4) was taken from each of the extracts prepared from a given cell 
line in a given experiment. These were then heated at 60°C for 7mins. 
to denature proteins other than CAT which utilise acetyl CoenzymeA as
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a substrate. Assays were then performed by the addition of llpl of a 
mixture consisting of 1 volume of D-threo-(dichloro- 
acetyl-l-1 4 C) -chloramphenicol (2xl09Bq/mmol; 7.4xl06Bq/ml) and 10 
volumes lOmM acetyl CoA to each sample and incubation at 37°C for 30 
min. Reactions were terminated by the addition of 300|ll ethyl acetate 
and vortexing. Phase separation was by microcentrifugation (12000g, 
2 min, room terrperature) after which the organic phase was removed to a 
fresh tube and dried down on a Savant speedivac concentrator (20 min) .
The mixture of unacetylated and acetylated chloramphenicol was 
then dissolved in 2 0 |ll ethyl acetate, transferred to plastic-backed 
thin layer chromatography (TLC) plates and chromatography performed 
using 95% v/v chloroform; 5% v/v methanol as the mobile phase. TLC 
plates were then exposed to Kodak XAR-5 at room temperature. 
Quantitation of CAT activity in each extract was achieved by 
separately counting the radioactivity in the unacetylated and 
acetylated spots, cut from the TLC plate, in an LKB 1217 Rackbeta 
liquid scintillation counter.
2.14.6 Correction of CAT activities for ft-galactosidase activity.
As described above, CAT assays in a given experiment were 
performed such that amounts of extract from a given cell line used in 
the CAT assay contained equivalent amounts of (3-galactosidase 
activity. However, different (3-galacosidase activities were used for 
different cell lines and for different experiments. So, to correct 
all results to the same level of p-galactosidase activity, results 
obtained by scintillation counting were adjusted so that they 
represented the CAT activity present in that amount of extract which 
produced lxl0-®moles ONP under the standard conditions of the 
p-galactosidase assay (Section 2.14.4). The number of moles produced 
can be calculated from the concentration of ONP in 0.85ml of the 
stopped reaction, as determined from the O D ^ q extinction
co-efficient of ONP (A = Eel, where: A is the OD^O'* e is the 
extinction co-efficient of ONP (2.13xl04ltr.mole_1.cm-1; c is the 
concentration of ONP; and 1 is the path length of the 
spectrophotometric measurement (1 cm)) .
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2.15 Preparation of nuclear protein extracts from eukaryotic cells.
Nuclear extracts for DNasel protection studies, kindly provided 
by M. Plumb, H. Wainwright and K. Macleod, were prepared essentially 
according to Plumb et al (1985).
Cells were lysed in Solution A (lOmM Tris-HCl pH7.5; 5mM MgCl2; 
0.25M sucrose; 0.2% w/v Triton X-100; 0.5mM PMSF (phenylmethyl
sulphonyl fluoride) and nuclei obtained by centrifugation (1600g, 
30min, 4°C) after filtration through three layers of gauze. The 
nuclei were washed twice with solution A, then resuspended at 
5-10mg/ml in lOmM Tris-HCl pH7.5; 5mM MgCl2; 0.25M sucrose; 0.5mM PMSF 
at 4°C. 4M NaCl at 4°C was added drop-wise to a final concentration 
of 0.3M, followed by incubation at 37°C for lOmin. After 
centrifugation (4000g, lOmin, 4°C), the supernatant was kept at 4°C 
while the extraction procedure was repeated on the pellet. The two 
final supernatants were then pooled and clarified by centrifugation at 
lOOOOOg for 60min at 4°C. Partial purification and concentration of 
nuclear proteins was achieved by addition of solid ammonium sulphate 
to a concentration of 0.35mg/ml, followed by centrifugation (lOOOOg, 
30min, 4°C) and resuspension of pelleted proteins in E^q buffer (50mM 
ammonium sulphate; 20mM HEPES (N-2-hydroxy-
ethyl-l-piperazine-N'-2-ethane sulphonic acid) pH7.9; 5mM MgCl2; O.lmM 
EDTA; 0.1% Brij35; ImM dithiothreitol; 20% v/v glycerol. The 
suspension was then dialysed overnight against E^q buffer at 4°C and 
the dialysate clarified by centrifugation (lOOOOOg, 60min, 4°C). The 
"crude" nuclear protein extracts were stored at -20°C, until required.
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Chapter 3. 
RESULTS.
3.1 SEQUENCE SURROUNDING THE ATG TRANSLATION INITIATION CODON OF THE
RBC 15-LOX GENE.
The approximate location of the first protein-coding exon within 
the rabbit RBC 15-LOX genomic clone, ?i8 , has been determined by 
hybridisation of labelled pGF6 cDNA insert:, which accurately predicts 
the first 30 N-terminal residues of the rabbit protein, to Southern 
blots of various restriction digests of the genomic clone (Thiele et 
al, 1987) . The 5' end of the cDNA insert of pGF6 hybridises to a 
276bp SstI fragment contained within a 1.5kb EcoRI fragment of the 
genomic clone (Fig. 3) .
The polarity of the RBC 15-LOX genomic clone has been determined 
by comparing a detailed restriction map of this region with the 
restriction map of pGF6 cDNA insert, determined from its nucleotide 
sequence. The same order of restriction sites (5'-TaqI-BalI-SstI-3') 
seen in both clones indicates that the 276bp SstI fragment lies within 
the 5' half of the 1.5kb EcoRI genomic fragment (Fig. 3) .
A 633bp Smal fragment containing the 276bp SstI fragment was 
isolated from the 1.5kb EcoRI genomic fragment and sequenced according 
to the strategy shown in Figure 3. Appropriate double-stranded 
fragments were sub-cloned into double-stranded replicative form Ml3 
virus (mplO, mpl8 or mpl9) (Rfessing and Vieira, 1982; Norrander et al, 
1983; Yanisch-Perron et al, 1985), and single-stranded M13 templates 
were sequenced by the dideoxy. chain termination method of Sanger et 
al (1977). Sub-clones containing the entire 633bp Smal fragment 
permit sequence to be established from either end of the fragment, 
while the central region of the Smal fragment was sequenced from 
sub-clones containing the 276bp SstI fragment. However, there are no 
convenient restriction sites available for cloning into Ml3 the region 
spanning the more 5' SstI site. To be sure that this SstI site is 
not, in fact, two closely-spaced sites, it was decided to perform 
"shot-gun" cloning of sonicated, end-filled fragments of the 633bp 
Smal fragment into Smal-cut M13npl0 (Fig. 3) . Thus, all regions have 
been sequenced on both strands, and almost the entire sequence has 
been determined from a minimum of three independent Ml3 sub-clones.
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3.1.1 The genomic clone/ AS, is a genuine RBC 15-LOX recombinant/
accurately predicting the N-teiminal amino acid sequence of 
the RBC 15-LOX protein.
The sequence of the 633bp Smal genomic fragment (Fig. 4) 
conclusively proves that the AS genomic recombinant represents a 
genuine clone of the RBC 15-LOX gene. The sequence accurately 
predicts the first 30 amino acids of the RBC 15-LOX protein, the codon 
for the N-terminal glycine residue being immediately preceded by an 
ATG codon.
The sequence of the 633bp genomic Smal fragment is identical to 
that of the pGF6 cDNA insert for 130nt, including the whole of the 
region which encodes the known N-terminal amino acid sequence of the 
RBC 15-LOX protein. However, a complete comparison of the genomic and 
cDNA sequences in this region, aligned according to the apparent 
protein-coding regions, shows two regions of non-homology, one 5' of a 
point llbp upstream of the translation initiation ATG codon, the other 
beginning 119bp downstream of the ATG (Fig. 4) .
The sequence mismatch downstream from the ATG codon probably 
represents an exon-intron boundary. The genomic sequence AGGTGAGC 
shows a 7 / 8  match with the splice donor consensus sequence 
(C/A) GGT (G/A) (A/G) GT of Senapathy (1988), the mismatched nucleotide 
being the final one of the eight. However, comparison of the genomic 
and pGF6 cDNA sequences show 4 mismatches within the 13nt preceding 
this motif. Recently, cDNA clones covering the entire length of the 
RBC 15-LOX mRNA have been obtained from an independently-constructed 
cDNA library (J. Fleming and B. Thiele, unpublished results) . One of 
these, PCR-AH25, matches the genomic sequence all the way to the 
putative splice donor sequence, after which point it matches neither 
genomic nor pGF6 cDNA sequences. This sequence is significant in 2 
respects. Firstly, it suggests that the genomic sequence motif does 
indeed represent a splice donor sequence, and that the mismatches with 
pGF6  insert sequences are due to errors in the sequencing of the pGF6  
cDNA. Secondly, the difference between PCR-AH25 and pGF6 cDNA
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sequences beyond the putative splice point suggests that either these 
two cDNAs correspond to alternatively-spliced transcripts, or that one 
or other represents a recombinant cDNA. In fact, sequencing of other 
RBC 15-LOX cDNA clones has very recently revealed that the pGF6 cDNA 
insert contains sequences which are not contiguous in a full-length 
cDNA: its final 126nt (nt 231 to 356), from immediately following the
putative splice site to its 3' end, correspond to sequences 1620 to 
1745nt beyond the ATG translation initiation codon in the full-length 
cDNA. While one cannot be sure that the pGF6 cDNA insert does not 
represent a shorter alternatively-spliced transcript, it seems more 
likely that it is a recombinant cDNA in which sequences from further
3' in the mRNA may have become linked to sequences encoding the
N-terminal region of the protein during the blunt-end ligation of 
double-stranded cDNA into blunt-ended vector in construction of the 
cDNA library. This suggestion is supported by the observation, in the 
same cDNA library from which pGF6 was obtained, of other recombinant 
clones containing RBC 15-LOX sequences from distant parts of the mRNA, 
joined end-to-end, which do not correspond to splice junctions in
genomic sequences (J. Fleming and B. Thiele, unpublished results) .
Whether the genomic sequence containing the AGGT motif does 
indeed represent a genuine splice donor site could easily be confirmed 
by performing an SI protection experiment using a 3' end-labelled 
genomic probe. This experiment has not yet been performed, as 
interest has been concentrated upon the 5' end of the mRNA and the 
transcription initiation site of the RBC 15-LOX gene.
3.1.2 The 5' end of the pGF6  cDNA insert is not derived from a RBC
15-LOX mRNA.
The other region of mismatch between genomic and cDNA 
sequences begins llbp upstream of the ATG translation initiation 
codon. This corresponds to a point 90bp from the 5' end of the cDNA. 
There can be no doubt, as explained above, that the central portion of 
the pGF6 cDNA insert arises from a genuine RBC 15-LOX mRNA, since its 
sequence correctly predicts the first 30 amino acids of the RBC 15-LOX 
protein (Thiele et al, 1987) . So, the question arises as to what the
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most 5' 90bp of the pGF6 cDNA insert represent. They may be derived 
from an upstream exon, in which case the first mis-matched nucleotide 
of the genomic sequence represents the final nucleotide of an intron. 
Alternatively, the 5' end of the pGF6 cDNA insert may be the result of 
an artefactual cloning event of the sort discussed above.
If the whole of the pGF6  cDNA insert 5' of the putative splice
point described in Section 3.1.2 above is derived from a single,
genuine RBC 15-LOX messenger, the first 90nt being transcribed from 
one or more short exons upstream of the first coding exon, then the
full length of any fragment from the 5' end of pGF6 should be
protected when used in an SI protection experiment with reticulocyte 
RNA.
So, a 72bp Sau3A fragment corresponding to nucleotides 66-137 of 
the pGF6 cDNA insert (Fig. 4), was end-labelled and used as a probe 
for SI protection (see Fig. 5) . This fragment spans the point at 
which the mismatch between cDNA and genomic sequences begins. Several 
attempts to separate the two strands of the fragment were 
unsuccessful. So, a double-stranded cDNA probe was hybridised with 
RNA. Since complete degradation of probe was seen in controls, where 
double-stranded probe was hybridised with rabbit total liver RNA and 
yeast tRNA (Fig. 5, tracks L and t), protection seen with reticulocyte 
RNA is not due to renaturation of the two strands of the probe.
No protection of full-length probe by reticulocyte total RNA is 
detectable. Rather, the reticulocyte RNA protects a cluster of 
fragments, the longest of which is 55nt long. As the 5' end of the 
probe's non-coding strand lies 42nt downstream of the complement of 
the ATG codon, the reticulocyte RNA population protects the cDNA probe 
to a position only 13nt upstream of the ATG codon. This corresponds 
to the point at which the sequence mismatch begins, and indicates that 
the cDNA sequences in the upstream mismatched region are not present 
in a genuine RBC 15-LOX messenger. It seems likely that, during 
construction of the cDNA library, there has been a linking of another 
cDNA fragment on to the 5' end of a genuine RBC 15-LOX cDNA.
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Figure 5. SI nuclease analysis using a 72bp Sau3A probe derived from
pGF6  cDNA insert.
The dephosphorylated 72bp Sau3A fragment was kinase 5' 
end-labelled and ethanol precipitated then denatured and loaded on to 
a 5% polyacrylamide non-denaturing strand-separating gel. After 
unsuccessful strand-separation, double-stranded end-label led fragment 
was recovered by electro-elution followed by ethanol precipitation 
using lOOpg yeast tRNA as carrier. Double-stranded probe was then 
denatured and hybridised with 50|ig of the appropriate RNA at 52°C 
overnight in 80% formamide; 0.4M NaCl; 40mM PIPES pH6.4; ImM EDTA. 
Digestion of hybrids was performed in 0^25ml of 250mM NaCl;30mM sodium 
acetate pH4.6; ImM zinc sulphate at 37 C for 1 hour using 60 Units of 
SI nuclease. Digestion products were ethanol precipitated and 
resolved on a 6 % denaturing polyacrylamide gel prior to 
autoradiography. Panel A, overnight exposure; panel B, 1 hour 
exposure of tracks U and R from panel A, showing micro-heterogeneity 
of products.
RNAs: rabbit reticulocyte total (R); rabbit liver total RNA 
(L); yeast tRNA (t) . U, undigested probe; M, 5' end-labelled 
pBR322/HaeIII markers (Sizes as shown) .
192 -  -  
184 -  *
124/123 -
104 -
89 -  
80 -
64 -  
57 -
51 -
-P robe  -
•  , -  55nt
In summary, it seams certain that the pGF6  cDNA insert is a 
hybrid cDNA, consisting of three portions: a central portion which is 
undoubtedly derived from an RBC 15-LOX mRNA; a 3' portion which 
represents a region from further 3' in the full-length mRNA; and a 5' 
portion of unknown origin which is not derived from a RBC 15-LOX mRNA.
3.2 MAPPING OF THE TRANSCRIPTION INITIATION SITE OF THE RABBIT RBC
15-LOX GENE.
In order to investigate the organisation and the function of the 
promoter region of the RBC 15-LOX gene, it is first necessary to 
establish the major site of transcription initiation.
Various pieces of evidence suggest that the first nucleotide of a 
mature mRNA corresponds to the site of transcription initiation by RNA 
Polymerase II. Ziff and Evans (1978) mapped the transcription 
initiation site of Adenovirus type 2 (Ad-2) late transcripts by
hybridising the shortest fraction of in vivo pulse-labelled 
transcripts to fragments of the Ad-2 genome and demonstrated that the 
5' terminal sequence of Ad-2 late mRNAs (determined by direct 
sequencing using RNases) corresponds to the genomic sequence in the 
region of transcription initiation. Consistent with the coincidence 
of transcription initiation site and the 5' end of the mRNA are 
observations that, for a variety of genes including mammalian globin 
genes, the 5' ends of mRNA precursors and mature mRNAs map to the same 
position in the genomic sequence (Weaver and Weissmann, 1979; Roop et 
al, 1980; Grosveld et al, 1981a) . Thus, mapping of the 5' end of the 
mature mRNA can be used to identify the site of transcription 
initiation.
3.2.1 Strategy for mapping the 5' end of the RBC 15-IPX mRNA.
To determine whether the transcription initiation site of the 
rabbit RBC 15-LOX gene lies within the 276bp SstI genomic fragment 
(Fig. 4) which contains N-terminal protein-coding sequence (see 
Section 3.1.1 above), or whether it lies further upstream, a 
combination of SI nuclease protection and primer extension analyses,
using RNA. from rabbit reticulocytes, were performed.
SI nuclease analysis involves the formation of partially 
double-stranded hybrids between RNA and a labelled DNA probe under 
conditions which favour the formation of RNA:DNA hybrids. SI nuclease 
degrades single-stranded nucleic acids, but, at low temperatures and 
in buffers of high ionic strength, double-stranded regions are 
resistant to digestion. Thus, RNA protects complementary regions of 
the radio-labelled DNA probe from SI digestion, but non-homologous 
sequences are removed from the probe, resulting in a shortened probe.
For mapping 5' and 3' termini of mRNAs, or splice points, an 
end-labelled genomic DNA restriction fragment is denatured and 
hybridised with mRNA prior to SI nuclease treatment. If the RNA 
terminus or a splice point does not lie within this fragment, 
full-length probe protection is seen. Otherwise, the reduced size of 
the protected fragment corresponds to the distance between the 
labelled end of the probe and the end of the mRNA or splice point.
Primer extension involves the generation in vitro of the cDNA 
complement of an RNA using the enzyme reverse transcriptase. The 5'-> 
3' RNA-dependent DNApfplymerase activity of reverse transcriptase 
requires a primer to initiate polymerisation. The size(s) of primer 
extension products obtained using a primer which is complementary to 
transcribed sequences indicate the distance between the primer and the 
5' end of the RNA. Primer extension can also be used to sequence an 
RNA. The dideoxynucleotide analogue of one of the four naturally- 
-occurring deoxynucleoside triphosphates can be included in each of 
four primer extension reactions, producing a sequence "ladder" in a 
manner analogous to that employed in dideoxy chain-termination 
sequencing reactions (Sanger et al, 1977) . For mRNA sequencing, 
however, an end-labelled primer is used to copy the single-stranded 
(mRNA) template, rather than incorporating a labelled deoxynucleotide 
into the polymerase reaction.
The transcription initiation site of the RBC 15—LOX gene has 
been determined by several independent methods (Fig. 6 ) . The 5' end
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Figure 7. SI nuclease mapping of the 5' end of the first protein-
coding exon using a single-stranded 276bp SstI genomic
probe.
The 276bp SstI fragment was 5' kinase end-label led,
denatured, and strand-separated on a 5% non-denaturing polyacrylamide
gel. After electro-elution, separate strands were hybridised with 
50|lg of the appropriate RNA at 52 C overnight in lOjil of 80%
formamide; 0.4M NaCl; 40mM PIPES pH6.4; ImM EDTA. SI digestion and 
resolution of protected products were as in Figure 5.
Panel A : SI protection of end-labelled coding (c) and
non-coding (nc) strands of the 276bp SstI fragment using various RNAs. 
R, rabbit reticulocyte total RNA; B, rabbit brain total RNA; t, yeast 
tRNA; U, equivalent amount of undigested probe to that used in each of 
the hybridisations. M, pBR322/HaeIII 5' end-labelled size markers
(sizes as shown).
Panel B: shorter exposure of tracks U(nc) and R(nc) from
- Panel A, showing micro-heterogeneity of protected fragments.
PaneJ A, overnight exposure at -70°C; Panel B, 1 hour
exposure at -70 C.
760bp EcoRI/Smal fragment 
276nt SstI S1 probe
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Figure 8 . SI nuclease analysis using a single-stranded 540nt 
EcoRI/Ball genomic probe.
Panel A: Protection of non-coding (nc) strand at various
digestion temperatures (Temp.) and using various amounts of enzyme
with rabbit reticulocyte RNA. (R), and with rabbit pancreas total RNA 
(P) or yeast tRNA (t) controls.
Panel B : Equivalent exposure of protection using the
coding (c) strand as probe under identical conditions to those for the 
non-coding strand in panel A.
Panel C: Long exposure (13 days) of a separate experiment
involving protection of non-coding and coding strands by rabbit
reticulocyte total RNA. The same fragment as in A and B, but labelled 
on a separate occasion, was used as probe. Protected fragments up to 
2 0 0 nt longer than the major protected species can be seen.
The 540nt EcoRI/Ball fragment was kinase 5' end-labelled, 
and strands were denatured, then separated on a 5% polyacrylamide 
non-denaturing gel. Isolated strands were recovered by 
electro-elution and ethanol precipitated with 100|ig yeast tRNA as 
carrier. Single-stranded probes' were hybridised with the appropriate 
RNA overnight at 52°C in 10|il 80% formamide; 0.4M NaCl; 40mM PIPES 
pH6.4; ImM EDTA. Hybrids were subjected to SI nuclease digestion for 
1 hour at various temperatures in 0.25mls 250mM NaCl; 30mM sodium 
acetate pH4.6; ImM zinc sulphate using various amounts of enzyme. 
Products were separated on a 6 % denaturing polyacrylamide gel prior to 
autoradiography.
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of the mRNA has been mapped using two different SI probes and two 
different primers. The localisation has been confirmed by mRNA 
sequencing, by the lack of primer extension seen with a primer which 
overlaps the transcription initiation site, and by hybridisation of 
probes from immediately upstream and immediately downstream of the 
transcription initiation site to Northern blots.
3.2.2 SI nuclease analysis using a single-stranded 276nt SstI 
probe: the 5' end of the first coding exon lies 28nt upstream 
of the ATG translation initiation codon.
Figure 7 shows the mapping of the 5' end of the first coding 
exon of the RBC 15-LOX gene by an SI nuclease protection experiment 
using as SI probes separated strands of the 276bp SstI genomic 
fragment sequenced in Section 3.1, which includes sequences predicting 
the first 30 amino acids of N-terminal protein sequence. Protection 
is seen with only one strand, indicating that this region of the gene 
does not show bi-directional transcription. With the non-coding 
strand, rabbit reticulocyte total RNA, but not rabbit brain total RNA 
or yeast tRNA, protects a cluster of fragments, two stronger bands 
being flanked by two weaker ones. Micro-heterogeneity in the size of 
protected fragments is frequently seen in SI nuclease analyses and may 
be due to exonucleolytic "nibbling" of the ends of double-stranded 
hybrids (Williams and Mason, 1985). As exonuclease "nibbling" will 
result in slightly shorter products, the longest protected fragment 
represents the most 5 ' limit possible for the start of the first 
coding exon. Here, the longest protected fragment is at 127nt. As 
the labelled 5' end of the 276nt non-coding strand of the SstI genomic 
fragment lies lOOnt downstream of the ATG translation initiation codon 
(Fig. 4), the RBC 15-LOX mRNA thus protects the probe to 27nt beyond 
the ATG codon. This protection indicates that the first coding exon 
begins 28nt upstream of the A nucleotide of the ATG translation 
initiation codon.
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3.2.3 SI nuclease analysis using a single-stranded 540nt EcoRI/Ball
probe confirms the localisation of the 5' end of the first 
coding exon, and reveals that microheterogeneity of protected 
fragments is not a function of digestion temperature or 
enzyme concentration.
The localisation of the 5' end of the first coding exon has 
been confirmed using a longer probe (Fig. 8 ) . A 540nt single-stranded 
EcoRI/Ball genomic probe produces a cluster of fragments, the longest 
of which is 11 Ont. This experiment also demonstrates that the same 
micro-heterogeneity of products is seen when SI digestion is performed 
under a variety of conditions. There is no alteration in the pattern 
of products when the digestion temperature is varied over a range of 
15°C, and the amount of enzyme varied by 5-fold either side of the 60 
Units used for the 276nt SstI probe in Figure 7.
It is not possible to establish by SI nuclease analysis using 
these probes whether the first coding exon is the most 5' exon of the 
RBC 15-LOX gene, or whether there might be one or more upstream exons, 
as, for example, in the case of the 5' non-coding exon of c-myc 
(Stanton et al, 1984) . However, the complementary technique of primer 
extension can be used to determine whether the 5' end of the first 
coding exon mapped by SI nuclease analysis represents the 5' end of 
the mRNA, or only the first nucleotide of a downstream exon.
3.2.4 Primer extension using a single-stranded 58nt genomic DNA 
primer: transcription initiation occurs 28nt upstream of the
ATG translation initiation codon.
Results with a 58nt Sau3A/SstI genomic DNA primer firmly 
establish the 5' end of the RBC 15-LOX mRNA as being 28nt upstream of 
the ATG translation initiation codon. A preliminary experiment (Fig. 
9) demonstrates that the 58nt primer has an optimum hybridisation 
temperature of approximately 52°C. Primer extension is considerably 
more efficient following hybridisation with reticulocyte RNA at 52°C 
than at 42°C or 60°C i.e. the same pattern of products is seen in all 
cases, but, at 52°C, the largest proportion of the primer is converted
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Figure 9. Optimum hybridisation temperature for primer extensions 
using a single-stranded 58nt Sau3A/SstI genomic primer.
Overnight autoradiograph of primer extension reactions with 
rabbit reticulocyte total RNA (R) and yeast tRNA (t), using the 
non-coding strand -strand (58nt) of the Sau3A/SstI fragment. (The 6 6 nt 
coding strand does not extend - see Fig. 10).
The double-stranded Sau3A/SstI fragment was kinase 5' 
end-labelled, denatured, and strands separated by running on a 6 % 
denaturing polyacrylamide gel. Separated strands were eluted, ethanol 
precipitated and hybridised at a variety of temperatures (37, 42, 52
and 60 C) with 50|ig of the appropriate RNA at 52°C overnight in lOjil 
80% formamide; 0.4M NaCl; 40mM PIPES pH6.4; ImM EDTA. Hybrids were 
ethanol precipitated and primer extension performed using AMV reverse 
transcriptase. Primer extension products were resolved on a 6 % 
denaturing polyacrylamide gel, followed by autoradiography.
Sizes indicated are of 5' end-labelled pBR322/HaeIII size
markers.
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to extension products. Consequently, all subsequenct primer 
extensions using this primer were performed after hybridisation of 
primer with RNA at 52°C.
As seen in Figure 10, extension occurs from one strand only. 
Primer extension with the non-coding strand produces the same pattern 
of products with both total and polyadenylated reticulocyte RNAs, 
indicating that extension is occurring on an mRNA. No extension is 
seen with control RNA from a rabbit non-erythroid tissue (adult liver) 
or with yeast tRNA, consistent with the observation that accumulation 
of the RBC 15-LOX mRNA is erythroid-specific (Thiele et al, 1987) . 
Micro-heterogeneity is seen in the longest primer extension products. 
Such micro-heterogeneity is frequently seen in primer extension 
experiments, and is thought to be due to premature termination of 
reverse transcription due to the methylated residue situated next to 
the mRNA cap (Williams and Mason, 1985) . Consequently, the largest 
product is most likely to be that which represents the 5' end of the 
mRNA. There are also multiple products which are considerably shorter 
than the longest. Comparison with products of the SI nuclease 
analyses indicates that these are not genuine full-length primer 
extension products (such as those which might be reverse transcribed 
from any RBC 15-LOX mRNAs which might be truncated at their 5' ends), 
since there are no corresponding SI-protected fragments. Rather they 
are likely to represent products of premature termination of reverse 
transcription.
The longest extension product is 127nt long. This is exactly 
the same length as the longest protected fragment in the SI nuclease 
analysis using the 276nt SstI probe. Since both the 58nt primer and 
the 276nt probe have the same labelled 5' end, the exact agreement of 
the lengths of products indicates that the 5' end of the first coding 
exon in fact represents the 5' end of the RBC 15-LOX mRNA. The major 
transcription initiation site of the RBC 15-LOX gene is thus located 
28nt upstream of the ATG translation initiation codon.
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3.2.5 mRNA. sequencing using the 58nt genomic primer: priming is
from a unique mRNA sequence which matches that of the RBC 
15-LOX gene.
One possible objection to the use of primer extension to 
confirm the identity of the 5' end of the first exon as the 5' end of 
the mRNA is that the primer might conceivably be hybridising to an RNA 
other than the RBC 15-LOX mRNA, and that the products of primer 
extension and SI analysis are the same size by coincidence. Although 
confirmatory results obtained with a different primer (see Section
3 .2 . 6  below) might be considered to effectively exclude this 
possibility, a more direct method to establish that primer extension
is occurring on the correct mRNA is to sequence the mRNA by primer
extension.
mRNA sequencing using the 58nt genomic primer (Fig. 10B, C and 
D) conclusively proves that priming is occurring from hybridisation to 
the RBC 15-LOX mRNA and that mRNA alone. The mRNA sequence is that of 
an mRNA capable of encoding a protein whose first 12 amino acids are 
identical to those of the RBC 15-LOX protein. The sequence which can 
be read directly from the autoradiograph is unambiguous through most 
of its length (Fig. 10D) and is the exact complement (Fig. IOC) of 
69nt of RBC 15-LOX genomic sequence (see Section 3.1.1), including the 
27nt upstream of the ATG codon. Comparison of the primer extension 
mRNA sequence with genomic sequence identifies the precise nucleotide 
at which the mRNA corresponding to the longest primer extension
product is initiated (an A residue 28 nt upstream of the ATG codon) .
Confirmation of the exact nucleotide at which transcription 
initiation occurs could be obtained, if required, by using the same 
primer to sequence an appropriate genomic DNA fragment and to run the 
products of the two sequencing reactions next to one another on the 
same sequencing gel.
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3.2.6 Primer extension using a single-stranded 166nt cDNA-derived
Ball primer: confirmation that the 5' end of the RBC 15-LOX
mRNA lies 28nt upstream of the ATG translation initiation 
codon.
A 166nt primer corresponding to nucleotides 183-348 of the 
356bp pGF6  cDNA insert (ATG = 100-102) overlaps the non-priming end of 
the 58nt genomic primer by 17nt (see Fig. 11) and confirms the 
localisation of the transcription initiation site made using the 58nt 
genomic primer. Since the first use of this primer in establishing 
the 5' end of the RBC 15-10X mRNA, nucleotides 231-356 of the pGF6  
cDNA insert have been discovered to be derived from a region of the 
RBC 15-LOX mRNA far downstream from that which corresponds to the more 
5' pGF6  sequences. Hybridisation of the 166nt to the RBC 15-LOX mRNA 
may therefore involve "looping out" of a region of the mRNA. However, 
mRNA sequencing using the 166nt primer (Fig. 11) shows that this does 
not have any effect upon hybridisation of the 48nt (nt 183-230) at the 
priming end. Although not completely unambiguous, the sequence is 
readable in several regions right up to the longest primer extension 
products, and matches the genomic sequence, demonstrating that primer 
extension is occurring from the correct site on the mRNA, as predicted 
by comparison of the genomic and cDNA sequences. Confirmation of this 
mRNA sequence has been obtained in subsequent experiments (see Section
3.2.7 below) . Figure 11 also shows that the 166nt primer has a 
similar optimum hybridisation temperature with the RBC 15-LOX mRNA to 
that for the 58nt primer. Subsequent experiments with the 166nt 
primer were, therefore, performed with hybridisation of the primer to 
RNA samples at 52°C.
Figure 12A shows primer extension using both coding and 
non-coding strands of the 166nt Ball fragment after hybridisation with 
RNAs at 52°C. As with the 58nt genomic primer above (Section 3.2.4), 
primer extension on reticulocyte total and polyadenylated RNAs 
produces the same pattern, showing micro-heterogeneity in the longest 
extension products. The longest of these is 276nt long i.e. primer 
extension has added 110 nt to the length of the primer. Inspection of 
the pGF6  cDNA sequence (Fig. 4) shows that the Ball site at the
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Figure 11. Optimum hybridisation temperature for primer extension
using the 166nt Ball cDNA-derived primer; preliminary mRNA
sequencing; and detection of minor transcripts.
The double-stranded 166bp Ball fragment from pGF6 was 
kinase 5' end-labelled, denatured, and strands were separated by 
running on a 5% non-denaturing polyacrylamide gel. Separated strands 
were eluted, ethanol precipitated and hybridised with 50jig of the 
appropriate RNA at the appropriate temperature (37, 42, 52, or 60 C)
overnight in 10}ll 80% formamide; 0.4M NaCl; 40mM PIPES pH6.4; ImM 
EDTA. Hybrids were ethanol precipitated and primer extension was 
performed using AMV reverse transcriptase. Products were then 
separated on a 6 % denaturing polyacrylamide gel prior to 
autoradiography for 23 days (Panel A) or for 1 day (Panel B).
mRNA sequencing was exactly as for primer extension except 
for the incorporation of one of the four dideoxynucleoside 
triphosphates (A, ddATP; C, ddCTP; G, ddGTP; T, ddTTP).
Panel A: Primer extension on rabbit reticulocyte total RNA
(R) and yeast tRNA (t) templates, using the non-coding strand of the 
166nt Ball cDNA fragment from pGF6  (the coding strand does not extend 
- see Figure 12).
Panel B: Shorter exposure of tracks 52t and 52R from panel
A, showing microheterogeneity within the major extension product.
The relationship between the 166nt cDNA-derived primer and 
the 58nt genomic primer used in Figures 9 and 10 is shown below. The 
mismatch between cDNA and genomic sequences beyond the splice donor 
site (Section 3.1.1) is indicated by a bent line.
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priming end of the non-coding strand primer lies 82nt downstream of 
the first nucleotide of the ATG translation initiation codon. These 
results therefore confirm that transcription initiation occurs 28nt 
upstream of the first nucleotide of the ATG codon.
In the left-hand half of Figure 12A, products seen with the 
coding strand as primer are presumably not the result of primer 
extension on the RBC 15-LOX mRNA, since they are also seen in controls 
using yeast tRNA and RNA from a non-erythroid rabbit tissue 
(pancreas) . These products may represent "self-priming" of the primer 
i.e. DNA-dependent DNA polymerase activity of the reverse 
transcriptase enzyme. Although secondary structure within the primer 
should be minimised under the conditions of hybridisation used, such a 
long primer might be able to form such secondary structures. Some 
primer extension protocols (e.g. Jones et al, 1985) include 
actinomycin D to reduce the degree of self-priming (Williams and 
Mason, 1985), but actinomycin D at 50|lg/ml had little effect upon the 
pattern of primer extension products obtained using this primer (data 
not shown).
3.2.7 mRNA sequencing using the 166nt Ball cDNA-derived primer.
Figures 12B and 12C confirm the mRNA sequencing with the 
166nt primer seen in Figure 11A and, thus, the results obtained with 
the 58nt genomic primer. Readable, though not completely unambiguous, 
mRNA sequence matches that of the RBC 15-LOX gene from 83nt downstream 
of the ATG translation initiation codon, right the way up to the 
transcription initiation site.
As described in more detail in Section 3.2.10, primer extension 
with the 166nt cDNA-derived primer also suggests the existence of 
multiple minor transcipts containing RBC 15-LOX mRNA sequences (Figs.
11A and 12D) .
In summary, the transcription initiation site of the RBC 15-LOX 
gene has been mapped by a combination of complementary techniques. 
Primer extension on a 58nt genomic DNA primer indicates that the
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products of SI nuclease analysis represent the 5' end of the 
transcription unit and not an intron/exon boundary. Comparison with 
the SI analyses provides evidence that only the longest primer 
extension products represent genuine RBC15-L0X mRNA 5' ends. Finally 
these primer extension results have been confirmed using a second 
(cDNA-derived) primer, and mRNA sequencing has confimed that priming 
is occurring on the RBC 15-LOX mRNA alone.
3.2.8 A genomic primer which extends beyond the predicted 5' end of 
the RBC 15-LOX mRNA does not primer extend on rabbit 
reticulocyte RNAs.
The localisation of the transcription initiation site of the 
RBC 15-LOX gene can be confimed in a number of ways (see also Section
3.2.9 below) . For example, a primer which extends beyond the 5' end 
of the messenger would not be expected to be capable of primer 
extension - even though its 5' end is annealed to the mRNA, its 3' 
end, from which primer extension occurs, overhangs the end of the 
mRNA. So, no primer extension would be expected using a primer 
consisting of genomic sequences from both sides of the predicted 
transcription initation site.
In designing an experiment to investigate whether this is the 
case for the RBC 15-LOX mRNA, it should be borne in mind that an 
absence of primer extension products might be due to a variety of 
factors other than an overhang of the 3' end of the primer, including 
failure of the primer to anneal with the RNA during hybridisation, to 
inappropriate buffer conditions, or the inability of reverse 
transcriptase enzyme to catalyse polymerisation for some reason. So, 
a positive control experiment was performed using the 58nt Sau3A/SstI 
primer described above. The two primers were annealed with the same 
RNA preparation under identical hybridisation conditions, at a range 
of hybridisation temperatures (37, 42, 52 and 60°C) . All hybrids were 
then resuspended in aliquots from the same (enzyme + buffer) solution 
and primer extension using the two primers was performed 
simultaneously under identical conditions. Neither strand (8 6 nt
and 92nt respectively) of a HhaI/Sau3A fragment extending 23nt 5' of
96
the transcription initiation site (see Fig. 6 ) is capable of primer 
extension with rabbit reticulocyte total RNA at any of these 
temperatures (data not shown). The 58nt positive control primer, 
however, extended to give the same qualitative result after 
hybridisation at all 4 temperatures.
The differing lengths of the test and positive control primers 
is unlikely to have been a factor in the efficiency of hybridisation 
of primers, since 67 nt of the 8 6 nt non-coding strand primer under 
test are complement airy to the mRNA, compared with 58nt of the 
Sau3A/SstI positive control primer. Furthermore, in a separate 
experiment (Section 3.2.6 above), the much longer 166nt Ball cDNA 
primer extended at all four of the temperatures used here, with the 
same qualitative results at each temperature, suggesting that primers 
of very different lengths can hybridise over the same range of 
temperatures.
Thus, results using the 86/92nt HhaI/Sau3A primer are consistent 
with the determination of the 5' end of the RBC 15-LOX mRNA made 
above.
3.2.9 None of the available upstream sequences show detectable 
levels of hybridisation with Northern blots of rabbit 
reticulocyte RNAs.
To provide further confirmation of the location of the 5' end 
of the mRNA, it has been possible to check that genomic sequences 
immediately 5 ' of the predicted transcription initiation site are not 
present in the cellular population of stable, mature mRNAs, while 
sequences immediately downstream of this site are expressed in the 
final messenger. This has been done by probing duplicate Northern 
blots of total cellular RNAs with genomic DNA fragments from 
immediately upstream and immediately downstream of the predicted 
transcription initiation site (Fig. 13) .
Hybridisation of sequences between 150 and 24bp upstream of the 
transcription initiation site, contained within a 127bp Sstl/Hhal
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Figure 13. Northern blot analysis of RBC 15-LOX transcripts.
Panel A: Probing of duplicate Northern blots of RNAs from
various rabbit tissues using genomic probes derived from immediately' 
upstream and immediately downstream of the rabbit RBC 15-LOX 
transcription initiation site.
Probes: The 127bp Sstl/Hhal fragment, extending from 150
to 24bp upstream of the transcription initiation site, and the 154bp 
Hhal/SstI fragment extending from 23bp upstream to 131bp downstream of 
this site, were both obtained from pLOX6/1.5R (Fig. 17), a sub-clone 
of the 1.5kb EcoRI genomic fragment (Fig. 3) ligated into EcoRI-cut 
pUC18.
RNAs: R, rabbit reticulocyte total RNA; A+, rabbit
reticulocyte polyadenylated RNA; FL21 and FL23; total RNA from liver 
of 21- and 23-day gestation rabbit foetuses; L, total RNA from rabbit 
adult liver; P, total RNA from rabbit pancreas; Lu, total RNA from 
rabbit lung; B, total RNA from rabbit brain.
Panel B: Probing of duplicate Southern blots of various
digests of pLOX6/1.5R (see Panel A above) and pCAT-2700 (Panel C 
below), using the same probes as in A. EcoRI-cut pUC18 (pUC18/RI) was 
used as a negative control for contamination of probes with vector 
sequences. pCAT-2700 plasmid digests: Ss/X = SstI and Xbal
double-digest; R1 = EcoRI digest.
Panel C : Probing of Northern and Southern blots
(duplicates of those used in Panels A and B above) with a 2.5kb 
KpnI/SstI fragment derived from pCAT-2700 (Fig. 18), an RBC 15-LOX/CAT 
recombinant which contains the entire 2.7kb of cloned RBC 15-LOX 5' 
flanking sequences, linked upstream of the bacterial CAT gene in pUC19 
vector sequences.
154 and 127bp fragments were isolated using an 8 %
non-denaturing polyacrylamide gel. The 2.5kb KpnI/SstI fragment was 
isolated by preparative agarose gel electrophoresis (0.7% low 
melting-point agarose) . Fragments were labelled by the random priming 
method and hybridised with the appropriate filters overnight at 42°C 
in 50% formamide; 10% dextran sulphate; 5xSSC; lx Denhardt's solution; 
lOOpg/ml polyA; 10|lg/ml polyC; 0.1% SDS. Southern blots were 
hybridised in the same bag as Northern blots and filters were rinsed
in 2x SSC; 0-1% SDS at room temperature, then washed in O.lx SSC; 0.1%
SDS at 65 C prior to autoradiography at -70 C (6-18 hours for
Northerns; 1-3 hours for Southerns).
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fragment was compared with hybridisation of a 154bp Hhal/SstI genomic 
fragment containing sequences extending from 23bp upstream of the 
transcription initiation site to 131bp downstream. Results are shown 
in Figure 13A. Southern blots of various restriction digests of 
genomic sequences were hybridised with the same probes in the same bag 
as the Northern filters to control for the possibility that a lack of 
hybridisation might be due to poorly-label led probe, or to 
inappropriate hybridisation conditions (Fig. 13B) .
The 154bp Hhal/SstI genomic fragment hybridises strongly to two 
bands in the polyadenylated reticulocyte RNA track: one at 2.9kb, and 
one at 1.6kb. The 2.9kb band is of a similar size to previous 
estimates for the rabbit RBC 15-LOX mRNA employing three independent 
methods (agarose gel electrophoresis, sucrose gradient centrifugation 
and electron microscopy of an enriched mRNA population) (Thiele et al, 
1982) . A 2.9kb mRNA would be sufficient to encode the rabbit RBC 
15-LOX protein, estimated by denaturing polyacrylamide gel 
electrophoresis to have a molecular weight of 6 8 kD (Thiele et al, 
1987). A 1.6kb messenger, on the other hand, is unlikely to contain 
sufficient coding sequence to be translated into the 6 8 kD RBC 15-LOX 
glycoprotein, unless glycosylation is responsible for a large 
proportion of the molecular weight. Rapoport et al (1979), however, 
have calculated that the protein contains only 5% neutral sugars. 
Thus, it seems unlikely that the 1.6kb mRNA is responsible for 
producing the mature protein. The strength of the hybridisation, 
however, does suggest that this 1.6kb mRNA contains sequences very 
similar to those in this region of the RBC 15-LOX gene. Unlike the 
2 .9 kb band, hybridisation to the 1 .6kb band is not seen in the total 
reticulocyte RNA track. Therefore, the most likely explanation for 
the 1 .6kb band is that it represents a degradation product present in 
the poly (A)+ preparation, but not in the total RNA sample.
No clear hybridisation of the 154bp probe is seen with any of 
the total RNAs from other rabbit tissues investigated here, though 
there is perhaps the suggestion of weak hybridisation to the RNA of 
liver from 2 1 -day gestation foetus, the major erythropoietic tissue of 
the rabbit foetus. The presence of RBC 15-LOX mRNA in foetal liver
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has since been confimed (J. Fleming, unpublished results) . Thus, 
within the limitations of sensitivity of Northern blots, this result 
confirms the observations from primer extension and SI nuclease
protection experiments above, and the results of Thiele et al (1987), 
that the accumulation of RBC 15-LOX mRNA. is erythroid-specific.
The 127bp Sstl/Hhal probe, containing sequences between 150 and 
23bp upstream, does not show hybridisation to poly (A)+ or to total RNA 
from reticulocytes, nor to any of the RNAs from other rabbit tissues 
tested (liver, pancreas, lung and brain). The lack of hybridisation is 
not due to any defect in the labelling of the probe, as can be seen by 
the hybridisation of the probe to the expected bands in the two
Southern blots shown in Fig. 13B. This failure of the 127bp Hhal/SstI
fragment to hybridise with reticulocyte RNA is in agreement with the
designation of the transcription initiation site by primer extension 
and SI nuclease analyses above.
Sequences upstream of the transcription initiation site 
identified above would not be expected to be present in the mRNA 
population as RBC 15-LOX mRNAs. An exception to this would be if
there existed a minor upstream RBC 15-LOX promoter whose transcript is 
spliced to an acceptor site downstream of the restriction sites used 
above to generate primers and SI probes, and which would not, 
therefore,be detected using these probes. Alternative promoter usage 
combined with alternatively-spliced mRNA products is known in the 
expression of other genes, including a gene expressed in erythroid
cells, the human porphobilinogen deaminase (PBG-D) gene (Grandchamp et 
al, 1987; Chretien et al, 1988) . In erythroid cells, the 5' end of
the PBG-D mRNA is transcribed from an exon which is expressed
exclusively in erythroid cells. In other cell types, however, 
transcription of the PBG-D gene is initiated from an alternative 
upstream promoter, and the 5' end of the mRNA is derived from an 
alternative exon to that used in erythroid cells. All sequences other 
than those from the alternative 5' exons are common to both mRNA 
species.
To investigate whether such an alternative transcription
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initiation site might be present in the RBC 15-LOX gene, it was 
decided to test whether any of the available 2.7kb of genomic 
sequences upstream of the transcription initiation site identified 
above are present in the mRNA. populations of various rabbit tissues. 
This was attempted by hybridising a 2.5kb KpnI/SstI genomic fragment, 
extending from the 5' limit of cloned RBC 15-LOX genomic sequences to 
150bp upstream of the transcription initiation site, with Northern 
blots of RNAs from various rabbit tissues (Fig. 13C)
None of the sequences in this 2.5kb fragment hybridise to either 
total or poly (A)+ RNAs from reticulocytes, suggesting that there is no 
upstream promoter in this region which is utilised in erythroid cells. 
Total RNAs from foetal liver, adult lung, pancreas and brain, however, 
show a smear of hybridisation with the 2.5kb fragment. The smearing 
does not seem to be due to degradation of the RNAs. The filter is a 
duplicate of those used in Fig. 13A, where discrete bands result, and 
all the total RNAs were judged to be intact by the appearance of 28S 
and 18S ribosomal RNAs after ethidium bromide staining of a fourth 
sample of each of the RNAs, run on the same gel. The integrity of the 
RNAs on this filter has not been checked by re-hybridisation with a 
cDNA probe from any ubiquitous rabbit mRNA, however. Smearing is not 
the result of some defect in preparation of the probe, since
hybridisation to the Southern blot control is as expected. However, 
studies by other members of the group have shown that the 2.5kb region 
being used as a probe contains a repetitive sequence (B. Thiele,
unpublished results) . It is conceivable that the sequence of such a 
repetitive region might hybridise to sequences present in a variety of 
messengers, ranging across the entire 0.5kb to 7.0kb size range of the 
smear seen here. However, why none of these messengers should be
present in reticulocytes or in adult liver is unclear.
The finding that none of the 2. 7kb of available genomic
sequences upstream of the putative transcription initiation site 
hybridise to rabbit reticulocyte RNA confirms that the 1.6kb mRNA 
detected using the 154bp probe (Fig. 13A), and suggested earlier to 
represent a RBC 15-LOX mRNA degradation product, does not arise from 
an alternative promoter within this 2.7kb region.
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Overall, the data obtained from the probing of Northern blots 
with sequences from the 5' end of the RBC 15-LOX genomic clone 
suggests that, within the limits of sensitivity of this technique, 
there is no transcription occurring in reticulocytes of sequences 
within the most 5' 2.7kb of genomic sequences, other than from the
transcription initiation site mapped above. This data does not 
exclude the possibility of alternative transcription sites lying 
outwith the available cloned sequences, nor the possibility that 
blotting has failed to detect low-level transcription of very short 
regions of 5' flanking sequences.
3.2.10 Possible multiple minor sites of upstream transcription 
initiation detected by primer extension and SI protection 
analyses.
A small proportion of the total population of transcripts from a 
variety of genes, including human and murine globins, have been shown 
by a combination of primer extension and SI analyses to arise from 
sequences upstream of the transcription initiation site (Allan et al, 
1983; Frampton et al, 1987) . These minor upstream transcription 
initiation sites have been suggested to reflect sites which are 
important for the regulation of transcription, possibly by providing 
entry sites for the transcriptional machinery, including RNA. 
Polymerase (Allan et al, 1983) . Transcription from upstream sites of 
globin genes have been found to be associated with cell type-specific 
DNasel hypersensitive sites (Zhu et al, 1984) and to alter with 
changes in development (Frampton et al, 1987) . Whether this reflects 
initiation by mechanisms which differ from that at the major 
transcription initiation site, and which are of regulatory importance, 
or whether they reflect low-level, non-specific initiation of 
transcription by RNA Polymerase at sites of open chromatin structure 
is unclear.
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3.2.10.1 Primer extension using the 166nt cDNA primer identifies
multiple minor transcripts.
Although no transcripts containing sequences upstream of the 
RBC 15-LOX transcription initiation site were detected by Northern 
blotting (Section 3.2.9 above), apparent minor transcripts were seen 
in primer extension experiments using the 166nt cDNA-derived primer 
described in Section 3.2.6. Multiple minor extension products, above 
those corresponding to the RBC 15-LOX mRNA transcribed from the 
transcription initiation site identified above, can be seen in Figure 
11A and in Figurel2D, which is a longer exposure of the primer 
extensions on reticulocyte total and polyadenylated reticulocyte RNAs 
seen in Figure 12A, tracks ncR and ncA+. Some of these minor products 
are 250-300nt longer than the major products.
Minor extension products were not seen with the 58nt genomic 
primer. This may be due to the fact that the specific activity of 
this primer was approximately 5-fold lower than that of the 166nt 
primer, as estimated by the duration of autoradiography required to 
obtain bands of roughly-equal intensity. Results obtained in mRNA 
sequencing using the 166nt primer suggest that the longer extension 
products seen in that case were all due to genuine RBC 15-LOX 
transcripts. In Figures 11A, 12B and 12C, a unique sequence can be
read in several regions, all the way up to the transcription 
initiation site, suggesing that primer extension was occurring on 
only a single mRNA species. Nevertheless, one cannot be sure that the 
minor primer extension products are not artefacts resulting from low 
efficiency hybridisation of the primer to sequences in other RNAs 
whjcjijh are similar, but not identical, to those of the RBC 15-LOX mRNA. 
If this were the case, it is possible that the signal resulting from 
sequencing of these other transcripts is simply not being detected.
In order to investigate whether any or all of these longer 
extension products do indeed represent genuine minor transcripts from 
the RBC LOX 15-gene, rather than coincidental hybridisation of the 
166nt primer to other mRNAs, it is necessary to establish, as for the 
major transcription initation site, whether the extension products
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correspond to protected fragments in an SI nuclease analysis.
3.2.10.2 SI nuclease analysis using the 540nt EcoRI/Ball genomic SI 
probe also produces multiple minor products.
One problem with using SI nuclease protection as a method to 
confirm the existence of minor transcripts is that any minor 
"protected" fragments seen by this method might represent incomplete 
digestion products. However, Figure 8A demonstrated that, using the 
longer 540nt EcoRI/Ball SI probe, there were no detectable minor 
products using a variety of digestion conditions. There appeared to 
be very little effect on the nature of protected products of varying 
the amount of SI nuclease used by 30-fold. Nor did a range of 15°C in 
the digestion temperature (27 to 42°C) appear to affect the 
distribution of products. It therefore seems unlikely that any SI 
protected fragments larger than the main products are due to 
incomplete digestion.
Figure 8 C shows a different protection experiment using the same 
540nt EcoRI/Ball fragment as probe, but end-labelled and 
strand-separated on a separate occasion. The specific activities of 
the two preparations of probe were similar on each occasion. A small 
amount of protection is seen with the coding strand, but this is very 
small in comparison with the protection seen using the non-coding 
strand, and is presumably due to imperfect separation of the strands. 
With the non-coding strand, minor protected fragments are seen at 
least 150-200nt longer than the major protected species. However, the 
minor protected products seen in Figure 8 C are from a three-times 
longer exposure than that in Figure 8A, as well as having been 
obtained on a separate occasion with a different pi^aration of 
end-labelled probe. In the absence of a longer exposure of the 
calibration experiment in Figure 8A, it is possible that minor 
products were not originally detected due to an insufficiently long 
exposure, and that they represent incompletely-digested products.
Furthermore, none of the protected fragment sizes seen in the SI 
protection experiment in Figure 8 C correlate with any of the more
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intense minor products of the 166nt primer extension reaction (Figs. 
11 and 12) . Consequently, there is no firm evidence for genuine RBC 
15-LOX minor upstream transcription initiation sites, since the 
possibility that the minor products of SI protection and primer 
extension analyses are merely the result of two different sets of 
artefacts cannot be completely excluded, despite the attempts to do so 
in the experiments shown here.
As the question of what the minor products represent does not 
affect the conclusion as to the major site of transcription 
initiation, based on two sets of primer extension and two sets of SI 
protection experiments, it was decided not to pursue the phenomenon of 
the minor products any further.
3.3 ORGANISATION OF RABBIT RBC 15-LOX GENE 5' FLANKING SEQUENCES AND 
BINDING OF NUCLEAR PROTEINS.
Mapping of the transcription initiation site of the rabbit RBC 
15-LOX gene to a position 28nt upstream of the ATG translation 
initiation codon (Section 3.2 and Fig. 14) permits analysis of the 
316bp of currently-available upstream sequence for the presence of 
sequence elements found in the 5' flanking regions of other genes. Of 
particular interest are the promoter regions of genes which are 
co-expressed with the RBC 15-LOX in erythroid cells and especially 
globin gene promoters.
3.3.1 Sequence elements upstream of the RBC 15-LOX transcription 
initiation site.
As described in greater detail below, the 316bp of available 
5' flanking sequence are G/C-rich (69%) and include (Fig. 14) an 
A/T-rich TATA-like sequence, TATTTA, between nucleotides 30 and 25 
upstream of the transcription initiation site, as well as a CCAAT, two 
CACCC, and GGGCGG sequences, and a sequence similar to the CTF/NF-1 
recognition sequence, all of which have been found in a variety of 
other genes.
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The A/T-rich element, TATTTA, differs from the canonical TATA 
sequence originally identified in Drosophila histone genes (Goldberg, 
1979; Breathnach and Chambon, 1981), as does the conserved ATA(A/T) AA 
element of mammalian globin genes (Efstratiadis et al, 1980) and 
A/T-rich regions in a similar position relative to the transcription 
initiation site in a variety of other genes. The similarity of 
position relative to the transcription initiation site with other 
A/T-rich, TATA-like elements in other genes may indicate that the 
TATTTA element of the RBC 15-LOX gene serves a similar function in 
determining the position of transcription initiation (Grosschedl and 
Bimstiel, 1980; Benoist and Chambon, 1981) . It is unclear at present 
whether the various A/T-rich, TATA-like sequences are recognised by a 
family of transcription factors which recognise slightly different 
sequences, or whether it is the A/T-richness of this region which is 
important for interaction with a factor (s) involved in positioning RNA 
Polymerase II for transcription initiation.
CCAAT sequences are found in a wide variety of genes (Benoist et 
al, 1980; Efstratiadis et al, 1980; McKnight and Tjian, 1986) and
there appear to be a family of transcription factors which bind to 
sequences which include a CCAAT motif (Santoro et al, 1988; Chodosh et 
al, 1988a, b; Dorn et al, 1987; Barberis et al, 1987) . The CCAAT
motif at -236 to -232nt in the RBC 15-LOX gene is further upstream of
the TATA-like sequence than, for example, the CCAAT sequence of
mammalian globin genes (Efstratiadis et al, 1980), but differing 
separations of CCAAT and TATA boxes are also seen in comparisons of 
other genes. For example, the separation of CCAAT and TATA sequences 
in mouse al globin is greater than that seen in the mouse
[F^-globi n gene (Nishioka and Leder, 1979; Konkel et_ al, 1979) .
The more proximal of the two CACCC motifs (nucleotides -79 to 
-75 relative to the transcription initiation site) present in RBC
15-LOX 5' flanking sequences is contained within an octanucleotide 
sequence CCACACCC identical to that conserved between rabbit, mouse 
and human adult (3-globin genes (Efstratiadis et_ al, 1980 and
references therein) and similar sequences are also seen in other genes 
(e.g. an inverted copy in the rat tryptophan oxidase promoter; Schule
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et al, 1988) . In both rabbit p-globin and in mouse (P^^-globin 
genes, the CACCC motif has been shown to be important for constitutive 
transcription initiation (Dierks et al, 1983; Chamay et al, 1985; 
Myers et al, 1986) and Mantovani et al (1988a) have recently reported 
the binding of both ubiquitous and cell type-specific proteins to the 
CACCC motif of the human p-globin gene.
The proximal CACCC motif of the RBC 15-LOX gene lies just 
downstream of a sequence element TGGAGACGAGCCAT very similar to the 
TGG(A/C) (N)^GCCAA consensus binding sequence for the CTF/NF-1 family 
of transcription factors (Dynan, 1985; Jones et al, 1987; Santoro et 
al, 1988).
Between the proximal CACCC motif and the TATTTA, TATA-like 
element, there is a single copy of the sequence GGGCGG, located 
between -50 and -45nt. This is contained within a sequence GGGGCGGGCC 
which shows only one difference from the extended consensus sequence, 
(G/T) GGGCGGPuPuPy, for the binding of the "general" transcription 
factor, Spl (Kadonaga et al, 1986) .
In addition to these sequences, present in a variety of genes, 
and known to be involved in the binding of transcription factors, the 
RBC 15-LOX 5' flanking sequences also contain direct repeats of two 
short sequence elements. A perfect direct repeat of the 
hexanucleotide TCGGGG lies between 164 and 153nt upstream of the 
transcription initiation site. Immediately downstream is another 
direct repeat, of the decanucleotide GGAGCTGCGG. This repeat contains 
one perfect and one imperfect copy of the sequence element GGGAG, 
which is also found in the promoter regions of several other genes 
(See Discussion).
Sequence comparisons, in themselves, of course, tell us nothing 
as to whether a sequence element is important in the regulation of 
transcription. Ideally, the importance of particular regions should 
be tested in vivo (see Section 3.4 below) . In addition, clues as to 
whether particular upstream sequences may be involved in the formation 
of a transcription pre-initiation complex can be obtained by analysing
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the ability of nuclear proteins to bind to such sequences.
3.3.2 DNasel in vitro footprinting of 5' flanking sequences of the
RBC 15-LOX gene.
In vitro DNasel footprinting involves the introduction of 
"random" single-stranded nicks into "naked" end-labelled DNA, to 
produce, at appropriate low concentrations, a series of labelled 
fragments differing from each other by one nucleotide. In the 
presence of DNA-binding proteins, DNasel cleavage is prevented in 
regions of the DNA. which have been bound by protein, resulting in the 
absence of labelled fragments in a particular size range. The 
protected fragments can be observed by running the products of a 
limited DNasel digestion on a polyacrylamide sequencing gel and 
comparing the products with a digestion of DNA digested in the absence 
of DNA-binding protein. Protected regions of the DNA appear as 
"footprints" in the ladder of labelled fragments on an autoradiograph 
(Galas and Schmitz, 1978).
In vitro DNasel protection was performed using crude nuclear 
protein extracts from murine erythroleukaemia (MEL) and mouse brain 
cells, and from human HeLa cells. Nuclei were isolated from cells by 
lysis in isotonic sucrose (0.25M) containing 0.25% Triton detergent, 
and proteins extracted by addition of sodium chloride to 0.35M. A 
partial purification and concentration of nuclear proteins was 
achieved by precipitation using 0.35g/ml ammonium sulphate. Nuclear 
proteins from murine cells, rather than from rabbit tissues, were used 
to allow a comparison of in vitro protein binding data, and in vivo 
functional analysis (Section 3.4) .
The crude nuclear protein extracts were used to footprint a 
450bp EcoRI/BamHI fragment, 5' end-labelled on only the non-coding 
strand, at the BamHI site. This labelled fragment consists entirely 
of RBC 15-LOX 5' flanking sequences, except for 27nt downstream of the 
transcription initiation site: 20nt complementary to RBC 15-LOX mRNA
5' untranslated sequences, and 7nt of pUC polylinker. Thus, distances 
of footprinted regions from the transcription initiation site were
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calculated by subtracting 27nt from the size of protected regions, as 
measured by comparison with end-labelled pBR322/HaeIII markers.
3.3.2.1 Footprinting using murine nuclear protein extracts.
Figure 15 shows a preliminary experiment using crude nuclear 
protein extracts from MEL and normal mouse brain cells. Six possible 
regions of protection (designated FP1-6) by nuclear proteins from 
mouse brain and/or MEL cells are indicated, and the sequences lying 
within these regions are shown schematically in Figure 16. Of these, 
two (FP2 and FP4) show clear protection compared with the zero protein 
control tracks and, in the case of FP4, the acquisition of so-called 
"hypersensitive sites" (not to be confused with DNasel HSS in 
chromatin structure) at the boundary of the protected region. In 
addition, FP1 may represent weak protein binding, but the possibility 
cannot be excluded that this merely represents a region of inefficient 
DNasel digestion. Confirmation of the other three possible protected 
regions must await further footprinting studies.
FP2 lies between 75 and 106nt upstream of the transcription 
initiation site, and is protected by nuclear proteins from both the 
erythroid and non-erythroid cell-types. It includes the more proximal 
of the two CACCC motifs, as well as the TGGA (N) ^ GCCAT sequence similar 
to the CTF/NF-1 recognition sequence. A combination of CACCC and 
CTF/NF-l-like recognition sequences are also seen, and have been 
footprinted, in chicken (3^ - and pH-globin genes (Plumb et_ al, 1986) . 
The weak protection seen in the region of FP1 between 38 and 58nt
upstream of the transcription initiation site, includes the GGGCGG 
motif, and also appears to be present with both erythroid and 
non-erythroid cell-types. No apparent protection was seen in either 
cell-type of two other sequences noted in sequence analysis of the 
upstream sequences - the TATTTA, TATA-like sequence and the
decanucleotide repeat containing the GGGAG motif.
3.3.2.2 Footprinting using HeLa nuclear protein extract.
HeLa nuclear protein extracts have been widely used in DNasel
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Figure 15. In vitro DNasel footprinting of the non-coding strand of
the rabbit RBC 15-LOX promoter using murine and human
nuclear proteins.
DNasel protection of sequences adjacent to the 
transcription initiation site was performed using a 450bp EcoRI/BamHI 
fragment extending from 420nt upstream of the transcription initiation 
site. pCAT-2700 (Fig. 18) was kinase 5' end-labelled, then subjected 
to secondary digestion with EcoRI and the resulting 450bp EcoRI/BamHI 
fragment, labelled only at the BamHI site, isolated by agarose gel 
electophoresis. An aliquot of the recovered end-labelled fragment was 
incubated with varying amounts of nuclear protein extract for 90 
minutes at 4 C. DNA/protein complexes were then subjected to limited 
DNasel digestion for 30 seconds at room temperature. After 
termination of the digestion, products were extracted once with 
phenol/chloroform, once with chloroform, then ethanol precipitated and 
resolved on a 6 % denaturing polyacrylamide gel. Autoradiography was 
for 9 days at -70 C.
Nuclear proteins used were from murine erythroleukaemia 
cells (MELC) and mouse brain cells and from human epithelial (HeLa) 
cells. Possible protected regions are designated FP1 to FP6  with 
increasing distance from the RBC 15-LOX transcription initiation site. 
Numbers 0, 20, 40, 60 and 80 indicate numbers of microlitres of
nuclear protein extract used in the protein binding step prior to 
DNasel digestion. M = end-labelled pBR322/HaeIII size markers. Sizes 
shown on the right indicate position relative to the transcription 
initiation site, obtained by subtracting 27nt (the distance of the 
transcription initiation site from the labelled BamHI end) from the 
size of the markers.
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footprinting analyses, and. for the isolation of a variety of nuclear 
proteins including the transcription factors CTF/NF-1 (Rosenfeld and 
Kelly, 1986; Jones et al, 1987) and Spl (Briggs et al, 1986; Kadonaga 
and Tjian, 1986).
Figure 15 also shows footprinting of RBC 15-LOX 57 flanking 
sequences using HeLa nuclear protein extract. The zero-protein 
control is unfortunately over-digested, but comparison of footprinted 
lanes can be made with the zero-protein controls next to the
footprints obtained with murine nuclear proteins.
Very little can be deduced from this experiment regarding FPs 
3-6. However, protection is seen in both FP1 and FP2 regions.
Protection of FP2 is very similar to that seen with MEL and murine 
brain nuclear protein extracts; the FP1 pattern, however, is
completely different. Here, there appear to be two closely-separated 
regions of protection. The region containing the GGGCGG motif (-50 to 
-45nt) lies between these two regions, and does not appear to be 
protected. As Spl was originally isolated from HeLa cells (Briggs et 
al, 1986; Kadonaga and Tjian, 1986) it would seem either that 
protection in the FP2 region with murine nuclear proteins is not due 
to Spl itself, or that binding of another protein (s) to adjacent 
sequences prevents binding of Spl to the GGGCGG motif. As noted 
earlier (Section 3.3.1) the decanucleotide containing the GGGCGG 
sequence in the RBC 15-LOX promoter differs from the extended
consensus Spl binding sequence at one position. The affinity of Spl 
for this particular variant has not been compared with that for the 
consensus G/C box sequence (Kadonaga et al, 1986) .
3.3.3 Proximal RBC 15-LOX upstream sequences may be involved in
constitutive promoter function.
Footprinting experiments are still at a preliminary stage and 
much work will be needed to clarify the situation, particularly 
regarding sequences upstream of -150nt (FPs 3-6) where resolution is 
poor (a longer sequencing gel run was performed, but did not provide 
any additional information) . Results presented here are from only a
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single experiment and with only a limited number of nuclear protein 
extracts. Furthermore, the location of footprints has only been 
determined relative to end-labelled size markers; a more accurate 
positioning will be achieved by comparing DNasel digestion products 
with a sequencing ladder obtained by chemical degradation of the same 
fragment (Maxam and Gilbert, 1977) .
Nevertheless, the presence of "general" cis-regulatory sequences 
and the lack of erythroid-specific nuclear protein-binding in the 
proximal upstream sequences of the RBC 15-LOX gene may indicate that 
immediate upstream sequences constitute a basic promoter, concerned 
with ensuring accurate and efficient transcription initiation, while 
sequences located elsewhere may be involved in regulating 
transcription in a cell type-specific fashion. It is thus of interest 
to investigate whether proximal RBC 15-LOX 5' flanking sequences do 
indeed function as a constitutive promoter, and whether sequences 
further upstream are involved in modulating promoter function, by 
analysing the in vivo function of the RBC 15-LOX flanking sequences in 
both erythroid and non-erythroid cell lines.
3.4 FUNCTIONAL ANALYSIS OF THE RABBIT RBC 15-LOX 5' FLANKING 
SEQUENCES IN MURINE CELLS.
3.4.1 Strategy for investigating the function of the RBC 15-LOX
promoter.
The strategy for investigating RBC 15-LOX promoter function 
in vivo can be summarised as follows: Various progressive deletions of 
the 5' flanking sequences of the rabbit RBC 15-LOX gene were linked to 
the bacterial chloramphenicol acety It ransferase (CAT) gene. CAT 
enzyme activity was then assayed following transient expression of 
these RBC 15-LOX/CAT recombinants in erythroid and non-erythroid mouse 
cell lines, transfected by the calcium phosphate co-precipitation 
method. Egression of p-galactosidase from a co-transfected plasmid 
containing the lacZ gene was used as an internal control for 
variability in the efficiency of transfection.
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In vivo functional analyses employing "chimaeric" genes, to 
investigate the ability of sequences of interest to direct the 
expression of a cis-linked heterologous gene, such as the bacterial 
CAT gene, are widely used as an assay for sequences involved in the 
regulation of transcription, including cell type-specific regulation 
(reviewed in Kelly and Darlington, 1985) . Assays of transient 
expression following transfection of established cell lines by the 
calcium phosphate co-precipitation method are frequently used to 
rapidly assay such sequences (reviewed in Spandidos and Wilkie, 
1984a) . Although established cell lines in culture are very widely 
used in experiments designed to assess the function of nucleic acid 
sequences in vivo, the difficulties of extrapolating results obtained 
from transformed or partly-transformed cell lines, often at high 
passage number, to the varied cell types of normal living tissues in 
an intact organism, should be clearly borne in mind.
In the absence of any suitable rabbit erythroid cell lines, it 
was decided to express the RBC 15-LOX/CAT recombinants in murine 
cells. Functional analysis of heterologous gene expression has 
frequently been performed in cells from other species. Such studies 
have included the expression of various rabbit |3-globin promoter 
deletions in both mouse 3T6 and L cell non-erythroid cell lines and in 
MEL erythroid cells (Dierks et al, 1981 and 1983; Wright et al, 1984) . 
To investigate whether RBC 15-LOX 5' flanking sequences contain any 
erythroid-specific regulatory elements, both erythroid and 
non-erythroid cell lines were used - the Friend leukaemia virus- 
-transformed murine erythroleukaemia (MEL) line, F4.12B2, and the 
murine fibroblast-derived STO cell line.
The use of CAT assays in the functional analysis of 
transcriptional regulation is a highly-sensitive, but indirect, 
method of assaying levels of transcription. The effects of sequences 
of interest, introduced into a CAT-containing plasmid (either 
immediately upstream of the CAT gene in the case of promoter 
sequences, or at a distance in the case of enhancers) on transcription 
are investigated by measuring CAT enzyme activity. The CAT enzyme 
catalyses the acetylation, using acetyl Coenzyme A, of 1 4 C-labelled
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chloranphenicol. The mobilities of acetylated chloramphenicol 
derivatives differ from that of the unacetylated molecule in thin 
layer chromatography, allowing separation of substrates and products 
of CAT enzyme activity. The proportion of chloramphenicol which has 
been converted to its acetylated derivatives provides a measure of 
this CAT activity. The use of radio-labelled substrate makes this an 
extremely sensitive assay, being capable of detecting as little as 
0.02pmoles of product (0.5% conversion), but since enzyme activity, 
rather than the level of correctly-initiated transcripts, is measured, 
results must be confirmed by CAT mRNA analysis (see Section 3.4.8) .
RBC 15-LOX/CAT recombinant plasmids containing progressive 
deletions of RBC 15-LOX 5' flanking sequences were derived from a 
pUC19-based vector, pCAT19 (Fig. 18) in which the CAT and lacZ 
transcription units are in the opposite orientation. The CAT gene 
fragment and transcription termination signals from the Herpes Simplex 
Virus (Type 2) Immediate Early-5 (HSV-2 IE-5) gene were obtained from 
the plasmid pLW2 (Fig. 17)
3.4.2 Variability in assays of transient expression of CAT enzyme
activity.
The variability of results obtained in assays of transient 
CAT gene expression is well known. Most of the variability is due to 
variations in the efficiency with which plasmid DNA is introduced into 
cells. Thus, differences can be observed between the CAT activities 
from two transfected populations of the same cell type, not only 
because the plasmids may be expressed with different efficiencies, but 
also because there are different amounts of plasmid present in the 
nucleus, and, hence, available for expression. Only a very small 
proportion of the cell population take up and express plasmid DNA in 
transfections. Experiments in which thymidine kinase negative (TK“) 
met, cells were stably transformed to the TK-positive phenotype by 
calcium phosphate transfection of HSV TK-containing plasmids produced 
transformation frequencies of approximately 1 transformant per 
microgramme of donor DNA per 106  cells transfected (Spandidos and 
Paul, 1982) . Such experiments, of course, involve an additional,
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Figure 17. Plasmids used in the construction of RBC 15-LOX/CAT 
recombinants or as transfection controls.
pLW2 (Gaffney et al, 1985) is a pUC9-based plasmid containing a 
773bp TaqI fragment from the CAT gene. Transcription is driven by a 
210bp fragment frcan the HSV-2 IE-5 gene promoter region (IE-5), 
including 90bp of 5' flanking sequence. Downstream of the CAT gene, 
is a lOObp fragment (T) containing the transcription termination and 
3' end processing signals from the HSV-2 IE-5 gene. Promoter and 
terminator fragments are in the same orientation as in the IE-5 gene.
pHSV-(3gal, used as internal control to standardise for 
transfection efficiency, is derived from the lacZ-containing plasmid 
pCHHO (Hall et al, 1983) . Transcription of the lacZ gene is driven 
by the HSV-2 IE-5 promoter (IE-5), obtained from pLW2 as a 210bp BamHI 
fragment, via cloning into the BamHI site of the shuttle vector pIC20H 
(March et al, 1984), and inserted as a 310bp HindiII fragment into the 
Hindlll site created by removal of the mouse mammary tumour virus 
promoter used to drive transcription in pCHHO.
pL0X6/1.5R and pL0X2.5R contain the 1.5kb and 2.5kb EcoRI 
fragments respectively from the rabbit RBC 15-LOX gene (Figure 6 ) 
derived from the genomic recombinant X8  (Thiele et_ al, 1987), and 
sub-cloned into EcoRI-cut pUC18 (Yanisch-Perron et ad, 1985; Norrander 
et al, 1983)
pgCATl contains a 750bp Ncol fragment from the mouse ocl-globin 
gene. Since the 5' overhang at the 3' end of this fragment contains 
the ATG translation initiation codon, this sequence was removed by SI 
nuclease treatment. Following end-filling, the blunt-ended fragment 
was inserted into Smal-cut p22, a plasmid which was constructed (J. 
Lang, unpublished results) in an identical fashion to pCAT19 (Fig. 
18), except that it is derived from pUC12 (Norrander et al, 1983) 
rather than from pUC19 (Yanisch-Perron et al, 1985) and which 
consequently has pUC sequences in the opposite orientation relative to 
the CAT gene and terminator sequences.
Restriction sites: B = BamHI; Sm = Smal; K = Kpnl; Ss = SstI; R 
= EcoRI; C = Clal; E = EcoRV; X = Xbal; Bg = Bglll; Xh = Xhol; N = 
Nrul; H = Hindlll; Pv = PvuII; Sp = SphI; P = PstI; A = AccI; Tq = 
TaqI; Ap = Apal
R.Ss
X.A.P.H
Amp
pLW2
3*8kb
H. P.A.B.Sm
Amp
Amp
R.Ss.K.B.Sm.X.A.P.H
Sm Sm‘
LOX
Sm
LOX SmSs SmSm
R
lacY
Amp
pHSV-Bgal 
7 5kb
Pv
fi S m  K Ss.R.C.E.X.Bq.Xh.Ss.N.H
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H .S p.P .A .X .B
Figure 18. RBC 15-LOX/CAT recombinants used in the investigation of 
RBC 15-LOX promoter function.
pCAT19 is a "promoterless" CAT recombinant used as the basis 
for construction of all the RBC 15-LOX recombinants used in this 
study. It was obtained by the insertion of a 900bp Xbal/BamHI 
fragment from pLW2 (Fig. 17), containing the CAT gene and HSV-2 IE-5 
transcription termination signals, into Xbal/BamHI-cut pUC19 
(Yanisch-Perron et al, 1985), such that the lacZ and Ampr 
transcription units of pUC sequences are in the opposite orientation 
to the CAT gene.
pCAT-40 contains RBC 15-LOX sequences extending from 40nt 
upstream of the transcription initiation site to 2 0 nt downstream, 
obtained as a 60bp BstNI fragment from pL0X6/1.5R (Fig. 17), 
end-filled and blunt-end ligated into Smal-cut pCAT19. Correct 
insertion of RBC 15-LOX sequences has been checked by sequencing.
pCAT-150 contains sequences from 150nt upstream of the 
transcription initiation site to 20nt downstream, obtained as a 170bp 
Sstl/BstNI partial digest from pIOX6/1.5R (Fig. 17) and ligated into 
SstI/Smal-cut pCAT19. Correct insertion of RBC 15-LOX sequneces has 
been checked by sequencing.
pCAT-2700 was obtained by co-ligation of a lkb Sstl/Xbal 
fragment from pCAT-150 (containing RBC 15-LOX sequences from -150 to 
+20, the CAT gene and HSV-2 IE-5 transcription termination signals) 
with a 2.5kb KpnI/SstI fragment from pLOX6/2.5R (Fig. 17) (containing 
sequences between 2.7kb and 150nt upstream) into KpnI/Xbal-cut pCAT19. 
Successful construction has been tested by extensive restriction 
enzyme mapping.
pCAT-316 contains a 330bp Smal/BamHI fragment from pCAT-2700,
including RBC 15-LOX sequences between -316 and +20, inserted into
pCAT19. Reconstruction of the Smal site has been checked by 
restriction digestion.
pCAT-450 contains 450nt of RBC 15-LOX 5' flanking sequences, 
obtained by insertion of a 700bp.EcoRI fragment from pCAT-2700 into 
EcoRI-cut pCAT19.
pCAT-1000 was obtained by cloning of a 700bp Smal fragment from 
pCAT-2700, containing sequences between lkb and 316bp upstream of the 
RBC 15-LOX gene into Smal-cut pCAT-316. Successful insertion and 
reconstitution of Smal sites was checked by restriction digestion.
As in Figure 17, CAT is a 773bp TaqI fragment of the
chloramphenicol acetyltransf erase gene, and T is a lOObp fragment 
containing HSV-2 IE-5 gene transcription termination signals.
Restriction sites: R = EcoRI; Ss = SstI; K = Kpnl; Sm = Smal; B 
= BamHI; Tq = TaqI; X = Xbal; A = AccI; P = PstI; Sp = SphI; H =
Hindlll.
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chromosome integration, step compared with transient expression 
experiments, and probably represent an underestimate of transfection 
efficiencies obtained in this case.
Experience has shown that variations in transfection efficiency 
using different calcium phosphate/DNA precipitates and/or different 
batches of cells are major contributors to varibility in transient 
expression experiments. In the experiments described here, various 
approaches were adopted to ty to reduce the variability in CAT assay 
results. The most important of these was the use of an assay for 
(3-galactosidase activity, expressed from a co-transfected 
lacZ-containing plasmid, as internal standard for transfection 
efficiency (see Sectiaon 3.4.3 below).
To try to reduce variability between different precipitates, 
each transfection was performed in duplicate, and each set of 
transfections repeated on several separate occasions. On each 
occasion, two plates of each cell type were transfected with 
different calcium phosphate precipitates, made up using the same 
solutions, but mixed separately. These duplicates, though made using 
the same reagents are assumed to represent separate experimental 
determinations. Different preparations of some plasmids (pCAT19, 
pCAT-40 and pCAT-150; Fig. 18) were each used on several occasions. 
These different plasmid DNA preparations were obtained by the same 
method (alkaline lysis, followed by gel filtration column 
chromotography), but on separate occasions. Plasmid concentrations 
were checked by OD2 5 0  OD280 measurements' and the proportion of
supercoils in each preparation were shown to be equivalent by running 
out lOOng aliquots on agarose gels. In all cases, the same total 
amount of DNA (20fig) was added to a fixed number of cells. Different 
precipitates, containing recombinants of different sizes, each 
contained the same amount (2.4pmoles) of the plasmid DNA under test. 
Since the RBC 15-LOX and CAT gene fragments are contained in pUC 
vector sequences, the amount of DNA per transfection was made up to a 
constant total of 20pg per 1ml precipitate using pUC18 plasmid DNA.
In order to compare the expression of a given precipitate in
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erythroid and non-erythroid cell types, half of the precipitate was 
added to a dish of cells of each type. These are assumed to
represent, as far as possible, an identical transfection, carried out 
on different cell types.
To try to reduce variability between transfections performed on 
separate occasions, using different batches of cells, low passage 
number cells (usually less than 2 0  i.e. 8 - 1 0  weeks of continuous 
culture) were plated out at 1x10^ cells per 9cm Petri dish to try to 
ensure healthy growth of cells and optimum expression of introduced 
sequences throughout the 72 hours duration of each transient
expression experiment. Transfection efficiency was found to be lower
with cells plated at 3x10^ cells per dish (data not shown) .
Transfections of the semi-adherent MEL cell line used were only
performed on populations containing approximately 30-40% of cells 
showing elongated morphology. Each dish of cells was plated from the 
same stock of cells, maintained in logarithmic growth at all times by 
seeding at low cell density in fresh medium every 2-3 days.
3.4.3 fr-galactosidase enzyme assay as internal standard for
transfection efficiency.
The use of ^-galactosidase enzyme activity as an internal 
standard to correct CAT activities for transfection efficiency 
involves co-transfection (with equal molar quantities of each of the 
CAT recombinant plasmids under test) of a fixed amount (10|ig; 2pmoles) 
of a plamid containing the bacterial lacZ gene, which encodes the 
p-galactosidase enzyme. In the internal control plasmid used here, 
pHSV-Pgal (Fig. 17), transcription of the lacZ gene was under the 
control of the HSV-2 IE-5 gene promoter. This promoter was obtained 
from the plasmid pLW2 (Fig. 17) which is expressed efficiently in both 
cell types used here (Fig. 20) .
The assay for (3-galactosidase activity relies upon the enzymic 
cleavage of the chromogenic substrate o-nitrophenyl-p-galactopyrano- 
side, producing o-nitrophenol, which has a yellow colour, and whose 
concentration can thus be measured spectrophotometrically at 420nm.
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Correction of CAT enzyme activities on the basis that 
P-galactosidase activity reflects the transfection efficiency of CAT- 
and lacZ-containing plasmids makes several assumptions. Firstly, it 
assumes, like the CAT enzyme assay, that the activity of the 
(3-galactosidase enzyme reflects, in direct proportion, the amount of 
mRNA transcribed and available for translation, and the amount of 
plasmid taken up and available for transcription. As for CAT assays, 
the amount of lacZ mRNA can be checked by RNA analysis (see Section 
3.4.8) . Further, the efficiency of expression of the lacZ plasmid in 
each dish of cell is assumed to be constant for each of the 
transfections in a given cell type on a given occasion. No assumption 
is made concerning the ability of different cell types to express 
(3-galactosidase, though the HSV IE-5 promoter used to drive the lacZ 
gene in pHSV-figal is known to work well in both cell types used here 
when driving expression of the CAT gene in the plasmid pLW2 (J. 
Frampton, unpublished results; and Fig. 20) . It is also assumed that, 
in all cases, the molar ratio of lacZ and CAT plasmids available for 
expression is the same. This assumption would be unnecessary if the 
lacZ and CAT genes were physically linked in the same plasmid. 
However, in this case, interpretation of results might be further 
confused by the possibility of transcriptional interference between 
the two genes.
All (3-galactosidase assays were performed in substrate excess so 
that the amount of product produced was never more than 1 0 % of the 
substrate originally present. p-galactosidase activity was then used 
to correct for transfection efficiency at two stages. Firstly, for 
each set of transfections with each cell type, amounts of extract 
containing equivalent amounts of p-galactosidase activity were used in 
CAT assays. This entailed the use of different amounts of extract in 
each CAT assay. As the range of the amounts of protein from a given 
cell type in a given set of transfections was never more than 4- to 
5 -fold, it was assumed that the varying amounts of protein used in 
each CAT assay had no effect upon reaction rate. (The amounts of 
protein used were such that the CAT assay reaction was always in 
substrate excess, percentage conversions usually being less than 2 0 %)
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Secondly, all the CAT activity results from several experiments were 
corrected to correspond to a standard p-galactosidase activity (see 
Section 2.14.6). Percentage conversions from 5 experiments, corrected 
in this way, are shown in Table I. In most cases, the correction 
factor involved was small (typically 0.5 to 2 times) with the result 
that the corrected percentage conversions are similar to those 
obtained directly by scintillation counting of the CAT assay products. 
However, for some CAT recombinants which are highly expressed, such as 
pLW2, even correction factors as small as these result in corrected 
percentage conversions which are greater than 1 0 0 % i.e. the amount of 
extract which would produce the standard amount of o-nitrophenol 
during the p-galactosidase assay would, if used in the CAT assay, have 
exhausted the chloramphenicol substrate before the end of the CAT 
assay.
As can be seen in Table I, the use of a p-galactosidase assay as 
internal standard for efficiency of transfection usually results in 
relatively little variability between duplicates in a given 
experiment. Although there are large variations in CAT expression 
from a given recombinant plasmid in different experiments, the 
relative expression from different recombinants in a given cell type 
is much less variable.
3.4.4 Strategy to define the minimal functional promoter.
To establish the minimal region required to function as a 
promoter in the cell types chosen, two initial RBC 15-LOX/CAT 
recombinants, pCAT-40 and pCAT-150, were constructed (Fig. 18) from 
the plasmid, pCAT19, which contains the CAT gene and the HSV-2 IE-5 
transcription termination signal from the plasmid pLW2 (Fig. 17) but 
lacks any heterologous promoter sequences. In the construction of 
pCAT19 and its derivatives, the CAT transcription unit is inserted 
into pUC19 polylinker sequences in the opposite orientation to the 
direction of transcription of the lacZ gene to try to avoid 
transcription initiation due to vector sequences. In fact, levels of 
acetylation of chloramphenicol in CAT assays using this vector do not 
show any significant difference from those seen with a "promoterless"
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CAT vector with CAT and lacZ transcription units in the same relative 
orientation (data not shown).
pCAT-40 contains sequences from 40bp upstream of the 
transcription initiation site to 2 0 bp beyond the initiation site. 
This recombinant therefore contains most of the 5' untranslated region 
of the wild-type RBC 15-LOX mRNA, but LOX sequences are truncated 
upstream of the ATG translation initiation codon, preventing any 
abnormal hybrid RBC 15-LOX/CAT translation products. If transcription 
initiation occurs from the normal RBC 15-LOX transcription initiation 
site, then the 5' untranslated region of the CAT mRNA produced from 
pCAT-40 should contain only 20nt of LOX sequences, 9nt of pUC 
polylinker, and the final 30nt of the usual 5' untranslated region of 
the CAT mRNA.
pCAT-150 is identical to pCAT-40, except that it contains an 
additional HObp of RBC 15-LOX 5' flanking sequences, extending to 
150bp upstream of the RBC LOX transcription initiation site. The RBC 
15-LOX/pUC polylinker/ CAT junctions of both pCAT-40 and pCAT-150 have 
been sequenced and are identical in the two plasmids.
Expression of CAT enzyme from these two RBC 15-LOX/CAT 
recombinants and from the "promoterless" parent plasmid vector, 
pCAT19, were determined in 5 independent experiments using two 
different batches of each recombinant to control for variations 
between plasmid DNA preparations. Representative autoradiographs are 
shown in Fig. 20. The percentage conversions of chloramphenicol to 
its acetylated derivatives, corrected for equivalent amounts of 
(3-galactosidase activity as in Section 3.4.3, are shown in Table I. 
The mean values for each set of transfections, and the standard error 
of the mean for each set, are represented as histograms in Figure 21.
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Table I. CAT activities of various KBC 15-LQX/CAT recombinants,
corrected for (3-galactosidase activity!"
Corrected percentage conversions are shown for 5 
independent sets of transfections (Experiments 1-5). All except 
experiment 5 were performed as duplicate transfections (a and b) . For 
each cell line, in each experiment, CAT assays were performed on 
amounts of extract containing equal (3-galactosidase activity. After 
determining the proportion of the amount of radio-label converted to 
acetylated products by scintillation counting, this amount was 
expressed as a proportion of the .total, and percentage conversions 
from all transfections were corrected so that they all represent the 
CAT activity which would be obtained from that quantity of extract 
containing a standard (3-galactosidase activity under standard assay 
conditions (see Sections 2.14.4 and 2.14.6).
CAT ACTIVITIES
Percentage conversions corrected for &-.galactosidase activity
Experiment 3a 3b 2a 2b 3a 3b 4a 4b 5
pCATlS
MEL
STO
2.7,
1.9,
1.7
2.2
0.4,
0.9,
0.9
1.5
0.9,
0.4,
0.1
0.5
0.4,
0.1,
0.6
0.1
1.8
0.1
pCAT-40
MEL
STO
2.9,
2.0,
2.3
2.0
0.5,
2.1,
0.7
0.8
0.1,
0.3,
0.4
1.2
0.4,
0.1,
0.3
0.2
1.7
0.3
MEL 5.9,
10.8,
7.5
4.8
2.3, 2.1 3.1, 2.9 7.5, 7.3 30.3
2.4,
3.4,
pCAT-150
STO 11.8,
17.6,
9.1
14.4
5.0 8.8, 8.9 2.2, 1.9 3.1
4.4, 7.7
MEL
STO
1.0,
5.7,
2.1 
Q ^
6 9 5 3 22.9
2.0
pCAT-330
1 A 1.4^m XmHf
MEL
STO
3.5,
12.5,
1.7
7.8
S A 5 4 18.1
2.7
pCAT-450 1 A 1.4*
MEL
STO
6.3,
1.3,
8.7 
1 0
32.5
1.8
pCAT-1000
MEL
STO
13.7,
4.3,
9.1 1.3,
0.8,
i a 7 R 7.4 
n ^
29.0
0.8
pCRT-2700
0.8 n 7u.o, UtO
MEL
STO
5.9,
3.0,
6.3 
3 S
26.7,
1.8,
24.8 
1 7
11.2 
2 1
paCATl
MEL
STO
223, 213
109
132,
121,
64
107
280
91
pLW2
MEL
MEL
STO
STO
2.2,
1.3,
1.7,
1.5,
1.4 
1.0
1.4 
5.2
5.9, 1.6
pCAT-40E
1-4, 0.4+
MEL
MEL
STO
STO
20.3,
25.5,
8.5,
12.8,
24.7
21.5
11.9
8.0
21.6, 21.9+
pCAT-150E ~
8.6, 9.7+
Figure 21. Basic RBC 15-LOX jpromotej: function and response to a
heterologous enhancer.
CAT activities (after standardisation for p-galactosidase 
activity) from several independent transfections of pCAT-40 and 
pCAT-150 recombinants in MEL and STO cells, and the effect on these 
sequences of Friend murine leukaemia virus LTR enhancer, placed 
downstream of the CAT gene (Figs. 18 and 19). Sizes of bars represent 
the mean; error bars the Standard Error of the Mean of figures from 
several experiments, as presented in Table I. Figures above the bars 
indicate the number of determinations (n), using independent calcium 
phosphate/DNA co-precipitates, for each RBC 15-LOX/CAT recombinant. 
pCAT-40E and pCAT-150E represent the combined figures for 
determinations of the effect of the enhancer in both orientations (+ 
and -) relative to RBC 15-LOX sequences.
24
22
20
18
1 6
14
12
10
8
6
4
2
CAT a c t i v i t y : %  Conversion 
(corrected for  0 -ga l  act iv i ty)
n
MEL cells
STO cel ls
n=13n=12
n = 9n  = 9 n = 9 n -9
n = 6n = 6
II
n =6 
1
pCAT19 pCAT-40 pCAT-150 pCAT-40E pCAT-
3.4.5 Sequences between 40 and 150bp upstream of the rabbit RBC
15-LOX transcription initiation site are sufficient to 
elevate expression of a linked CAT gene in both erythroid and 
non-erythroid murine cells.
A low level of acetylation of chloramphenicol (0.3%) is seen, 
under the standard conditions used, with extracts from cells which are 
transfected using either pUC18 plasmid alone, or with pHSV-(3gal and 
pUC18 sequences, but with no CAT recombinant (see Fig. 22) . This 
background acetylation is presumably due to cellular acetylases. Such 
acetylase activity must be heat-stable to survive the heat treatment 
used prior to the assay for CAT activity. This background level was 
subtracted from each of the values for percentage conversion obtained 
with each of the transfections using CAT recombinants.
An additional low level of conversion is seen in cells of both 
types transfected with the "promoterless11 CAT plasmid, pCAT19 (see 
Fig. 22) . This additional level of conversion is presumed to be due 
to the presence of the CAT-containing plasmid and therefore due to CAT 
enzyme activity. As explained above, the design of the pCAT19 plasmid 
should prevent initiation of CAT gene transcription from either lacZ 
or Anpicillin-resistance promoters, but it is possible that the low 
level of CAT expression is due to initiation elsewhere in the pUC 
vector sequences.
Expression of CAT activity from pCAT-40 is not significantly 
higher than the pCAT19 background level in either cell type (Figs. 20 
and 22 and Table I) . Thus, the TATA-like element of the RBC 15-LOX 
promoter, on its own, is insufficient to function as an efficient 
promoter and requires additional sequences for high levels of 
transcription. This is consistent with other investigations of 
TATA-like regions of other genes. For example, the TATA-box of the 
SV40 early promoter is dispensable for high-level expression of SV40 T 
antigen in monkey cells (which does require additional upstream 
sequences), but has a key role in defining the site of transcription 
initiation (Benoist and Chambon, 1981)
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In determining cell type-specificity in the expression of 
heterologous genes in different cell lines requires a comparison to be 
made between the recombinant under investigation, and some other 
reference recombinant. Choosing a reference CAT plasmid which has no 
preference for expression in different cell types provides a problem. 
pCAT19 is not suitable, since the CAT gene is "promoterless", and no 
specific transcription of CAT mRNA would be expected in either cell 
type. In experiments described here, pCAT-40 was chosen as an 
arbitrary reference plasmid for determining cell type-specificity.
; ’.o
The extra lint of RBC 15-LOX gene 5' flanking sequences present 
in pCAT-150 have a marked effect upon expression of the CAT gene in 
both cell types tested. In both MEL and STO cells, the CAT activity 
from pCAT-150-transfected cell extracts is approximately 7 or 8 times 
higher than that seen after transfection with pCAT-40. The 
observation that the difference between CAT expression from pCAT-150 
and from pCAT-40 is the same in both cell types suggests that there 
are no sequences in the first 150bp of 5' flanking sequence of the RBC 
15-LOX gene which have any cell type-specific effect in the two cell 
types being investigated. This is in good agreement with the 
footprinting data (Section 3.3) which showed that the CACCC, 
CTF/NF-l-like, and GGGCGG sequences within 150nt of the transcription 
initiation site are protected by extracts from both MEL and mouse 
brain cells, and lends support to the suggestion (Section 3.3.3 above) 
that sequences within 150nt of the transcription initiation site are 
concerned with basic, "constitutive" promoter function, and that any 
sequences involved in modulation of levels of transcription lie 
elsewhere.
3.4.6 Sequences present in RBC 15-LOX promoter can respond to a
heterologous enhancer.
Having established that sequences between +20 and -150nt from 
the transcription initiation site can act as a basic functional 
promoter, it was decided to investigate whether expression from this 
basic promoter region can be modulated by other regulatory elements. 
In order to do so, a fragment from the U3 region of the long terminal
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repeat (LTR) of the Friend murine leukaemia virus, which contains an 
erythroid-specific enhancer (Bosze et al, 1986) and a CCAAT box, but 
no TATA box or transcription initiation site, was inserted into a 
Hindi 11 site downstream from the transcription termination signals of 
pCAT-40 and pCAT-150 (Fig. 19) .
A comparison of results obtained with pCAT-40 and the two 
pCAT-40E (+ and -) plasmids shows that the Friend virus LTR enhancer 
has little effect upon expression of CAT activity in either of the 
cell types examined, when placed downstream of 40bp of 5' flanking
sequence. The effect of the Friend virus LTR enhancer upon CAT
expression driven by RBC 15-LOX promoter sequences up to 150bp
upstream of the transcription initation site, however, is markedly 
different from its effect upon only 40bp of upstream sequence. 
Comparing expression of CAT enzyme activity from the two pCAT-150E (+
and -) plasmids with that from pCAT-150 in the same cell type shows 
only a slight increase (of approximately 25%) in STO cells, but a 
larger, 2- to 3-fold, increase in either orientation in MEL cells
(Figures 20 and 21, and Table I) . The magnitude of this cell
type-specific effect of the Friend virus LTR enhancer on the RBC 
15-LOX basic promoter in murine cells is smaller than the effect on 
the enhancerless SV40 Early promoter in human cells observed by Bosze 
et al (1986), who obtained a 50-fold increase in CAT activity driven 
by the SV40 promoter in the presence of the Friend virus enhancer, 
situated downstream of the CAT gene, in K562 human erythroid cells, 
but only a 1.5-fold increase in non-erythroid HeLa cells. The 
difference between these two sets of results may be attributable 
either to the use of cell lines from a different species, or to 
different effects of the enhancer on different heterologous promoters.
These results indicate that sequences between 40 and 150bp
upstream of the transcription initiation site of the rabbit RBC 15-LOX 
gene can respond to a heterologous enhancer in a cell type-specific 
fashion, and provide further evidence that sequences immediately 
upstream of the rabbit RBC 15-IOX transcription initiation site can 
act as a functional promoter, albeit for expression of a heterologous 
gene in heterologous cells.
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3.4.7 Sequences between 1000 and 2700bp upstream of the rabbit RBC
15-LOX transcription initiation site have a cell 
type-specific effect upon expression of a linked CAT gene in 
murine cells.
Having ascertained that sequences within 150bp upstream of 
the RBC 15-LOX transcription initiation site can act as a basic 
functional promoter and can respond to heterologous regulatory 
elements, it was decided to investigate whether any regions in the 
2.7kb of available 5' flanking sequences of the rabbit gene could 
exert a regulatory influence upon expression from the +20 to -150nt 
region in the same experimental system. paCATl, a plasmid containing 
700bp of 5 ' flanking sequence from the mouse al-globin gene linked 
upstream of the CAT gene in an analogous fashion to the RBC 15-LOX/CAT 
recombinants (Fig. 17), was used as a positive control for 
erythroid-specific expression. This region of the mouse al-globin 
gene has been previously shown to have a 4- to 5-fold 
erythroid-specific effect in the same assay system used here (Frampton 
et al, manuscript in preparation) .
Various progressive 5' deletions of the RBC 15-LOX promoter were 
made such that, in all cases, sequences were in the same relative 
position and orientation as in the wild-type rabbit gene. So, in 
considering the results of functional expression studies, problems 
raised by incorrect spatial separation of regulatory elements should 
not arise. Figure 18 shows the strategy for construction of 
additional RBC 15-LOX/CAT recombinants containing 316, 450, 1000 and
2700bp of RBC 15-LOX 5' flanking sequence, linked upstream of the CAT 
gene. A representative autoradiograph of transfections of these 
recombinants into MEL and STO cells is shown in Figure 22, and 
corrected CAT activities are given in Table I.
It was seen earlier (Section 3.4.5) that pCAT-150 appears to 
show no apparent cell type-specificity. To determine whether upstream 
sequences have any cell type-specific regulatory effects upon 
sequences within 150nt upstream of the transcription initiation site,
121
Figure 22. CAT expression in murine cell lines from various
progressive deletions of RBC 15-LOX 5' flanking sequences.
Representative autoradiographs of the products of CAT 
enzyme activity in extracts from MEL and STO murine cell lines 
transfected with various RBC 15-LOX/CAT recombinant and control 
plasmids. pCAT-40, pCAT-150, pCAT-316, pCAT-450, pCAT-1000 and
pCAT-2700, containing 40, 150, 316, 450, 1000 and 2700bp of RBC 15-LOX 
5' flanking sequences respectively, are as shown in Figure 18. pUC18 
and pHSV-(3gal (Fig. 17) are controls for background acetylation in the 
absence of CAT-containing plasmid; paCATl (Fig. 17), containing 700bp 
of 5 ' flanking sequences of the mouse al-globin gene, is a positive 
control for cell type-specific CAT expression.
Cells were transfected by the addition of a calcium 
phosphate/DNA co-precipitate containing 2.4pmoles of the RBC 
15-LOX/CAT plasmid under test, 2pmoles (10pg) of pHSV-pgal as internal 
standard, and pUC18 to a total gf 20pg DNA. Results shown, obtained 
in a 30 minute CAT assay at 37 C? using amounts of transfected cell 
extract showing equal amounts of p-galactosidase activity, range from
0.3% (pUC18 and pHSV-pgal in STO cells) to 32% conversion (paCATl in 
MEL cells). Percentage conversions from this experiment, after 
standardisation for (^-galactosidase activity to allow comparison with 
other experiments (Section 2.14.6), are shown as Experiment 4 in Table
1. Autoradiographs shown here were exposed for 7 days at room 
temperature.
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levels of CAT expression from the various deletions were compared in 
each cell type with that from pCAT-150 in the same experiment, given 
the arbitrary value of 1. Relative CAT activities of the various 
recombinants are shown in Figure 23.
RBC 15-LOX/CAT recombinants containing 5' flanking sequences 
within lkb upstream of the transcription initiation site do not have 
any significant effect upon CAT enzyme expression relative to pCAT-150 
in either MEL or STO cells, with the possible exception of pCAT-1000 
which shows a slight reduction in STO cells. However, expression of 
the CAT gene from pCAT-2700 seems to show a marked cell type-specific 
effect, expression of CAT activity relative to pCAT-150 in STO cells 
being approximately 6 -fold lower than in MEL cells and barely above 
the expression seen from pCAT-40. Although the most obvious 
interpretation of this cell type-specific effect is that it is an 
STO-specific negative effect, this cannot yet be established with any 
certainty (see Discussion) . The degree of this cell type-specific 
effect would appear to be slightly larger than the 4- to 5-fold effect 
seen with paCATl, consistent with earlier observations that the region 
of the mouse al-globin gene contained within this fragment is 
responsible for some, but not all of the erythroid-specific regulation 
of transcription of this gene by sequences within 4kb of the 
transcription initiation site (Frampton et al, manuscript in 
preparation) .
In summary, CAT assays on extracts from murine cells transfected 
with rabbit RBC 15-LOX/CAT recombinants suggest that sequences 
upstream of the RBC 15-LOX transcription initiation site include at 
least two regions important for the expression of CAT enzyme in murine 
cells (see Sections 3.4.5 - 3.4.7 above) . One, between 40 and 150bp 
upstream is capable of increasing expression of the CAT enzyme in both 
erythroid and non-erythroid murine cell lines (Fig. 21) . The other, 
between 1000 and 2700bp upstream, exerts a cell type-specific effect 
upon expression driven by the -40 to -150 region (Fig. 23) .
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3.4.8 Analysis of CAT mRNAs from murine cells transfected with RBC
15-LOX/CAT recombinants.
CAT assays are widely used to investigate the effects of 
defined sequences upon transcription. However, the CAT assay itself 
is only an indirect measure of transcription as it assesses only 
levels of CAT enzyme activity. Thus, analysis of CAT mRNAs, in 
addition to that of CAT enzyme activity, is important for several
reasons. Firstly, it provides confirmation that CAT mRNAs transcribed
from the various RBC 15-LOX/CAT recombinants are correctly initiated 
at the RBC 15-LOX transcription initiation site in the heterologous 
cell lines used. Secondly, it establishes that differences in CAT 
enzyme activity from different RBC 15-LOX/CAT recombinants are not due 
to differences in sites of initiation, in which case CAT enzyme 
activities might be a result of differential post-transcriptional 
effects upon CAT mRNAs differing in their 5' untranslated regions. 
Finally, quantitation of CAT mRNA levels can provide =aneh-^ henee- 
confirmation that CAT enzyme activity accurately reflects the levels 
of transcripts from each CAT recombinant. Of course, such analysis 
still does not provide clear evidence that CAT transcripts are 
regulated at the level of transcription.
In order to analyse CAT mRNAs transcribed from the RBC 15-LOX
promoter in STO and MEL cells, 2xl06  cells of each type were
transfected with pCAT19, pCAT-40, pCAT-150, pCAT-1000, pCAT-2700 and
pLW2. pLW2 was used as a positive control: as CAT expression from
this plasmid in both cell types is approximately 1 0 -fold higher than 
from any of the RBC 15-LOX recombinants (Table I), it was hoped that 
detection of CAT mRNA from this recombinant would be possible even if 
transcripts from the RBC 15-LOX/CAT recombinants were not detectable. 
The lacZ-containing plasmid pHSV-pgal was co-transfected with each RBC 
15-LOX/CAT recombinant to allow standardisation of CAT mRNA levels by 
comparison with lacZ mRNA levels, analogous to the correction of CAT 
enzyme activities according to (3-galactosidase activity.
CAT enzyme assays were performed on extracts from one fifth of 
the cells from each transfection as above (results are shown as
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Experiment 5 in Table I) . The remaining cells were used to prepare 
RNA. RNAs were judged to be intact by the appearance of intact 18 and 
28S ribosomal RNAs on ethidium bromide-stained agarose gels. Mapping 
of 5' ends and quantitation of CAT and lacZ mRNAs was attempted using 
both SI nuclease protection and primer extension analyses. 
Unfortunately, both were unsuccessful for various reasons discussed 
below.
3.4.8.1 Analysis of CAT mRNAs by primer extension.
A single primer, derived from sequences within the CAT gene, 
can be used to map the 5' ends of CAT transcripts from any recombinant 
containing the CAT gene. The primer chosen was a synthetic 
single-stranded 35-mer oligodeoxyribonucleotide of sequence 5'-GTGGTA- 
TATCCAGTGATTTTTTTCTCCATTTTAGC-3' (34% G/C) . This sequence is the
complement of CAT gene sequences extending from 6 nucleotides upstream 
of the translation initiation codon to 29nt beyond. Although this 
primer is very A/T-rich, there is no region sufficiently close to the 
start of the CAT gene to allow efficient primer extension which has a 
lower A/T content. A 35-mer was thus chosen rather than a shorter 
oligo. in order to optimise the hybridisation to the CAT mRNA.
For standardisation of CAT mRNA levels relative to lacZ mRNA 
levels, a synthetic 30-mer oligodeoxyribonucleotide of sequence 5'-CC- 
TTCGCGATGCCGCCGCTGCCGTCCCGGT-3' (77% G/C) was chosen as primer." This 
sequence is complementary to pHSV-pgal sequences extending from 38 to 
67bp beyond the translation initation site, within the region of the 
HSV-2 IE-5 promoter which is used to drive transcription from the lacZ 
gene. The extreme G/C-richness of this region does not permit the use 
of a less G/C-rich primer.
These two primers were 5' end-labelled and used in primer 
extension reactions with approximately 10|ig of total RNA from 
transfected STO cells and 20-50jig from MEL cells. Unfortunately, 
results of primer extension on these RNAs were not satisfactory using 
either of the primers, and it was not possible to obtain quantitation
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of CAT mRNAs by this method. In all RNAs tested, including a tRNA
control, primer extension using the oligo. designed to prime on lacZ
mRNAs gave a ladder of primer extension products, extending well 
beyond the normal transcription initiation site of the HSV IE-5 gene, 
(data not shown) . The observation of an identical pattern in a tRNA 
control suggests that non-specific priming is occurring, probably from 
a tRNA species, perhaps due to a hybridisation temperature too low for 
the G/C-richness of the primer.
However, with the CAT primer, there were no visible primer 
extension products, even after a two-week exposure. In contrast to 
the situation with the lacZ primer, the failure to observe extension 
products may have been due to a hybridisation temperature that was too
high for the A/T-rich primer. Alternatively, it might be due to the
fact that only a small proportion of the population of cells to which 
DNA was added have actually taken up, and are expressing, the CAT 
recombinants, in which case CAT mRNAs would be present only at very 
low levels, representing an extremely small proportion of the total 
cellular RNA extracted from each transfected population of cells. It 
is notable in this respect that many of the reports of successful 
primer extension analyses of CAT mRNAs have been obtained with RNA 
isolated from pools of drug resistant cells obtained by
co-transfection of CAT recombinants with a selectable drug-resistance 
marker, such that a larger proportion of cells will be expressing the 
CAT plasmid (e.g. Hemonat et al, 1988) . Furthermore, the CAT mRNA is 
thought to be a relatively unstable messenger. Consequently, primer 
extension with an end-labelled primer might not be sufficiently 
sensitive to produce detectable extension products.
There are several possible solutions to this technical problem 
of sensitivity. A first would be to put the RBC 15-LOX promoter in 
all the CAT recombinants under the influence of a non-cell
type-specific enhancer in the hope of increasing the level of CAT mRNA 
transcription. However, this might provide additional problems of 
interpretation of results. An alternative solution would be to
increase the amount of CAT mRNA available as template for primer 
extension. This could be achieved either by including larger
125
quantities of total RNA in each hybridisation, or by using poly (A) + 
enriched RNA. Another possibility would be to increase the specific 
activity of the products. This could be achieved either by including 
a radio-labelled nucleotide in the primer extension reaction, or by 
using a primer of higher specific activity. As it would be difficult 
to obtain a synthetic oligo. of higher specific activity than one 
which is end-labelled, other than by incorporating radio-labelled 
deoxynucletides in the oligo. synthesis, it was decided that an
attempt should be made to obtain a probe of higher specific activity 
by performing SI protection experiments with uniformly-labelled probe.
3.4.8 .2 Analysis of CAT mRNAs by SI protection.
Single-stranded uniformly-labelled probes for detecting 57 
ends of both lacZ and CAT mRNAs were generated by the method of 
Bentley (1984). This involves sub-cloning of restriction fragments 
into double-stranded (replicative form) Ml3 virus, and the generation 
of single-stranded recombinant M13 DNA templates, followed by the
incorporation of a radio-labelled deoxynucleotide into a complementary 
strand by primer extension on the Ml3 Universal primer using Klenow 
enzyme, and, finally, liberation of radio-label led single-stranded 
probe by cleavage of the resulting duplex with a single restriction 
enzyme cut. The probe can then be isolated by running out on a 
sequencing gel.
The fragment chosen for generation of an SI probe for analysis 
of CAT mRNAs was a 419bp Sstl/EcoRI fragment from pCAT-150, cloned 
into Sstl/EcoRI-cut M13mpl9. Following generation of a complementary 
strand, and cleavage with SstI, a probe of 436nt, including the Ml3
Universal primer, was obtained. Initiation of transcription from the
usual RBC LOX transcription initiation site should yield a 290nt 
protected fragment; any transcripts initiated more than 146nt upstream 
of this site would produce full-length protection.
The fragment chosen to generate a single-stranded SI probe for 
quantitation of lacZ mRNA levels was a 246bp Xbal/SstI fragment from 
pHSV-(3gal, containing approximately lOObp of sequence from either side
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of the HSV IE-5 transcription initiation site. Transcripts initiated 
at this site would be expected to protect a fragment of 167nt.
The CAT and lacZ probes were labelled using [oc-^P] dCTP at
1.1x10 ^Bq/mmol. Radio-label was present at a final concentration of
3(JM in the labelling mixture, along with 50|JM unlabelled dCTP,
producing a final specific activity of 6.7x10 Bq/mmol. This should
produce probe labelled at 6 residues in every hundred nucleotides of
probe i.e. approximately 26 labelled residues per molecule
(1.7x10 ^Bq/mmol) of the 436nt CAT probe (assuming even distribution of
1 4the 4 bases), and 16 labelled residues per molecule (1.1x10 Bq/mmol) 
of the 269nt lacZ probe. Obviously, this labelling of an SI probe 
with more than one molecule of isotope per molecule produces probes of 
far higher specific activity than can be achieved by end-labelling.
Unfortunately, using the same quantities of RNA as in the primer 
extension analysis of CAT mRNAs above, no 5' end analysis or 
quantitation of CAT mRNAs expressed from any of the RBC 15-LOX/CAT 
recombinant plasmids was possible using this method either. No 
full-length protected fragments were seen. Protected fragments of the 
expected size were seen from both cell types transfected with the 
highly-expressed pLW2 plasmid, but no protection could be detected, 
even after a 2-week exposure, with RNAs from either cell type 
transfected with RBC 15-LOX/CAT recombinants (data not shown). This 
suggests that the technical problem of detecting CAT mRNAs has been at 
least partly overcome - the probes used are of a suitable specific 
activity to detect CAT mRNAs from the pLW2 plasmid, but transcripts 
from the RBC 15-LOX/CAT recombinants, present at lower levels, have 
not been detected. A repetition of this experiment using larger 
amounts of the CAT mRNAs (either larger quantities of total RNA, or 
similar quantities of polyadenylated RNA) might be expected to achieve 
successful quantitation of CAT mRNAs expressed from the RBC LOX/CAT 
recombinants. However, a lack of sufficient time has meant that this 
experiment has not yet been performed.
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Chapter 4. 
DISCUSSION.
4.1 OVERVIEW OF THE PROJECT.
As part of a group effort directed at investigating the 
co-expression of genes transcribed in erythroid cells, this project 
has been concerned with the organisation and function of the promoter 
region of the gene encoding the rabbit erythroid-specific RBC 15-LOX. 
This enzyme, until recently the only mammalian LOX to have been 
purified to homogeneity (Rapoport et al, 1979), is one of the major 
non-globin proteins of anaemic peripheral blood, and shows several 
interesting features in its expression, including an 
erythroid-specific accumulation of RBC 15-LOX mRNA (Thiele et al, 
1987; and Section 3.2 above) and translational inactivation of the 
messenger until the final stages of erythroid maturation (Thiele et 
al, 1982; and Introduction Section 1.6.3).
This project has mainly been concerned with transcription of the 
recently cloned RBC 15-LOX gene, involving: mapping of the
transcription initiation site; characterisation of proximal 5' 
flanking sequences, including the binding of nuclear proteins in 
vitro; functional analysis of proximal upstream sequences for promoter 
function in vivo; and investigation of the effect of sequences further 
upstream of the transcription initiation site on promoter function. 
The following discussion will concentrate on possible future areas of 
research into RBC 15-LOX transcription, but will also deal with 
elements of the work presented here which, in conjunction with the 
recent results of others, may have implications for 
post-transcriptional or translational regulation of RBC 15-LOX 
expression and for the evolution of the LOX enzyme family.
4.2 FUNCTIONAL ANALYSIS OF THE RBC 15-LOX PROMOTER.
In investigating the ability of 5' flanking sequences to 
function as a promoter in the efficient initiation of transcription in 
living cells, one would ideally want to perform functional analysis 
in cells from the appropriate species. However, in the absence of 
suitable rabbit cell lines, rather than attempting to clone the mouse 
or human RBC 15-LOX genes, it was decided to investigate promoter
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function in heterologous, murine cell lines.
The system chosen to investigate promoter function involved the 
use of murine erythroleukaemia (MEL) and STO fibroblast cell lines. 
Promoter deletions of other rabbit erythroid-specific genes have, in 
the past, been shown to be capable of functioning in both erythroid 
and non-erythroid murine cell lines. For example, Dierks et al (1981 
and 1983) have demonstrated that 5' flanking sequences of the rabbit 
(3-globin gene are required for accurate and efficient transcription 
initiation both in transient expression experiments in mouse 3T6 cells 
and in stably transfected mouse L cells. So, transfection into murine 
cell lines should permit investigation at least of "constitutive" 
cis-acting sequences involved in transcription initiation from the 
rabbit RBC 15-LOX promoter. Furthermore, Wright et al (1984) have 
demonstrated that transcription from a minimal rabbit (3-globin 
promoter containing only 58bp of 5' flanking sequence could be 
correctly regulated upon induction of differentiation of MEL cells 
into which the rabbit (3-globin recombinants had been stably 
transfected. This suggests that murine cell lines may also be 
legitimate cells in which to study the effects of regulatory elements 
upon transcription from the rabbit RBC 15-LOX promoter.
4.2.1 Two regions of rabbit RBC 15-LOX upstream sequences 
important for expression of a reporter gene from the RBC 
15-LOX promoter in murine cell lines.
Functional data presented here indicate two regions of rabbit
RBC 15-LOX gene 5' flanking sequences which affect expression of a
cis-linked CAT gene in murine MEL and STO cell lines. A proximal
element, between 40 and 150nt upstream of the transcription initiation 
site, functions as a "constitutive" promoter, increasing expression of 
a linked CAT gene by 7- to 8 -fold in both the erythroid and 
non-erythroid murine cell lines studied (Section 3.4.5), while a 
distal element located between 1000 and 2700nt upstream has a 6 - to 
8 -fold cell type-specific effect upon CAT expression (Section 3.4.7).
These observations are reminiscent of the situation in the
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(3-like globin gene family, in which 5' flanking sequences within lOOnt 
of the adult (3-globin genes drive transcription in both erythroid and 
non-erythroid cell types (Dierks et al, 1983; Grosveld et al, 1982; 
Myers et al, 1986; Chamay et al, 1985) while sequences downstream of 
the polyadenylation signal appear to be involved in erythroid-specific 
expression (Antoniou et al, 1988; Choi and Engel, 1986) . This is in 
contrast to the situation for the human al-antitrypsin gene, however, 
where cell type-specific regulatory sequences have been found 
immediately upstream of the transcription initiation site. Here, 
sequences between -137 and -37nt upstream of the transcription 
initiation site have been found to be sufficient to confer 
liver-specific expression upon the homologous gene or upon a 
heterologous SV40 promoter (De Simone et al, 1987).
A priority for the immediate future is the confirmation of CAT 
enzyme activity results by analysis of CAT mRNAs, in order to 
demonstrate firstly that the increase in expression of CAT enzyme seen 
from the -150 and -40 regions occurs from the correct transcription 
initiation site and, secondly, that differences in CAT activities 
reflect CAT mRNA levels rather than different translational 
efficiencies of mRNAs transcribed from different recombinants. These 
studies, commenced as part of this project (Section 3.4.8), have not 
yet been successfully completed, and are currently being pursued by 
other members of the group.
4.2.2 Potential cis-regulatory sequences in the RBC 15-LOX
promoter.
One of the principal objectives in studying the structure and 
function of the rabbit RBC 15-LOX gene promoter has been to 
investigate whether there are any functionally important cis-acting 
sequences in common with other genes expressed in erythroid cells. 
The basic functional rabbit RBC 15-LOX promoter, contained within 
150nt of the transcription initiation site, includes (Section 3.3) 
CCAAT, CACCC and TATA-like sequences seen in the promoter of the 
rabbit |3-globin gene (Hardison et al, 1979; van Ooyen et al, 1979), 
and other mammalian globin genes (Efstratiadis et al, 1980), as well
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as other sequences present in the promoters of a wide variety of 
non-globin genes, most notably a single GGGCGG, G/C-box sequence, the 
recognition sequence for transcription factor Spl (Kadonaga et al,
1986), and a potential binding site for CTF/NF-1, one of a family of 
transcription factors which recognise sequences which include the 
CCAA.T motif (Santoro et al, 1988; Chodosh et al, 1988a, b; Jones et 
al, 1987) . This assortment of sequences which are also found in the 
promoter regions of other genes is reminiscent of findings in a 
variety of other gene promoters which contain modular arrangements of 
cis-acting sequences recognised by "general" transcription factors 
involved in basic promoter function (see Introduction Section 1.2.3) .
4.2.3 DNA-protein interactions in the RBC 15-LOX promoter.
Preliminary data from DNasel footprinting of the proximal 
region, show that some of these "general" promoter sequence motifs 
are protected by nuclear protein extracts from both erythroid and 
non-erythroid murine cells (Section 3.3.2) and support the suggestion 
from functional data that this region represents a basic functional 
promoter, which is bound by transcription factors present in many cell 
types, and that any sequences which may be involved in cell 
type-specific regulation of the level of transcription from this 
region may be located elsewhere in the RBC 15-LOX gene.
A variety of experiments will be required in the near future to 
clarify the situation regarding the binding of transcript ion factors 
to the RBC 15-LOX promoter, particularly whether the same factors are 
involved in binding to the RBC 15-LOX promoter as are involved in the 
function of other promoters. For example, a region (FP2) which is 
protected by both erythroid and non-erythroid murine nuclear protein 
extracts contains both the more proximal of two CACCC motifs, and a 
sequence immediately upstream, which resembles the recognition 
sequence for the CTF/NF-1 family of transcription factors (Section 
3.3.2.1) . It will be of interest to examine whether either or both 
motifs are bound by factors which bind similar sequences in other 
genes. Mantovani et al (1988a) have reported both ubiquitous and 
erythroid-specific nuclear proteins which bind to the CACCC box of the
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human (3-globin promoter, while, as mentioned in Section 3.3.2.1, a 
combination of CACCC and CTF/NF-l-like sequences have also been
footprinted in chicken (3^ - and (3H-globin genes (Plumb et_ al, 1986) . 
Protection at FP2 might be the result of the binding of factors to 
either or both of the CACCC and CTF/NF-l-like motifs. This could be 
investigated by comparing the electrophoretic mobility shift patterns 
obtained using erythroid nuclear proteins bound to three
double-stranded synthetic oligos: one containing only the
CTF/NF-l-like motif; one containing only the CACCC motif, and another 
containing both. If this third oligo. simultaneously binds two
proteins, a mobility shift greater than that from binding to either of 
the other two oligos. might be expected. A comparison of the mobility 
shifts obtained with purified CTF/NF-1 proteins (Jones et al, 1987) or 
CTF/NF-1 expressed from cloned cDNAs (Santoro et al, 1988) and with 
murine nuclear proteins could also be used to investigate whether it 
is a CTF/NF-1 protein or a murine variant which is responsible for the 
protection observed. Further information as to the nature of the 
factor binding the CTF/NF-l-like sequence could be obtained by 
performing in vitro footprinting and mobility shift experiments using 
large molar excesses of competitor oligos. containing sequences known 
to be bound by CTF/NF-1 in other promoters.
Both MEL and mouse brain extracts also weakly protected a region 
(FP1) containing the GGGCGG sequence recognised by the transcription 
factor Spl. However, a different pattern was obtained with HeLa cell 
extract (Fig. 15), the original source of purified Spl (Kadonaga and 
Tjian, 1986; Briggs et al, 1986). It therefore seems likely that the 
protection around GGGCGG is not due to Spl itself, but might be due to 
a murine protein with similar sequence specificity in its DNA-binding. 
This suggestion might also be tested using a mobility shift assay. In 
a similar experiment to that suggested above, the question of whether 
Spl itself is capable of binding to the RBC 15-LOX GGGCGG sequence 
could be investigated by observing the pattern of shifted products 
when a double-stranded synthetic oligonucleotide corresponding to the 
RBC 15-LOX G/C-box is incubated with MEL or mouse brain extracts with 
the pattern obtained using either purified Spl (Kadonaga and Tjian, 
1986; Briggs et al, 1986) or with Spl expressed from its cloned cDNA
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(Kadonaga et al, 1987) in an expression vector.
If the RBC LOX G/C box is indeed bound by some murine factor,
but not by Spl, this might be explained by the context of the G/C-box 
i.e. the nature of surrounding sequences. Kadonaga et al (1986) have 
presented an extended consensus sequence, (G/T) GGGCGG (G/A) (G/A) (C/T), 
for Spl binding, and investigated the affinity of Spl binding to 
variants of this sequence. The G/C-box contained in the RBC 15-LOX 
promoter differs from this consensus sequence at only one position, a 
C residue occupying the ninth position, rather than G or A. 
Unfortunately, this variant was not one of those tested by Kadonaga et 
al (1986). The proportion of synthetic oligonucleotide showing
altered mobility with pure Spl could be compared with that of another
oligo. corresponding to the extended Spl consensus sequence to 
determine the relative affinity of Spl for the G/C box of the RBC 
15-LOX promoter.
i$~
To date, protein binding to the rabbit RBC/LOX promoter has only 
been investigated using murine nuclear extracts, in order to correlate 
results with those obtained by functional assays in murine cell lines. 
To examine whether such sequences are also recognised by rabbit 
transcription factors, it will be necessary to perform DNasel 
footprinting with rabbit nuclear proteins. Foetal liver, as the 
principal erythropoietic organ of the developing rabbit, might prove a 
suitable tissue for obtaining erythroid nuclear proteins, since it 
represents a more homogeneous population of erythroid cells than, say, 
bone marrow from anaemic animals. Furthermore, Northern blot 
hybridisation studies presented here (Fig. 13), and subsequently 
confirmed in other studies (J. Fleming, unpublished results), suggest 
that this tissue expresses the RBC 15-LOX mRNA.
4.2.4 GGGA3: a sequence motif present in the RBC 15-LOX promoter
and in upstream regions of a variety of other genes.
In addition to sequence motifs resembling TATA-like, CCAAT, 
CACCC, GGGCGG and CTF/NF-l-binding site which have been found in a 
variety of other genes, RBC 15-LOX flanking sequences also contain two
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short: direct repeats. One of these, a perfect decanucleotide repeat, 
contains a previously undescribed sequence element GGGAG (Fig. 14). 
This sequence element is also seen in the promoter regions of a 
variety of genes, including genes expressed in erythroid cells, and 
some which are not (Table II) . As discussed below, the distribution 
of GGGAG sequences shows several interesting features which may 
suggest that it represents a general transcription regulatory element.
The FBC 15-LOX promoter decanucleotide repeat contains one 
perfect and one imperfect copy of the GGGAG element in the 
arrangement, CGGAG(N) ^ GGGAG. Intriguingly, similar repeat 
arrangements are also seen in the mouse a-globin and human carbonic 
anhydrase III (CAIII) gene 5' flanking sequences (see Table II for 
references). In mouse a-globin, the arrangement is GGGAC(N)^GGGAG, 
while in the human CAIII gene, it is GGGAG (N) gGGGAG.
Multiple copies of the sequence GGGAG are also seen in the 
upstream sequences of mouse band 3 anion antiport and mouse ^-globin 
genes (Table II) . In the former, two copies of GGGAG are present as 
an inverted repeat separated by 47nt. One of the two copies in the 
mouse P-globin promoter region is conserved in an identical position 
in rabbit and human p-globin genes.
As well as its presence in the RBC 15-LOX promoter, GGGAG is 
also present in four tandemly repeated copies in one of the RBC 15-LOX 
introns (B. Thiele, personal communication). Interestingly, a 
conserved GGGAG motif is also present in the first intron of human and 
mouse erythropoietin genes (Table II) . The introns of the two 
erythropoietin genes show unusually highly-conserved sequences, and 
this sequence similarity has been suggested to imply some functional 
significance, perhaps the presence of an enhancer (Shoemaker and 
Mitstock, 1986) in a situation analogous to the enhancers present 
within the introns of immunoglobulin genes (Gillies et al, 1983; 
Banerji et al, 1983; Queen and Baltimore, 1983).
Of course, sequence comparisons are not sufficient, in 
themselves, to indicate that a sequence is of Importance for
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regulation of transcription. Further evidence must be obtained from 
DNA-protein interactions and from functional studies. Intriguingly, 
the decanucleotide repeat of the RBC 15-LOX promoter which contains 
the GGGAG motif lies just within the -150 to -40nt region shown here 
to be important for the up-regulation of a cis-linked CAT gene in 
murine cells (see Section 3.4.5). However, in initial in vitro DNasel 
protection studies using murine nuclear proteins (Section 3.3.2.1), 
the GGGAG motif does not appear to be protected by extracts from 
either erythroid or non-erythroid cells, as might have been expected 
if GGGAG were indeed a motif involved in the regulation of a wide 
variety of genes. Thus, at present, the possibility cannot be 
excluded that the presence of the GGGAG motif in the 5' flanking 
sequences of the various genes shown in Table II does not merely 
represent random occurrences of a short, pentanucleotide sequence, an 
occurrence which has a probability of occurring approximately once in 
every kilobase in a random sequence of the four deoxyribonucleotides.
Whether the GGGAG motif is important for basic promoter function 
can be investigated by further deletions of the -150 to -40nt region. 
Further functional dissection of the -40 to -150 region using the same 
system is also of interest in defining the minimal promoter necessary 
for up-regulation of transcription in this assay system. For example, 
do further promoter deletions removing the footprinted CTF/NF-l-like 
and/or CACCC motifs abolish expression of the cis-linked reporter 
gene?
4.2.5 A distal element which confers cell type-specificity upon
expression driven by the proximal element.
It has been demonstrated here that the RBC 15-LOX promoter 
sequences within 150nt of the transcription initiation site can 
respond to cis-regulatory sequences, either to the heterologous Friend 
Virus enhancer (Fig. 21), or to sequences from the -2700 to -lOOOnt 
region of RBC 15-LOX 5' flanking sequences which confer a 6 - to 8 -fold 
cell type-specific effect (Fig. 23) . It therefore seems likely that 
regulation of transcription may be at least one factor involved in the 
cell type-specific accumulation of RBC 15-LOX mRNA seen by Thiele et
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al (1987), and confirmed by SI and primer extension analyses and 
Northern blot hybridisation data presented here (Figs. 7, 8 , 10, 12
and 13) . It has thus become a matter of importance to establish 
whether transcriptional regulation is indeed important for control of 
RBC 15-LOX gene expression in rabbit erythroid cells. Nuclear run-on 
transcription experiments using isolated nuclei from an erythroid 
tissue such as rabbit foetal liver (see Section 4.2.3 above) are 
therefore essential in the immediate future. Further information as 
to the likely importance of transcription in the cell type-specific 
accumulation of the RBC 15-LOX mRNA will be provided by investigating 
whether there are cell type-specific DNasel HSS associated with the 5' 
flanking sequences of the RBC 15-LOX gene in erythroid and 
non-erythroid tissues. Work is currently in progress to investigate 
this possibility (J. Fleming, unpublished results) .
Thus far, the difference in level of expression conferred by the 
distal, -2700 to -lOOOnt, element has only been observed in erythroid 
and fibroblast-derived cell types. It is conceivable that the lower 
expression seen in STO cells is characteristic only of fibroblast 
cells, and not of other non-erythroid cell types. Other members of 
the LOX enzyme family are expressed in other cell types (see 
Introduction Section 1.5.1), including epithelial cells. If similar 
mechanisms of expression apply to all LOX genes, then other cell types 
might contain factors similar to those which permit higher levels of 
expression of pCAT-2700 in MEL cells than in STO cells. Analysis of 
expression from the pCAT-2700 recombinant is currently being 
investigated in other murine cell lines (J. O'Prey, unpublished 
results) . Data obtained thus far indicate that a similar effect to 
that seen with STO cells is also seen in an epithelial cell line.
4.2.6 Is the cell type-specific effect seen with the -2700 to -1000
region a positive or a negative effect?
The cell type-specific effect conferred upon CAT expression 
by 5' flanking sequences between 2700 and lOOOnt upstream of the RBC 
15-LOX gene results in a higher level of expression in MEL cells than 
in STO cells. The STO cells show a lower level of expression than
137
that obtained with the pCAT-150 recombinant which contains the minimal 
functional promoter (Fig. 23). The most straight-forward explanation 
of these observations would be that STO cells contain a negative 
regulatory factor which is absent from, or prevented from binding its 
cognate sequence, in MEL cells. However, pCAT-2700 contains 6.3kb of 
DNA, while pCAT-150 is only 3.8kb in size. There is some evidence 
that the size of transfecting plasmid has a non-cell type-specific 
effect upon transfection efficiency into both MEL and STO cells (J. 
Frampton, unpublished results) . Expression in MEL and STO cells of a 
recombinant CAT plasmid which contains 4kb of bacteriophage lambda 
sequences inserted downstream of the CAT gene in pooCATl (Fig. 17), 
shows an equivalent decrease in both cell types of CAT activity 
relative to that from the parent, paCATl, plasmid. Thus, an
alternative explanation of the cell type-specific effect seen with
pCAT-2700 may be that the effect of sequences between -1000 and -2700
is a positive effect seen only in MELC( cells, but which is masked by a
negative effect of plasmid size.
Competition experiments using sequences between -1000 and -2700 
could be used to investigate whether the cell type-specific effect is 
a MEL-specific positive or a STO-specific negative effect. A large 
molar excess of these sequences, not linked to a CAT gene, would be 
expected to increase expression from pCAT-2700 in STO cells if it is 
an STO-specific negative effect, by competing for binding of a 
negative regulatory factor. If, however, these sequences are involved 
in an MEL-specific positive effect, they would be expected to compete 
out a positive factor, resulting in a decrease in CAT expression in 
pCAT-2700 transfected MEL cells. Similar competition experiments were 
used to define a cell type-specific negative regulatory region between 
-334 and -253 of the human retinol-binding protein (RBP) gene 
(Colantuoni et al, 1987) following a similar set of experiments to 
those used in this project, employing RBP promoter-delet ion/CAT 
recombinants.
A resolution of this question may also be provided by further 
CAT expression experiments, using additional deletions of upstream 
sequences to more accurately localise sequences responsible for the
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cell type-specific effect. Having done so, it should be possible to 
investigate the effect of such sequences on RBC 15-LOX promoter 
function in smaller CAT plasmids.
4.2.7 Future analysis of the cell type-specific regulatory element.
Having localised the cell type-specific effect to within two 
or three hundred base pairs by functional analysis of further promoter 
deletion/CAT recombinants, a large number of experimental approaches 
can be adopted. Firstly, sequences involved in the binding of 
transcription factor proteins could be investigated by footprinting, 
preferably using rabbit nuclear extracts. Secondly, the 
tissue-distribution of proteins binding to these sequences could be 
rapidly assessed by electrophoretic mobility shifts with nuclear 
extracts from a variety of cell types, providing information upon 
whether the sequences involved in cell type-specific effects are 
recognised by cell type-specific binding activities. Thirdly, 
residues which are Important for the binding of the appropriate 
factor (s)- could be assessed either by mobility shift assays using 
oligos. containing point mutations relative to the RBC 15-LOX 
sequence, or by methylation interference footprinting studies to 
identify which methylated residues inhibit binding of the factor (s) .
It will be interesting to see whether such sequences include any 
sequences not previously associated with cell type-specific 
expression, or whether they include elements previously shown to bind 
cell type-specific nuclear proteins. Within the available 316bp of 
rabbit RBC LOX 5' flanking sequence, there is no apparent homology, in 
either orientation, with the GATAAG sequence (Section 1.4.3) present 
in the promoter and enhancer regions of a variety of globin and 
non-globin gene promoters, which binds an erythroid-specific protein 
(Mantovani et al, 1988b; Plumb et al, submitted for publication), and 
which has been suggested to be involved in the co-expression of a 
variety of genes in erythroid cells (Plumb et al, submitted for 
publication) . It will be of interest to discover whether there is a 
GATAAG motif within the RBC 15-LOX distal element.
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The identification of sequences involved in conferring cell 
type-specificity will allow an investigation of whether such
sequences, when linked to a reporter genes as synthetic
double-stranded oligos., are sufficient to confer cell
type-specificity upon expression from a minimal promoter, as is the 
case for the immunoglobulin octamer when linked to a region of the 
mouse renin-1 promoter containing only a TATA box (Dreyfus et al,
1987) . Furthermore, it should be possible to investigate whether the 
positioning of these sequences relative to other cis-acting regulatory 
elements in an artificial', "designer11 promoter has any effect upon 
expression, as has been suggested to be the case for the "enhanson" 
sub-units of enhancer elements, which appear to differ from intact 
enhancer elements in being more sensitive to alterations in spacing 
(Ondek et al, 1988).
4.2.8 Other cis-regulatory elements in the RBC 15-LOX gene?
In data presented here, the function of RBC 15-LOX upstream 
sequences in regulating expression of a cis-linked CAT gene from the 
RBC 15-LOX promoter has been investigated only using 5' flanking 
sequences and only in an erythroid cell line which represents a 
relatively immature stage of differentiation. Experiments to 
investigate whether RBC 15-LOX 5' flanking sequences contain 
regulatory elements which function only at certain stages in 
differentiation were commenced as part of this project, and have been 
continued by other members of the group. The design of these 
ejqperiments is analogous to those of Wright et al (1984) which 
investigated the expression of the rabbit p-globin gene in MEL cells 
upon induction of differentiation. For the study of RBC 15-LOX 
expression during MEL cell differentiation, the same RBC 15-LOX/CAT 
recombinants used in the transient expression experiments described 
here were stably introduced into the genome of MEL cells and 
transformants obtained by selection for a co-transfected 
G418-resistance plasmid (Homer 6 ; Spandidos and Wilkie, 1984b) . No 
results are yet available, however, for the expression of CAT activity 
from these RBC 15-LOX/CAT transformants prior to or following chemical 
induction of MEL cell maturation.
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The discovery of various 3' enhancers downstream of the 
transcription initiation site which play important roles in 
developmental and cell type-specific regulation of globin genes (Choi 
and Engel, 1986; Antoniou et al, 1988) raises the possibility that not 
all of the cis-acting sequences necessary for regulation of the RBC 
15-LOX gene are contained within the 5' flanking sequences. This 
possibility is supported by a set of experiments (J. O'Prey, 
unpublished results), in which RBC 15-LOX 3' flanking sequences have 
been linked downstream of the CAT gene in pCAT-150. A region between 
1.5 and 3.7kb downstream of the RBC 15-LOX polyadenylation signal 
confers a 2- to 3-fold cell type-specific effect upon expression of 
CAT in the transient assay system described here.
4.2.9 Regulation of the rabbit RBC 15-LOX gene in the intact
animal.
In the long-term, one would like to study the expression of 
the RBC 15-LOX gene, and of various recombinants containing 
modifications of regulatory sequences, in intact animals. One way to 
do this would be to investigate the expression of the RBC 15-LOX mRNA 
during erythroid differentiation in lethally-irradiated animals whose 
bone marrow has subsequently been repopulated by bone marrow cells 
infected in vitro by recombinant retroviral vectors containing RBC 
15-LOX sequences. Haemopoietic stem cells have been shown to be 
capable of repopulating bone marrow and expressing G418-resistance and 
human HPRT (hypoxanthine/guanine phosphoribosyl transferase) genes 
introduced by retroviral vectors, though only a proportion of the 
progeny of infected stem cells continue to express the G418-resistance 
gene (reviewed in Dick et al, 1986). Cone et al (1987) have further 
demonstrated that expression of the human (3-globin gene following 
infection of MEL cells with a retroviral vector containing globin 
sequences can be correctly regulated upon chemical induction of MEL 
cell differentiation.
Another method for studying RBC 15-LOX expression in a
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physiological situation would be the generation of transgenic animals. 
A variety of genes which are expressed in a cell type-specific 
fashion, including elastase, y-crystallin, protamine, albumin, 
immunoglobulin and T cell receptor genes have been studied in 
transgenic animals (reviewed in Jaenisch, 1988). The 
erythroid-specific, developmentally-regulated expression of the human 
{3-like globin genes has already been studied following introduction of 
the globin genes into the germ-line of the mouse. For example, 
transgenic mice have been used to demonstrate cell type-specific and 
developmentally-regulated expression of hybrid mouse/human (3-globin 
genes (Chada et al, 1985; Magram et al, 1985), and in the localisation 
of sequences regulating transcription, where Townes et al (1985) were 
able to obtain appropriate expression of the human (3-globin gene with 
as little as 48bp of 5' flanking sequences. Following this 
demonstration in transgenic animals of the importance of sequences
downstream of the transcription initiation site for the regulation of 
globin gene expression, Kollias et al (1987) have also used transgenic 
mice to localise at least part of the human f3-globin 3' enhancer to 
between 0.5 and 1.2kb downstream of the polyadenylation signal.
One of the problems with the use of retroviral infection and
transgenic technologies in the study of gene expression has been that 
the site of integration of the exogenous gene can have a strong
influence on the regulation of expression. For example, Nandi et al 
(1988) have observed that expression of the human (3-globin gene in 
MEL/human cell hybrids could be induced during differentiation when 
targetted to the recipient cell's (3-globin locus, but not when
randomly inserted. Two recent advances may facilitate the study of 
regulated expression of genes such as the RBC 15-LOX gene in erythroid 
cells of intact animals. Firstly, the ability to "target" genes to 
the appropriate chromosomal location by the technique of "homologous 
recombination" (Smithies et al, 1985), as employed in the targetted 
correction of HPRT deficiency in mouse embryonic stem cells 
(Doetschman et al, 1987), may reduce the problem posed by such 
chromosomal "position effects". Secondly, Grosveld et al (1987) have 
observed that the "domain boundary" sequences lying 50kb upstream and 
2 0 kb downstream of the human (3-globin gene can confer high-level,
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position-independent/ cell type-specific expression of the human 
^-globin gene in transgenic mice. It is unknown at present whether 
these domain boundary sequences are specific for (3-globin genes, or 
whether they will have a similar effect when linked to other genes. 
If the latter is the case, such sequences might be extremely valuable 
in obtaining efficient erythroid-specific expression of the rabbit RBC 
15-LOX gene in transgenic animals, allowing study of its regulation 
during erythroid differentiation by using various modified forms of 
the gene.
4.3 POSSIBLE ROLES FOR NON-CODING mRNA SEQUENCES IN CONTROL OF RBC
15-LOX EXPRESSION.
The cell type-specific effect conferred by sequences between 
-2700 and -lOOOnt upstream of the RBC 15-LOX transcription initiation 
site upon CAT expression driven from the RBC 15-LOX promoter has been 
suggested above (Section 4.2.5) to indicate that regulation of 
transcription may play a role in the observed erythroid-specific 
accumulation of RBC 15-LOX mRNA (Thiele et al, 1987; Figs. 7, 8 , 10,
12 and 13 above). However, until nuclear run-on transcription assays 
have been performed on nuclei isolated from rabbit tissues, there is 
as yet no firm evidence that there is erythroid-specific regulation of 
transcription from the RBC 15-LOX promoter. Although there is no data 
concerning events immediately following transcription of the RBC 
15-LOX mRNA it is conceivable that its erythroid-specific 
accumulation might also involve differential post-transcriptional 
regulation in erythroid and non-erythroid cell types, and that 5' and 
3 ' untranslated sequences might play a role in such 
post-transcriptional regulation. The untranslated sequences may also 
be candidates for the translational inactivation of the RBC 15-LOX 
mRNA observed in younger reticulocytes (Thiele et al, 1982; see 
Introduction, Section 1.6.4).
The mapping of the RBC 15-LQX transcription initiation site 
reported here (Section 3.2) indicates that the RBC 15-LOX mRNA 
contains a short 5' untranslated region of only 27nt. This finding 
may have implications for the translational inactivation and/or
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possible post-transcriptional regulation of the RBC 15-LOX mRNA. 
Examples of an involvement of 5' untranslated sequences in
translational control are known in a variety of other genes (reviewed 
in Hunt, 1985) . For example, in the case of the mRNA encoding the 
yeast GCN4 transcription factor protein, deletion from the unusually 
long 5' untranslated region of yeast GCN4 mRNA of four short
open-reading frames upstream of the authentic translation initiation 
codon almost completely abolishes the translational repression of the 
GCN4 messenger (Mueller and Hinnebusch, 1986) . This may be due to 
relief from interference with authentic initiation of translation
occurring in accordance with the scanning ribosome model (Kozak, 
1986). Furthermore, the insertion of multiple linker sequences 
capable of forming strong secondary structures into the 5'
untranslated region of the HSV thymidine kinase gene can result in a 
decrease in translation (Pelletier and Sonenberg, 1985) . The short 5' 
untranslated region of the RBC 15-LOX mRNA suggests that neither of 
these mechanisms is a realistic possibility for translational 
regulation of the RBC 15-LOX mRNA, though a mechanism for 
translational repression which involves the inhibition of translation 
by annealing of a single-stranded, "anti-sense" RNA to the 5' 
untranslated region, such as that seen when anti-sense globin mRNA was 
injected into frog oocytes (Melton, 1985), cannot be ruled out.
If the short 5' untranslated region of the RBC 15-LOX mRNA is 
not responsible for the translational inactivation seen by Thiele et 
al (1982), then it is possible that the 3' untranslated region may be 
involved. Recent cDNA sequence analysis (B. Thiele, unpublished 
results) of the 3' untranslated region of the rabbit RBC 15-LOX mRNA 
shows that the 575nt 3' untranslated region contains an array of ten 
tandem repeats of a 19nt C-rich sequence corresponding to the 
consensus CCCNNCCCTCTTCCCCAAG, beginning 50nt downstream of the TGA 
translation termination signal. It seems unlikely that such an 
arrangement could occur in an actively transcribed mRNA purely by 
chance, and no such sequence is seen in the 3' untranslated region of 
any of the other cloned LOXs.
There is, as yet, no indication as to whether these sequences
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are involved in the translational inactivation of the RBC 15-LOX mRNA. 
However, it will be interesting to see whether removal of some or all 
of the 10 repeats alters the translation of the RBC 15-LOX mRNA in 
extracts made from rabbit reticulocytes at various stages of 
maturation, or, conversely, whether insertion of these sequences into 
the 3' untranslated region of another mRNA results in translational 
inhibition. It is intriguing to note that Thiele et al (1982) have 
observed an association in reticulocytes of some, but not all, of the 
RBC 15-LOX mRNA population with messenger ribonucleoprotein (mRNP) 
particles, separated from polysomes by sucrose density-gradient 
centrifugation. mRNA within these particles was translationally 
inactive in a cell-free reticulocyte lysate translation system, but 
deprotein^sat ion of the mRNPs permitted in vitro translation of 
authentic RBC 15-LOX protein, v It will be of interest to see whether 
removal of the repeat sequences from the RBC 15-LOX mRNA, or their 
insertion into a non-LOX mRNA results in an alteration in the
distribution of the mRNA between polysomes and the mRNP population.
An alternative possibility is that the repeated sequences might 
be involved in the cell type-specific accumulation of the RBC 15-LOX
mRNA, perhaps by influencing the stability of the messenger in
erythroid and non-erythroid cells, for example. There is accumulating 
evidence for the importance of 3' untranslated sequences in the
determination of mRNA stability (reviewed in Raghow, 1987) . For 
example, a 51nt A/T-rich sequence from the 3' untranslated region of 
the mRNA of the human lymphokine, granulocyte/ macrophage 
colony-stimulating factor (GM-CSF), which includes an AUUUA motif also 
seen in the 3' untranslated regions of various lymphokines, cytokines 
and proto-oncogenes, has been shown to have destabilising effects when 
introduced into the 3' untranslated region of globin mRNAs (Shaw and 
Kamen, 1986) . 3' untranslated sequences have also been suggested to
be involved in the rapid degradation of the c-fos mRNA, following 
transient transcription of the gene (Treisman, 1985).
An intriguing experimental possiblity would be to insert the 
repeated sequences of the RBC 15-LOX mRNA into the 3' untranslated 
regions of mRNAs which are usually unstable, to examine whether the
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presence of the repeats confers a decrease in mRNA stability in
erythroid cells, or whether, in complementary experiments, insertion
into the 3' untranslated region of an unstable messenger results in
selective stabilisation in erythroid cells.
4.4 AN EVOLUTIONARY RELATIONSHIP BETWEEN THE LIPOXYGENASES.
Data presented here includes a region of the rabbit RBC 15-LOX 
gene which accurately predicts the first 30 amino acids of the rabbit 
RBC 15-LOX protein (Thiele et al, 1987) . An alignment of this protein 
sequence with the N-terminal sequence of the human leukocyte 5-LOX as 
predicted from CDNA sequences (Dixon et al, 1988; Matsumoto et al,
1988) and with the peptide sequence of a 5-LOX from rat basophilic 
leukaemia cells (Hogaboom et al, 1986) is shown in Figure 24. As 
noted by Dixon et al (1988), and by Matsumoto et al (1988), the human 
and rat N-terminal sequences are virtually identical, showing the same 
amino acids at 28 of the first 30 residues. The rabbit RBC 15-LOX, 
however, shows identity with the human 5-LOX at only 11 of the first 
30 amino acid residues (37% homology) with a further 6 residues 
showing "conservative" changes. The greater divergence of rabbit from 
human and rat sequences may represent different evolutionary pressures 
operating on enzymes which differ in their positional specificity, 
rather than a cross-species difference.
Dixon et al (1988) have noted similarities of different regions 
of the human 5-LOX protein with the predicted partial amino acid 
sequence of RBC 15-LOX (Thiele et al, 1987) and with another 15-LOX, 
the soybean LOX-1 isozyme (Shibata et al, 1987) . Yenofsky et al 
(1988) have further observed 70% amino acid homology between three 
soybean isozymes. Although not yet completely sequenced, 
recently-obtained cDNA clones covering the full length of the RBC 
15-LOX mRNA (B. Thiele and J. Fleming, unpublished results) allow a 
more detailed comparison of LOX protein sequences from these three 
species, and provide some clues as to the evolution and 
structure-function relationships of the LOXs. An alignment of the 
incomplete RBC 15-LOX protein sequence with the sequences predicted by 
the soybean LOX-3 gene and human leukocyte 5-LOX cDNA sequences is
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shown in Figure 24, and schematically in Figure 25.
The predicted RBC 15-LOX amino acid sequence shows three regions 
of significant homology, designated C, D, and E in Figures 24 and 25, 
with those of the soybean and human proteins. When these three 
regions are aligned in each of the three proteins, the soybean protein 
appears to contain an N-terminal region (A) of 135 amino acids which 
is not present in either the human of ' rabbit proteins. There is 
limited homology between soybean and human proteins over the first 364 
amino acids of the human protein (region B) . Other than the 
N-terminal sequence, RBC 15-LOX peptide sequence is not yet available 
for this region.
Of the regions for which amino acid sequence is available in all 
three proteins, regions C and E, which are well conserved between all 
three species, are separated by a region, D, which does not seem to be 
strongly conserved between the plant and mammalian enzymes, but is 
strongly conserved between the human and rabbit LOXs (Figure 25) .
Within regions C, D and E, the degree of conservation between 
soybean LOX-3 and human 5-LOX sequences, and between human 5-LOX and 
rabbit 15-LOX sequences are very similar (Figure 25), but the degree 
of homology between rabbit and soybean is less than that between human 
and soybean in all cases, especially in region E. This would seem to 
indicate that the evolutionary divergence between soybean and human 
LOXs is less than that between the soybean and rabbit enzymes. This 
might be attributed to different selection pressures operating during 
evolution on LOXs having different positional specificities. 
Intriguingly, a study of the 3' untranslated region of the soybean LOX 
isozymes (Yenofsky et al, 1988) has shown that LOX-1 and LOX-2 are 
more closely related to each other than either is to LOX-3. Yet the 
enzymic properties, including positional specificity, of LOX-2 are 
more similar to LOX-3 than to those of LOX-1. Thus, the rate of 
evolution of LOX genes in soybean does not seem to reflect their 
positional specificity. It may, therefore, reflect different 
biological functions. While the physiological functions of the 
soybean LOX isozymes is incompletely understood (see Introduction
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Section 1.5.2), the widely different functions of human 5-LOX and 
rabbit 15-LOXs, in leukotriene synthesis and mitochondrial degradation 
respectively, lend support to this idea.
The conservation of regions of LOX proteins from plants to 
mammals may suggest that these sequences are of functional importance, 
perhaps forming part of the catalytic site. In fact, Dixon et al 
(1988) have noted that the portion of the human 5-LOX protein sequence 
within region C is related to the interface-binding domain of human 
and rat lipases, suggesting that the mechanism of interaction of LOX 
and lipase enzymes with their substrates may be similar. There is no 
homology, however, between the available LOX protein sequences and the 
protein sequences predicted by the recently-published cDNA sequence of 
the sheep seminal vesicle cyclo-oxygenase (Marlie et al, 1988), whose 
main substrate, arachidonic acid, is also oxidised by all of the LOXs 
discussed here.
Whatever their function, the conservation of these three 
extended regions of protein sequence homology over such long periods 
of evolutionary time would seem to suggest that these three members 
of the LOX enzyme family, at least, are encoded by an 
evolutionarily-related family of genes rather than being the result of 
convergent evolution towards a common function.
4.5 FUTURE DIRECTIONS.
The rabbit erythroid-specific RBC 15-LOX gene thus presents 
several interesting avenues for further research. Firstly, the 
continuation, as outlined in Section 4.2 above, of the investigation 
begun here into the importance of transcription in the 
erythroid-specific accumulation of RBC 15-LOX mRNA, and further 
localisation of the regulatory signals involved. Secondly, to study 
whether the repeated region within the 3' untranslated region of the 
RBC 15-LOX mRNA. plays a part in post-transcriptional regulation of RBC 
15-LOX expression: either by influencing the erythroid-specific
accumulation of the mRNA by cell type-specific effects upon a 
post-transcriptional event; or by playing a role in the translational
148
inactivation of RBC 15-LOX mRNA translation seen in younger 
reticulocyte populations. Finally, comparison with the products of 
other LOX genes may provide important information concerning 
structure-function relationships in the LOX enzymes, including the 
nature of the catalytic site, and the basis for the different 
positional specificities of the various members of the LOX enzyme 
family.
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